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Abstract 
Recent studies have demonstrated a key role for platelets and microthrombi in the 
pathophysiology of intestinal ischaemia-reperfusion (IR) injury.  Mechanistic studies have 
identified a role for the coagulation pathway in regulating platelet recruitment and 
activation.  In addition, recent evidence suggests a role for the subendothelial matrix in 
mediating platelet activation in IR injury. Endothelial cells are extremely susceptible to 
ischaemia and their detachment, as well as damage to the basal lamina, has been 
demonstrated following IR injury.  The research described in this thesis investigates the 
role of the major platelet glycoprotein receptors in recruiting and activating platelets 
following intestinal IR injury, namely GPVI, GPIb-IX-V and the integrins IIb 3 and 2 1.  
The role of the intracellular protein PLC 2 was also determined.  Remote organ injury to 
organs such as the liver and lungs is also frequently associated with intestinal IR injury.  
Therefore the contributory role of platelets in remote microcirculatory injury has also 
been determined. Intravital microscopy was utilised to monitor individual platelet 
adhesion and microthrombus formation in anaesthetised mice undergoing intestinal IR 
injury in vivo using a novel dual labelling methodology. This method allowed us to 
quantitate three platelet events: (i) microthrombus formation (ii) individual platelet 
adhesion to endothelium and (iii) free flowing platelets.  This study focussed on the 
microcirculation of the mucosal villi as this luminal surface is most susceptible to IR injury.  
Microthrombi development played a critical role in the pathophysiology of intestinal IR 
injury through their involvement in microvessel re-occlusion. This event was inhibited by 
targeting GPIb , which conferred a short-lived benefit to the gut.  However, we further 
demonstrated that it was necessary to inhibit both microthrombus formation as well as 
platelet-leukocyte-endothelial interactions in order to ensure longer lasting improvement 
in gut microcirculation and histology. This was achieved through a dual therapy that 
targeted both GPIb  and P-selectin.  No benefit was observed with blocking GPVI or 2 1 
or the IIb 3 integrin.  Interestingly, inhibiting PLC 2 was associated with a decrease in 
individual platelet adhesion. Overall, the research within this thesis suggests that 
therapeutic strategies targeting GPIb  and P-selectin may prove beneficial in improving 
the clinical morbidity associated with gut IR injury.  
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1.0. Introduction – the role of platelet receptors in intestinal ischaemia-reperfusion 
injury in vivo 
         
1.1.1 Intestinal ischaemia-reperfusion (IR) injury 
Hypoxia refers to any state of reduced oxygen availability. It maybe caused by reduced 
amounts or saturation of haemoglobin. Ischaemia is the withdrawal of blood flow to a tissue 
or organ which causes a deprivation of oxygen and nutrients required to keep internal 
structures in a healthy state. In contrast to hypoxia, during which glycolytic energy 
production can continue, ischaemia compromises the delivery of substrates for glycolysis. 
Consequently, in ischaemic tissues, anaerobic energy generation stops after glycolytic 
substrates are exhausted, such as adenine triphosphate ATP. This inevitably leads to 
glycolytic function becoming inhibited by the accumulation of metabolites that would have 
been removed otherwise by blood flow. For this reason, ischaemia tends to injure tissues 
faster than does hypoxia.  
Ischemia-reperfusion (IR) injury is the damage that occurs to tissues after the restoration of 
blood flow (reperfusion) to an area that had previously experienced deficient or no blood 
flow (ischaemia).  This is the most common type of cell injury in clinical medicine and has 
been studied extensively in humans and experimental animals 
IR injury of the small intestine is associated with several inflammatory pathologies where 
reduction in gut perfusion is followed by reperfusion e.g. shock, vasculitis, strangulated 
hernias and neonatal necrotizing enterocolitis (Carden et al., 2000;  Kong et al., 1998).  It also 
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results from a number of surgical procedures, including thoracoabdominal aorta aneurysm 
repair and cardiopulmonary bypass (Harward 1996; Kharbanda 2006).  Small intestinal IR 
injury is also an inevitable consequence of the clinically challenging procedure of small bowel 
transplantation which continues to be beset with high rates of graft loss, rejection and an 
overall poor prognosis (Fishbein 2009).  Although long-term survival of the intestinal 
transplant is hampered by chronic rejection, it is now becoming apparent that the initial IR 
injury the graft endures can also adversely influence the short- and long-term survival of the 
graft.  Indeed, studies have demonstrated that early events such as graft preservation and IR-
induced tissue damage contribute significantly to the development of the rejection process 
(Wang et al., 2003).   
 
Although rare (1-2 cases in every 1000 hospital admissions) acute intestinal ischaemia is also 
a clinical problem in its own right due to its associated high mortality rate.  Indeed, there 
have been no convincing reports of any significant improvement in the prognosis of this 
condition over the last 50 years (Endean et al., 2001).  The underlying causes of acute 
intestinal ischemia are either thrombotic (eg. mesenteric venous thrombosis) or non-
thrombotic (eg. sepsis, hypovolemia, strangulated hernia). The treatment for this condition is 
revascularization and resection of the affected bowel (Foley et al., 2000).  However, this is 
only affective if acute intestinal ischemia is diagnosed within 12 hours from the onset of 
symptoms with the benefits of surgery decreasing by 70% after 24 hours.   
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1.1.2. Histological disturbances associated with intestinal IR injury 
The intestinal luminal or mucosal surface is folded into numerous microscopic finger-like villi 
that increase the absorptive surface area to ensure adequate nutrient absorption.  Intestinal 
IR injury not only reduces the overall absorptive capacity, but also disturbs the integrity of 
the mucosal surface (Chen et al., 2005).  This leads to loss of barrier function of the gut lining 
and thus permits bacterial translocation across the epithelial surface and into the 
bloodstream (Jones et al., 1991).  Bacterial translocation, and the subsequent sepsis that 
ensues, is a major clinical problem associated with intestinal IR injury with a reported 44% of 
paediatric patients showing microbiological complications after small bowel transplantation 
(Cicalese, 2000). Indeed, this event is one of the major causes of the poor morbidity and 
mortality associated with intestinal IR injury.  Therefore, it is essential that the barrier and 
absorptive function of the mucosal surface is not compromised.   
 
Unfortunately, the intestinal mucosal villi are extremely sensitive to IR injury and even short 
durations of ischemia can elicit substantial localised tissue injury (Kalia et al., 2002 & 2003 & 
2005; Chan et al., 1998; Blikslager et al., 2007).  The outer submucosal, muscular and serosal 
layers often undergo minimal damage with injury confined mostly to the villus structures.  As 
the duration of IR injury increases tissue damage becomes apparent, starting at the tips of 
the villi (superficial mucosal injury) and proceeding to full villous destruction (transmucosal 
injury). In very severe circumstances, IR injury can lead to the complete destruction of the 
villi as well as damage to the underlying crypts within the submucosa (transmural injury) 
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(Haglund, 1994).  Intestinal stem cells, that continually replace the villous epithelial cells on a 
daily basis, are located within the base of these crypts of Lieberkühn.  Therefore, although 
mild mucosal injury can be repaired by these stem cells, severe injury which damages the 
crypts means the regenerative potential of the mucosa is also lost  (Zmora et al., 2005). 
Evidence suggests that different areas of the small intestine have the ability to cope with IR 
injury better than others, although it is not clear why this is the case (Boyd et al., 1994).  
Chan and colleagues demonstrated that after segmental transplantation, healthier mucosal 
tissue was observed in the more distal ileum rather than the more proximal jejunum (Chan et 
al., 1998). 
 
1.1.3. Microcirculatory disturbances associated with intestinal IR injury 
Within the mucosal villi, a central arteriole passes up to the villus tip and then breaks into a 
capillary network that flows down the villus as a plexus that can exchange with the artery on 
the way its way up (Chen et al., 2003). However, this peculiar microvascular anatomy makes 
the villus tip highly susceptible to injury during periods of low blood flow as oxygen diffuses 
to the venule at the base of the villus before reaching its tip (Figure 1).  Hence, if blood flow 
is compromised, as during intestinal IR injury, the mucosal villus is the most susceptible to 
damage (Haglund 1994; Figueiredo et al., 2002.).  This microvascular anatomy suggests that 
mucosal injury should occur predominately during an ischaemic period.  However, early 
seminal studies demonstrated that the mucosal injury produced by 3 hours of ischaemia 
followed by 1 hour of reperfusion was more severe than that produced by 4 hours of 
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ischaemia without reperfusion (Parks and Granger, 1986).  This phenomenon, known as 
intestinal IR injury, clearly demonstrates that restoration of blood flow is paradoxically 
associated with greater injury than ischaemia alone. 
There are a number of microcirculatory disturbances that are generally associated with IR 
injury and these also occur within the small intestine.  The generation of reactive oxygen 
species (ROS), activation of inflammatory neutrophils and the release of damaging 
proteolytic enzymes including elastase from them, are amongst the most damaging events to 
take place during IR injury (refer to Sections 1.2 and 1.3).   
Due to their close anatomical association with the endothelial lining of the microvessels, it is 
no surprise that the first structure within the ischaemically-reperfused tissue to undergo 
injury is the local microcirculation.   Lysis of endothelial cells (ECs) and damage to underlying 
basement membrane leads to vascular albumin leakage (Welbourn et al., 1991).  This also 
occurs as a result of surrounding mast cell degranulation and subsequent histamine release, 
which increases the permeability of the microvessels (Kalia et al., 2005).  Seminal intravital 
studies by Kalia and colleagues demonstrated in vivo increased vascular leakage of 
fluorescently labelled albumin from the rat mucosal villous microcirculation following 
intestinal IR injury, which was directly proportional to the severity of injury (Kalia et al., 2002 
& 2003 & 2005). Furthermore, these studies demonstrated that, although a number of 
pharmacological interventions could confer tissue protection by preventing neutrophil 
recruitment, it was very difficult to maintain mucosal microvessel integrity as leakage was 
never completely inhibited.  An extensive loss of fluid from the microcirculation leads to 
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oedema and this is often associated with red blood cell congestion and blood flow stasis.  
Recruitment of inflammatory cells following IR injury also further contributes to vascular 
stasis.  These effects quickly become pronounced enough in reperfusion to block the 
microcapillaries entirely and this phenomenon, known as the no-reflow phenomenon, 
unfortunately further exacerbates the initial ischaemic injury.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.1  Countercurrent exchange of oxygen between the arteriole and venule within 
the villi, showing the progressive decrease in arteriolar PaO2.  Intestinal mucosal cells are 
normally under a low oxygen tension, because effective haematocrit within the villi is 
decreased due to a phenomenon called “plasma skimming”.  Also, the villi have a peculiar 
microvascular architecture, characterized by a countercurrent exchange of oxygen from 
arteriole to adjacent venule along its length. Under normal conditions, this shunting of 
oxygen is not harmful to the villi. However, in conditions in which blood flow to the gut 
becomes greatly reduced curtailed, such as in circulatory shock, the oxygen deficit in the tips 
of the villi can become so severe that they can suffer ischemic death and disintegrate.  Taken 
from de Figueiredo et al., 2002. 
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1.1.4. Remote organ injury following intestinal IR injury  
In addition to localised injury, the intensity of inflammation in post-ischaemic intestinal tissue 
can be so severe that reperfusion related responses can also manifest in distant organs 
(Simpson et al., 1993).  This is a common sequel of intestinal IR injury and is one of the most 
investigated subjects in experimental surgery as it accounts for a high proportion of the 
morbidity following intestinal IR injury (Granger 1999).  These systemic effects are bought 
about predominantly by circulating neutrophils that became ‘primed’ or activated when they 
circulate through the injured gut microcirculation and are thus able to induce injury in 
remote sites (Victoni et al., 2010).  Increasing evidence has associated intestinal IR injury with 
the development of remote tissue damage, particularly to the lungs and liver (Chen et al., 
2003; Simpson et al., 1993).  Simpson and colleagues demonstrated that within 4 hours of 
intestinal reperfusion, increased neutrophil accumulation within these two remote sites 
contributed to their damage.  A lack of neutrophils decreased the pulmonary microvascular 
permeability by 80% and the liver injury by 60%.  Interestingly, in this study, the local injury 
to the mucosal villi was unaffected in neutropenic mice, suggesting factors in addition to 
inflammatory neutrophils could also induce injury (Simpson et al., 1993).   
 
1.2. Reactive oxygen species (ROS) contribute to ischaemia-reperfusion injury 
Generally, IR injury starts by affecting cell metabolism and ultimately leads to cell death via 
apoptosis and necrosis (Wiegele et al., 1998).  Ischaemia is the withdrawal of blood flow to a 
tissue or organ which causes a deprivation of oxygen and nutrients but also compromises the 
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removal of waste products of metabolism.  In contrast to hypoxia, during which glycolytic 
energy production can continue, ischaemia compromises the delivery of substrates for 
glycolysis and hence adenosine triphosphate (ATP) production decreases. Consequently, in 
ischaemic tissues, anaerobic energy generation stops after glycolytic substrates are 
exhausted.  During this ischaemic period, ATP is catabolized to adenosine which is further 
catabolised to yield an increasing amount of hypoxanthine (Figure 2).  Concomitantly, 
ischaemia also leads to an influx of calcium ions (Ca2+), which triggers the very rapid and 
irreversible conversion of xanthine dehydrogenase, highly prevalent within the small 
intestine, to xanthine oxidase (Engerson et al., 1987; Racasan et al., 2003).  
 
During reperfusion, molecular oxygen is reintroduced into the tissue via the blood.  Along 
with xanthine oxidase, it reacts with hypoxanthine to produce a burst of very  
toxic reactive oxygen species (ROS), including superoxide anions (O2
-), hydroxyl radicals (OH-), 
hydrogen peroxide (H2O2) and nitric oxide-derived peroxynitrite.  These highly reactive and 
toxic ROS initiate lipid peroxidation of cell membrane components (Moore et al., 1995).  This 
is evidenced by the presence of increased intestinal fatty acid binding protein, a marker of 
cell damage, within circulating blood following IR injury (Derikx et al., 2008).  Hence a 
number of pharmacological agents may be of benefit during IR injury including allopurinol, a 
xanthine oxidase inhibitor and superoxide dismutase, a free radical scavenger. 
Furthermore, a pro-inflammatory environment is also generated by local endothelial up-
regulation of adhesion molecules and release of pro-inflammatory mediators.  This results in 
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Figure 1.2.  Generation of reactive oxygen species (ROS) occurs following events that take 
place during the ischaemic and reperfusion phases.  During ischemia, ATP is degraded to 
hypoxanthine and xanthine dehydrogenase is converted to xanthine oxidase. If perfusion is 
re-established, oxidative free radicals are formed.  Hence a number of pharmacological 
agents may be of benefit during IR injury including allopurinol, a xanthine oxidase inhibitor 
and superoxide dismutatse, a free radical scavenger.  ATP, adenosine triphosphate; ADP, 
adenosine 5'-diphosphate; AMP, adenine monophosphate.  Adapted from Mallick et al., 
2004. 
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the attraction, activation and adhesion of leukocytes to the endothelium, which 
subsequently play a key role in intensifying the initial cell injury caused by ischaemia and 
cause further EC injury via the release of superoxide and various proteases (Pierro et al., 
2004).   
 
1.3. The role of leukocytes in intestinal IR injury 
The main function of leukocytes is to protect the body from foreign bodies such as bacteria 
or parasites. Leukocytes can be separated into the two distinct groups of polymorphonuclear 
leukocytes (PMN’s) or mononuclear leukocytes. PMN’s, neutrophils in particular, are 
reported to be the major player in exacerbation of tissue injury not only following intestinal 
IR injury, but also in similar injuries of the numerous other organs including the heart, liver, 
kidney and lungs (Kochanek et al., 1992). Reperfusion is associated with elevated circulating 
levels of a number of cytokines, particularly tumour necrosis factor-  (TNF ), interleukin 1 
(IL-6) and IL-8, the eicosanoids leukotriene B4 (LTB4) and thromboxane B2 (TxB2), endothelin 
1 (ET-1) and platelet activating factor (Simpson et al., 1993).  All of these are powerful 
chemoattractants and chemoactivators of neutrophils which work by activating the local ECs.  
Thus the reperfused intestine is associated with a massive influx of neutrophils which 
contributes to the mucosal and microcirculatory barrier dysfunction and exacerbates the 
tissue damage from the previous ischaemic episode (Granger et al., 1989; Carmody et al., 
2004).  Furthermore, these soluble factors can also work in concert narrowing the capillary 
lumen and elevating blood flow resistance to impair perfusion within the microcirculation.   
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The process of leukocyte recruitment and subsequent migration through activated 
endothelium is defined by a well characterised adhesion cascade (Figure 3).  It begins with 
leukocyte tethering or rolling on the vessel wall using leukocyte L-selectin and/or endothelial 
P- and E-selectins binding to P-selectin glycoprotein ligand-1 (PSGL-1) and other glycosylated 
ligands such as E-selectin ligand-1 (Ley et al., 2007). This rolling slows leukocyte velocity 
sufficiently to permit their subsequent firm arrest on activated ECs.  This is mediated by the 
binding of leukocyte 1 and 2 integrins such as VLA-4, LFA-1 (CD11a/CD18) and Mac-1 
(Cd11b/CD18) with endothelial immunoglobulin superfamily members such as ICAM-1 and 
VCAM-1. L-selectin has also been shown to be critical in recruiting other leukocytes to the 
endothelium through leukocyte/leukocyte rolling interactions (Mitchell et al, 2000).  During 
inflammation, ECs are activated by inflammatory cytokines to express these adhesion 
molecules and also synthesise chemokines that are then presented on their luminal surface.  
Chemokines can modulate the affinity of leukocyte integrins which subsequently leads to 
firm leukocyte adhesion.  This is achieved through surface clustering of integrins, the 
induction of their transition from a bent low-affinity conformation to an extended high-
affinity conformation or from increased expression from endothelial Wiebel-palade bodies 
(Oynebraten et al, 2004).  Leukocyte transmigration through venular endothelial junctions is 
the least characterised stage of the adhesion cascade and is mediated by endothelial 
junctional adhesion molecules (JAMs). It is well reported the adhesion molecules ICAM-1, 
VCAM-1, CD99 and platelet-endothelial cell adhesion molecule-1 (PECAM-1) play a key role in 
this transmigratory mechanism (Ley et al., 2007).  Once activated, leukocytes release a  
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Figure 1.3. Leukocyte recruitment to IR activated endothelium under flow conditions.  The 
leukocyte initially interacts with the endothelium via the selectins and associated ligands. 
This generates the release of chemokines and the following leukocyte activation. Strong 
adhesion to the endothelium, through integrin interactions, then allows for transmigration of 
leukocytes into the extracelluar matrix and surrounding tissue. Redrawn from Panes et al., 
1998 
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variety of factors that are capable of damaging the surrounding endothelium, extracellular 
matrix proteins and the tissue parenchyma. 
 
1.4. The role of platelets in intestinal IR injury 
 
1.4.1 Platelets in haemostasis and disease 
Platelets are discoid shaped cells with a diameter of between 0.5 and 3μm. They are 
produced by cytoplasmic fragmentation of precursor megakaryocytes found within the bone 
marrow. The major physiological role of circulating platelets in the vasculature is prevent 
blood loss at sites of vessel injury through the formation of platelet plugs or thrombi (Becker 
et al., 1976).  The pathophysiological effects of thrombus formation become apparent when 
too much or unnecessary platelet activation and recruitment occurs which can lead to the 
formation of an oversized thrombus that has the ability to fully occlude the injured vessel 
(Varga-Szabo et al., 2008).  This obliterates the flow of blood downstream from the site of 
injury causing cell and tissue death. This is the typical underlying mechanism leading to the 
cardiovascular complications of myocardial infarction and stroke (Stoll et al., 2008).  
As previously stated, it is now well established that reperfusion initiates injury by triggering 
extensive leukocyte-endothelial interactions following ROS synthesis.  In addition, increasing 
evidence has implicated platelets as potential modulators of IR-induced tissue injury and re-
occlusion of microvessels in a variety of tissue beds as a consequence of ROS and pro-
inflammatory chemokine release (Gawaz et al., 2004; Kupatt et al., 2002; Xu et al., 2005; 
Singbartl et al., 2001; Khandoga et al., 2002 & 2003; Hackert et al., 2005; Ishikawa et al., 
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2003; Salter et al., 2001; Kalia et al., 2001). Indeed, an important feature of organ failure 
development following intestinal IR is the abundance of platelet-rich intravascular 
microthrombi observed in mucosal and submucosal microvessesls (Salter et al., 2001; Kalia et 
al., 2001; Massberg et al., 1999) (Figure 4).  Moreover, a beneficial effect of platelet 
depletion on IR injury pathogenesis has been described (Cooper et al., 2003; Kuroda et al., 
1994 & 1996). 
 
 
 
 
Figure 1.4.  Platelet thrombi formation following intestinal IR injury.  (a) Formation of large 
leukocyte-platelet aggregates (arrows) within the base of the villous microcirculation 
following rat intestinal IR injury – taken from Kalia et al., 2001  (b) Formation of platelet 
aggregates (arrow head), identified by intense staining for P-selectin, within the mouse 
intestinal venule – taken from Massberg et al., 1999. 
Intestinal IR injury is associated with significant recruitment of rolling and adherent platelets 
in post-capillary venules (PCVs; Massberg et al. 1998).  It is postulated that this may 
significantly aggravate EC damage and contribute to leukocyte recruitment at the site of 
injury.  Indeed, studies of IR injury in the heart (Gawaz et al., 2004; Kupatt et al., 2002; Xu et 
al., 2005), kidney (Singbartl et al., 2001) and liver (Khandoga et al., 2002 & 2003) 
demonstrate that accumulation of platelets in the microcirculation during reperfusion 
enhances recruitment of activated leukocytes, thereby exacerbating the intensity of the 
inflammatory response.  Furthermore, IR-induced recruitment of leukocytes may be 
a b 
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dependent on the initial adhesion of platelets to venular endothelium (Massberg et al. 1998; 
Cooper et al., 2004).   
 
1.4.2. Platelets contribute to intestinal IR injury via interactions with intact endothelium 
Platelet thrombi are able to form when ECs lining the blood vessels, become damaged 
following vessel injury.  This subsequently exposes underlying pro-thrombogenic extracellular 
matrix (ECM) proteins to platelets.  This process will be described later (refer to Section 1.5).  
However, in recent years it has become increasingly evident that endothelial denudation is 
not an absolute pre-requisite to allow platelet attachment to the arterial wall (Roberts et al., 
2004).  The intact, non-activated endothelium normally prevents platelet adhesion to 
underlying ECM and controls platelet reactivity through inhibitory and modulating 
mechanisms involving nitric oxide, COX-2 and PGI2.  However,  damaged or inflamed ECs 
develop properties that render them adhesive for platelets (Massberg et al. 1998 & 1999; 
Frenette et al., 1998; Tull et al., 2006, van Gils et al., 2009).   
 
The most extensively studied stimulus for platelet adhesion to endothelium is IR injury 
(Singbartl et al., 2006; Cooper et al., 2003; Kleinschnitz et al., 2007; Takaya et al., 2005) and 
following intestinal IR injury, rolling and adhesion of platelets in post-PCVs is observed 
(Massberg et al. 1998).  Although the adhesion receptors involved in platelet attachment to 
the subendothelial matrix have been well defined during the past decade (refer to Sections 
1.5.2 and 1.5.3), the molecular determinants that promote platelet-endothelial interactions 
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are incompletely understood (Figure 5).   However, the limited studies to date investigating 
the role of platelets following intestinal IR injury have focused on platelet interactions with 
an intact endothelium.  Unlike leukocyte-endothelial interactions, which are generally 
confined to PCV’s , platelet-endothelial interactions can also occur in arterioles.  Arterioles 
are the blood supplying vessels of a tissue and so platelets, through arterio-occlusion, can 
contribute to poor tissue perfusion following IR injury (Roberts et al., 2004).  After 
stimulation with endotoxin, IL-1 or TNF , ECs synthesize tissue factor and bind soluble 
fibrinogen on their surface and thereby promote thrombosis (Frenette et al., 1998).  
Alternatively, stimulation of ECs with a combination of TNF  and TGF  can lead to exposure 
of von Willebrand factor (vWF) on their surface and thus platelet adhesion (Tull et al., 2006).  
Significantly, increases in these prothrombotic proteins are associated with blood flow stasis 
and reduced flow, conditions that occur following IR injury (Salter et al., 2001; Schoots et al., 
2003; Mackman et al., 2003).   
 
1.4.3. Endothelial P-selectin primarily mediates platelet-endothelial interactions following 
IR injury 
Most attention has been devoted to defining the role of P-selectin, an adhesion molecule 
stored in both platelet -granules and endothelial Weibel-Palade bodies, in supporting 
platelet adhesion to ECs.  P-selectin is minimally (or not all) expressed on resting platelets.  
Following platelet activation it can be swiftly transported to the cell surface and play a role in 
platelet recruitment to injured vessels (Merten et al., 2000). In their activated state there are 
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approximately 10,000 molecules of P-selectin present on the platelet surface (Hsu-Lin et al., 
1984).  Massberg and colleagues demonstrated increased platelet-endothelial interactions 
within 5 minutes post-reperfusion in mice undergoing intestinal IR injury which was 
dependent upon P-selectin (Massberg et al, 1998).  It is well documented that endothelial, 
rather than platelet P-selectin plays a greater role in the initial rolling of platelets to 
endothelium in vessels of medium and high shear stresses (Michelson 2007). Indeed 
Massberg and colleagues also demonstrated that endothelial P-selectin was the main 
mediator since P-selectin-deficient platelets injected into wild-type mice could still adhere 
but platelet recruitment was reduced when wild-type platelets were injected into P-selectin-
deficient mice (Massberg et al. 1998).   
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Figure 1.5. Molecular adhesive mechanisms that govern platelet adhesion to endothelium.  
Platelet adhesion to endothelium primarily involves surface expression of P-selectin on 
activated platelets and binding to PSGL-1, the counter-receptor present on endothelium.  The 
ligand-receptor combinations P-selectin, PSGL-1 and GPIb are involved in the tethering and 
rolling of platelets on the EC. Upon activation of integrins, platelets firmly adhere to the 
endothelium, mainly via the additional bridging molecules fibronectin, fibrinogen and vWF. 
Upon firm adhesion, also CD40L-CD40 (amongst others) interactions are initiated with this 
binding inducing an inflammatory response in the EC.  Adapted from van Gils et al., 2009. 
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1.4.4. Platelet integrin IIb 3 can also mediate platelet-endothelial interactions following IR 
injury 
A critical role for the integrin IIb 3 (GPIIb/IIIa) in platelet recruitment to the endothelium 
was demonstrated by a reduced interaction of platelets from a patient with Glanzmanns 
disease (which lack functional IIb 3) or in the presence of an antagonist to this integrin 
(Massberg et al., 1999).  A role for this integrin in mediating platelet recruitment to the 
endothelium following IR injury was identified within the venules of post-ischemic gut (Salter 
et al., 2001) and middle cerebral artery (Ishikawa et al., 2004).  IR injury led to deposition of 
fibrinogen on ECs which interacted with platelet IIb 3.  An anti-fibrinogen antibody, that 
prevented IR-induced fibrinogen deposition, reduced the accumulation of adherent platelets 
in both arterioles and venules (Tailor et al., 2005).  
 
1.4.5. Platelets can recruit inflammatory leukocytes to sites of IR injury 
Activated platelets adherent to the endothelium may significantly aggravate EC damage by 
subsequently recruiting inflammatory leukocytes to sites of injury.  Indeed, studies of IR 
injury in the heart (Gawaz et al., 2004; Kupatt et al., 2002; Xu et al., 2005), kidney (Singbartl 
et al., 2001) and liver (Khandoga et al.,  2002 & 2003) demonstrate that accumulation of 
platelets in the microcirculation during reperfusion enhances recruitment of activated 
leukocytes, thereby exacerbating the intensity of the inflammatory response.  Furthermore, 
some studies have suggested that IR-induced recruitment of leukocytes may be essentially 
dependent on the initial adhesion of platelets to venular endothelium (Cooper et al., 2003 & 
2004).   These two cells adhere to each other through interactions between platelet P-
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selectin and leukocyte PSGL-1 (Chen et al., 2005).  The platelet-leukocyte aggregates that 
form have the capability to block microvessels and interrupt blood flow (Frenette et al., 
1998).  It is also well documented that small platelet-leukocyte aggregates can form within 
the circulation due to specific activatory mechanisms of both cell types not requiring pre-
vessel wall interaction.  Hydrogen peroxide, superoxide dismutase and homocysteine, all of 
which are expressed during IR injury, play a key role in these associated cell activatory 
mechanisms. Although these aggregates primarily involve P-selectin- PSGL-1 interactions, 
other platelet and leukocyte receptors and integrins are also capable of binding these two 
cell types and are summarised in Figure 6.  
Platelets can further initiate and exacerbate inflammation within damaged vessels as they 
can also release cytokines and a variety of inflammatory modulators including interleukin 1β 
(IL-1β) and CD40L upon activation (Lindemann et al., 2007).  CD40L, a member of the TNF 
family, is not expressed on the resting platelet surface.  However, platelets translocate 
preformed intra-platelet stores of CD40L to the platelet surface within seconds of activation 
in vitro and in the presence of thrombus  formation  in vivo (Henn et al., 1998).   Both IL-1  
and CD40L induce an inflammatory response within the endothelium by initiating the release 
of chemoattractants IL-8 and MCP-1 that recruit leukocytes.  CD40L and IL-8 also cause 
increased expression of a variety of adhesion receptors on the surface of the endothelium 
such as VCAM-1 and αvβ3 (Gawaz et al., 2005).  Inflammation proceeds with leukocytes, in 
particular neutrophils and monocytes, being recruited due to the signals generated from the 
initial platelet-endothelial interactions. 
Chapter 1 – Introduction 
22 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.6. Molecular adhesive mechanisms that govern platelet adhesion to leukocytes.   
Leukocyte adhesion to platelets primarily involves surface expression of P-selectin on 
activated platelets and binding to PSGL-1, the counter-receptor present on neutrophils and 
monocytes.  In addition to the endothelium, leukocytes can also tether, roll and subsequently 
rest on activated platelet monolayers via sequential action of platelet P-selectin and ICAM-2 
binding to their leukocyte counterreceptors PSGL-1 and αMβ2 (CD11b/CD18; MAC-1), 
respectively. Recent data indicated that platelet GPIb and JAM-3 are also potential counter-
receptors for leukocyte αMβ2. Furthermore, ICAM-2 and IIb 3-associated fibrinogen have 
also been proposed to mediate αMβ2-dependent platelet-leukocyte adhesion.   
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1.4.6. Denudation of the endothelium occurs following intestinal IR injury 
The studies summarised above have identified a critical role for platelet-endothelial 
interactions following IR injury.  However, there is currently a paucity of studies investigating 
the pathophysiological role of platelet-subendothelial ECM protein interactions in mediating 
platelet recruitment following IR injury.  This is despite the fact that the microcirculatory 
component most damaged by IR injury is the EC itself (Carden and Granger 2000; Granger 
1999; Seal and Gewertz et al., 2005).  Massberg and colleagues demonstrated platelet 
recruitment in a murine model of intestinal IR injury.   Interestingly, their electron 
microscopy studies confirmed the presence of platelets adherent to intact ECs, with no 
obvious endothelial denudation detected (Massberg et al., 1998 & 1999).   However, they 
induced only segmental intestinal ischemia by isolating and clamping the mesenteric arterial 
vessels supplying a small (1-2cm) segment of the jejunum.  This type of segmental ischemia 
did not induce severe mucosal injury, remote organ injury or significant morbidity, key 
features associated with clinical and experimental models of whole gut IR injury.  Therefore, 
it is possible that the injury was not severe enough to lead to endothelial loss and ECM 
exposure.   
 
Following IR injury, a loss in the integrity of vascular endothelium has been observed which 
could potentially expose underlying matrix components to circulating platelets (Nievelstein 
et al., 1988).  Within the intestinal villous microcirculation, haemorrhage and a significant 
increase in plasma albumin leakage in response to IR injury has been demonstrated, which 
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could not be attenuated by a variety of pharmacological manipulations, suggesting gap 
formation between or denudation of ECs occurs (Kalia et al., 2001; 2002a, 2002b, 2003 & 
2005).   Morphological studies of post-ischaemic tissue have also demonstrated swelling and 
detachment of ECs from the basement membrane with a resultant impairment of endothelial 
barrier function.  Degradation of basal lamina and ECM components following IR injury has 
also been observed (Brodsky et al., 2002; Mueller et al., 1994).  Indeed, Boyle and colleagues 
suggested migrating neutrophils were responsible for the proteolytic digestion of endothelial 
basement membranes that led to EC detachment, increased vascular permeability, and 
microvascular obstruction by these detached cells (Boyle et al., 1996). It therefore seems 
plausible that exposure of underlying subendothelial ECM following intestinal IR injury may 
play a critical role in platelet recruitment and activation. 
 
1.5. Platelet adhesion, activation and aggregation  
 
1.5.1. Subendothelial matrix collagen mediates powerful platelet activation 
At the site of vascular lesions, ECM proteins and immobilised von Willebrand factor (vWF) are 
exposed to the blood.  Among these constituents of the subendothelial matrix, collagen, the 
most abundant vessel wall protein, has been proposed to be the most thrombogenic.  
Collagen not only supports weak platelet adhesion, but also acts as a powerful activator of 
platelets which leads to their subsequent firm adhesion and aggregation (Nievelstein et al., 
1988; Watson 1999; Nieswandt and Watson 2003).  The three stages of thrombus 
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development induced by platelet-collagen interactions are dependent upon a number of 
specific platelet glycoproteins (GPs) and integrins (Nievelstein et al., 1988; Clemetson 1999).  
GPIb-IX-V and integrin IIb 3 (GPIIb/IIIa; fibrinogen receptor) interact indirectly with collagen
 
via vWF, whereas GPVI and integrin 2 1 (GPIa/IIa) interact directly with collagen (Figure 7).  
Interactions between these molecules are significantly influenced by flow and trigger 
intracellular signaling events that reinforce adhesion and promote platelet activation.  
Similarly to the leukocyte adhesion cascade, platelet capture by ECM also involves rolling, 
activation and firm adhesion but also an additional platelet aggregation stage which leads to 
thrombus growth.  The role of these individual platelet receptors specifically in IR injury will 
be introduced in the relevant results chapters.  This chapter will simply provide an 
introduction to their general role in thrombus formation.  Suffice it to say, that there are 
currently limited studies that have investigated the role of platelet collagen receptors in 
contributing to the pathophysiology associated with IR injury. 
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Figure 1.7.  Models for platelet adhesion to extracellular matrix collagen.  The initial contact 
and subsequent tethering or rolling of platelets involves the weak interactions of GPIb and 
GPVI with vWF and collagen respectively.  GPVI-collagen interactions initiate cellular 
activation followed by shifting of integrins to a high-affinity state and release of ADP and 
TxA2.  Firm platelet adhesion to collagen through activated 2 1 (directly) and IIb 3 
(indirectly via vWF) results in sustained GPVI signalling and enhanced agonist release which 
mediates thrombus growth by activating additional platelets.  Adapted from from Gawaz et 
al., 2005 and Nieswandt & Watson, 2003. 
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1.5.2. Platelet rolling is mediated primarily by GPIb-von Willebrand interactions 
The initial step in platelet recruitment following endothelial denudation is that of platelet 
rolling or tethering via the interaction of GPIb with immobilised vWF.  This occurs through 
the rapid onset of association and rapid dissociation that occurs between GPIb and vWF.  
Weak interactions between the platelet surface glycoproteins and other subendothelial 
matrix proteins, most notably through the immunoglobulin GPVI which binds to collagen, 
lead to activation of integrin 2 1 and  IIb 3, and firm adhesion (Watson et al.,2005).  These 
initial weak interactions allow platelets to remain attached to the vessel wall despite the high 
shear forces generated within the vascular lumen (Jurk et al., 2003).  
   
 There are approximately 25,000 copies of GPIb-IX-V on each platelet (Bergemeier et al., 
2007). This glycoprotein receptor is a product of 4 genes: GPIbα (135kDa), GPIbβ (25kDa), 
GPIX (22kDa) and GPV (82kDa). The N-terminus of GPIbα, between His 1 and Glu 282, is 
where the binding site for vWF is situated (Canobbi et al., 2004).  The GPIbα sub-unit 
primarily mediates the initial transient tethering or rolling of platelets over vWF bound to 
collagen.  In addition, platelets can be recruited to activated endothelium through 
interactions between platelet GPIb-IX-V and endothelial P-selectin. However, similarly to 
platelet-collagen interactions under flow, these interactions also require integrin activation 
for strong adhesion (Berndt et al, 2001).  Lack or dysfunction of the GPIb-IX-V receptor 
complex is associated with the Bernard Soulier syndrome (BSS), a congenital bleeding 
disorder characterized by macrothrombocytopenia and inability of these platelets to 
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aggregate in response to the antibiotic ristocetin (Kunishima et al., 1999).  As stated earlier, 
GPIb-IX-V has also been shown to play a role in platelet adhesion to leukocytes via a αMβ2 
(CD11b/CD18; MAC-1) dependent pathway (Hirahashi et al., 2009).   
 
Bacterial translocation from the gut lumen into the systemic circulation is a major 
complication of intestinal IR injury. This takes place due to a break in the barrier function of 
the mucosal surface which allows entry of opportunistic indigenous viable bacteria into the 
bloodstream.  Interestingly, translocated bacteria present within the systemic circulation 
have the ability to bind to platelets through interactions with GPIb.  Thereafter, these 
bacterial-platelet complexes induce platelet activation leading to platelet-endothelial and 
platelet-platelet  interactions which can further exacerbate the initial IR injury (Fitzgerald et 
al., 2006). 
 
1.5.3. Platelet activation is mediated primarily by GPVI-collagen interactions 
Deceleration of platelets through tethering/rolling permits GPVI-collagen interactions which 
are essential for subsequent platelet activation (Elvers et al., 2010).  Platelet activation is a 
process that mediates the ‘inside-out’ activation of the IIb 3 and 2 1 integrins from an 
inactive form to an active form, which is a pre-requisite for firm adhesion.  Individual 
platelets contain approximately between 1500–3000 copies of GPVI (62KDa) on their surface.  
This receptor requires co-expression with the Fc receptor (FcR) -chain to form a functional 
unit (Watson 1999; Nieswandt et al., 2003; Clemetson 1999).  Interaction of collagen with 
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this receptor complex initiates an intracellular signalling cascade, with the FcR -chain being 
the critical signalling element of the complex (Nieswandt et al., 2003).    
 
1.5.4. Phospholipase C 2 plays a critical role in intracellular platelet signaling 
Numerous downstream proteins form key elements of the GPVI/FcR -chain signaling 
pathway, which lead to tyrosine phosphorylation and activation of the effector enzyme 
phospholipase C 2 (PLC 2) by collagen.  The signaling pathway of α2β1 also requires PLC 2 
(Michelson 2007).  PLC 2 lies downstream of the receptors GPIb-IX-V, GPVI and α2β1. 
Activation of Src and Syk family kinases leads to the phosphorylation of PLC 2.  This results in 
the mobilisation of calcium ions (Ca2+) and activation of protein kinase C (PKC), which are the 
two main mediators of platelet activation (Leoncini et al., 2007).  PLC 2 mediates a number 
of events which include platelet degranulation and release of internally stored agonists such 
as ADP and de novo synthesis of TxA2. These two agonists then interact with their receptors 
on the platelet surface.  TxA2 binds to TxA2R, whilst ADP binds to both the low affinity P2Y12 
receptor and the high affinity P2Y1 receptor.   
 
This leads to a secondary, synergistic platelet activation which activates and increases the 
expression of the integrins αIIbβ3 and α2β1 and also increases their affinity for their ligands.  
Approximately 800-3000 copies of the α2β1 integrin are expressed on the platelet surface. 
This integrin can also mediate weak platelet activation after which it undergoes a 
conformational change from a low to high affinity state which enables it to interact with 
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collagen (Auger et al., 2005).  These activated integrins are responsible for the stable 
adhesion of platelets to collagen. Once this stable adhesion occurs, platelets undergo 
spreading which is mediated by αIIbβ3, α2β1 and GPVI, and reinforced by release of ADP and 
TxA2. The formation of filopodia and lamellipodia result from platelet spreading which 
stabilise and strengthen platelet adhesion to collagen and fibrinogen (Nieswandt & Watson 
2003).   
 
1.5.5. Platelet aggregation is mediated primarily by IIb 3-fibrinogen interactions  
Following initial platelet adhesion to collagen and subsequent activation, the final event is 
platelet aggregation.  This is mediated by soluble (or released) plasma fibrinogen interacting 
with IIb 3 on adjacent platelets.  This integrin has two major functions.  Firstly it forms 
strong adhesive interactions with the vessel wall that are capable of withstanding the effects 
of blood flow.  Secondly, it assists in platelet to platelet cross-linking to allow for thrombus 
formation and growth.  There are between 40,000-80,000 copies of αIIbβ3 on the platelet 
surface making it the most abundant receptor in these anucleate cells.  Several agonists, such 
as collagen and ADP, through ‘inside out’ signalling, have the capability of activating αIIbβ3 
(Watson 2009).  Fibrinogen and vWF are considered the main ligands for this integrin but 
vitronectin and fibrin are amongst others capable of filling this role. These ligand interactions 
reinforce platelet activation by the generation of `outside-in’ signals (Massberg et al., 2005). 
Since platelet aggregation is a key stage of thrombus development, IIb 3 antagonists 
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(commonly called GPIIb/IIIa antagonists) are used both clinically and experimentally to 
prevent aggregation (Lefkovits et al., 1995).   
 
1.5.6. Limited studies have investigated platelet-subendothelial interactions following IR 
injury 
Despite the importance of ECM proteins such as collagen in inducing thrombus formation 
physiologically during haemostasis, limited studies have investigated their pathological role 
following IR injury.  Takaya and colleagues demonstrated using scanning electron microscopy 
(SEM) that murine myocardial IR injury induced platelet aggregation in areas clearly 
undergoing traumatic EC disruption and basement membrane exposure (Takaya et al., 2005).  
They further demonstrated that infarct size, numbers of microthrombi and infiltrating 
neutrophils  were significantly smaller in mice deficient in FcRγ-chain (and thus GPVI).  The 
authors concluded that the GPVI / FcR γ-chain complex could be an important therapeutic 
target for cardiovascular disorders and that new anti-platelet strategies directed against the 
collagen receptor GPVI might improve cardiac perfusion. 
 
More recently, Kleinschnitz and colleagues demonstrated in vivo that interfering with the 
early steps of platelet-vessel wall interactions mediated by GPIb and GPVI using an antibody 
approach protected mice from ischemic brain injury in an experimental stroke model. In 
contrast, blockade of the final common pathway of platelet aggregation with anti-αIIbβ3 
antibodies had no positive effect on infarct size and stroke outcome (Kleinschnitz et al., 
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2007).  Indeed, blocking αIIbβ3 significantly increased the rate of intracerebral haemorrhage 
and mortality in a dose-dependent manner (4 out of 7 mice tested died).  This study 
concluded that endothelial denudation associated with stroke could recruit platelets through 
indirect interactions of GPIb with collagen and that blocking GPIb could open new avenues 
for acute stroke treatment in humans. 
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1.6. Summary 
A number of studies have demonstrated a key role for platelets in the pathophysiology of 
intestinal IR injury.  Mechanistic studies have identified a role for the activated endothelium 
in regulating platelet recruitment and activation.  Studies on intestinal IR injury have so far 
only focused on inhibiting platelet-endothelial interactions using IIb 3 receptor antagonists 
(Salter et al., 2001; Massberg et al., 1998 & 1999).  However, recent evidence suggests a role 
for the subendothelial matrix in mediating platelet activation in IR injury (Takaya et al., 2005; 
Kleinschnitz et al., 2007).  ECs are extremely susceptible to ischaemia and their detachment 
as well as damage to the basal lamina has been demonstrated following IR injury.  Platelet-
subendothelial matrix interactions, particularly platelet-collagen interactions, are bought 
about by a range of platelet receptors and integrins which lead to their adhesion, activation 
and aggregation.  Platelet receptors are at the forefront of recent research and major 
advances have been made in understanding their molecular functions and their downstream 
signaling pathways.  
 
The use of pharmacological inhibition and knocking out of nearly all known receptors, 
adhesion molecules, and many signaling molecules have helped to reveal new mechanisms 
for how the thrombotic and haemorrhagic propensity of platelets is controlled in health and 
disease.  However, the role of the glycoprotein receptors GPVI, GPIb-IX-V and the integrins 
IIb 3 and 2 1, which interact directly or indirectly with collagen, in mediating platelet 
adhesion and activation have not been determined following intestinal (or non-intestinal) IR 
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injury in vivo.  Indeed the role of these receptors in experimental models of disease generally 
is limited.  Comparison of the effect of blockade of these glycoprotein receptors would 
provide important information on the role of the subendothelial collagen in contributing to 
platelet activation in intestinal IR injury. 
 
1.7. Aims and Hypothesis 
In accordance with previously published research, we anticipated endothelial activation to 
occur as a result of intestinal IR injury.  Therefore, we expected to observe platelet-
endothelial interactions.  However, we further hypothesised that intestinal IR would also lead 
to localized areas of endothelial detachment and denudation, which would be increased as 
the duration of the ischaemic insult increased.   As a consequence of this, we hypothesized 
that the resulting interaction with exposed subendothelial collagen would lead to platelet 
activation and formation of microthrombi, which would contribute significantly to the 
resulting intestinal pathology.  This research therefore aimed to specify the role of 
subendothelial collagen in supporting formation of microthrombi and subsequent tissue 
injury in vivo using fluorescent intravital microscopy (IVM).  
 
Studies were focussed primarily on the mucosal villous microcirculation due to its 
susceptibility to IR injury.  We initially aimed to determine the time course, kinetics and 
pattern of platelet events in this region in vivo using fluorescent intravital microscopy (IVM).  
Thereafter, experiments were conducted in mice deficient in FcR -chain (and hence GPVI), 
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mice-deficient in the IIb 3 or in mice perfused with blocking antibodies to the integrins 2 1, 
and GPIb .  Additional studies were also conducted in PLC 2 deficient mice to determine the 
importance of this intracellular signalling protein.   
 
Specifically the aims of this research were as follows: 
 
1. Develop a viable model of murine intestinal IR model and monitor in vivo using IVM the 
recruitment of platelets both spatially and temporally.   
 
2. Monitor whether platelet recruitment varied : 
with different durations of ischaemic injury  
in different regions of the gut i.e.  proximal jejunum vs the distal ileum 
in different layers of the gut wall i.e. inner mucosal vs outer serosal layer 
 
3. Determine whether platelets interacted with intact endothelium and/or exposed 
subendothelial collagen.  In order to conduct these studies, a novel dual labelling method 
was developed that allowed three platelet events to be monitored within the same 
animal simultaneously in vivo, namely: 
microthrombi formation 
adhesion of individual platelets 
circulation of individual freely flowing platelets 
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4. Determine the platelet collagen receptors involved in platelet recruitment following 
intestinal IR injury.   Specifically, the role of GPVI, GPIb-IX-V, IIb 3, 2 1, PLC 2 and P-
selectin was determined using function blocking antibodies or knockout mice.   
 
5. Determine the role of platelets in contributing to the remote organ injury to the liver and 
lungs which is frequently associated with intestinal IR injury.  
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2.1. Materials  
 
2.1.1. Antibodies 
All antibodies used in this thesis were used at the concentrations detailed in Table 2.1.  
 
Antibody Conj Clone Origin  Target  Isotype Company Conc
n
 
anti- GPIbα N/A Xia. B2 Rat mouse IgG2a Emfret 0.5mg 
anti- GPIbα FITC Xia.B2 Rat mouse IgG2a Emfret 0.5mg 
anti- GPIbα N/A Xia. H10 Rat mouse IgG2a Emfret 0.5mg 
anti – α2β1 N/A Sam.C1 Rat mouse IgG2b Emfret 0.5mg 
anti – α2β1 N/A Sam.G4 Rat mouse IgG2b Emfret 0.5mg 
anti – α2β1 FITC Sam.G4 Rat mouse IgG2b Emfret 0.5mg 
Alexa 594 N/A CY3 dye  Goat Rat IgG1 Invitrogen 2mg/mL 
CD41 FITC Leo.A1 Rat Mouse IgG1 Emfret 0.5mg 
CD41 N/A MWReg30 Rat Mouse IgG1 BD Pharmingen 1mg 
 
Table 2.1. Antibodies used in this thesis to investigate the function and mechanisms of 
recruited platelets at the sites of injury. Antibodies were purchased from Emfret, Invitrogen 
and BD Pharmingen. 
 
 
 
2.1.2 Common materials 
A number of materials were used repeatedly in this thesis and are presented in Table 2.2 for 
clarity. Materials referred to in the text were obtained from the indicated suppliers unless 
otherwise stated. 
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Material Abbreviation  Manufacturer Location 
Acetone - Fisher Scientific Leicestershire, UK 
3-aminopropyltriethoxysaline APES Sigma Poole, UK 
Ammonium Hydrochloride NH4Cl Sigma Poole, UK 
Bovine Serum Albumin BSA Sigma Poole, UK 
5’6-carboxyfluorescein diacetate 
succinimidyl ester 
CFSE 
Molecular Probes 
(Invitrogen) 
Paisley, UK 
Endothelial cell growth supplement 
from neural tissue 
EC growth 
supplement 
Sigma Poole, UK 
Heat inactivated Fetal Bovine Serum FBS Invitrogen Paisley, UK 
HEPES - Sigma Poole, UK 
Gelatin (Type I from porcine skin) - Sigma Poole, UK 
Glucose - Sigma Poole, UK 
Ketamine Hydrochloride - 
Pharmacia Animal 
Health 
Northampton-  shire, 
UK 
L-Glutamine (Glutamax
TM
) - 
Invitrogen 
PAA Laboratories 
Paisley, UK 
Peterborough, UK 
Magnesium Chloride MgCl2   
2-mercaptoethanol - Invitrogen Paisley, UK 
Murine Epidermal Growth Factor mEGF Peprotech London, UK 
Sodium Carbonate NaHCO3   
Sodium Chloride NaCl Sigma Poole, UK 
Sodium Phosphate Na2HPO4   
Penicillin - 
Invitrogen 
PAA Laboratories 
Paisley, UK 
Peterborough, UK 
Phosphate Buffered Saline PBS Invitrogen Paisley, UK 
Potassium Chloride KCl   
Sodium ethylene tetraacetic acid Na.EDTA Sigma Poole, UK 
Sodium Chloride NaCl Sigma Poole, UK 
Streptomycin - Invitrogen Paisley, UK 
Trypsin-EDTA - Invitrogen Paisley, UK 
Xylazine Hydrochloride - Millpledge Vetinary Nottinghamshire, UK 
 
 
 
Table 2.1. Names and purchasing information of the chemicals used in this thesis. 
Abbreviations (if applicable) are also shown. 
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2.2. Cell Isolation and preparation 
 
2.2.1. Isolation of mouse platelets 
Mouse blood (700-900ul) was drawn from CO2 asphyxiated mice following isofluorane 
anaesthesia by descending aorta puncture into 100 μL of acid citrate dextrose (ACD).  This 
was added to an eppendorf containing 200μl of tyrodes solution (129 mM NaCl/0.34 mM 
Na2HPO4/2.9 mM KCl/12 mM NaHCO3/20 mM Hepes/5 mM glucose/1 mM MgCl2) and spun 
at 2000rpm for 5 minutes in a microfuge. Platelet rich plasma (PRP) and 1/3 of the red blood 
cells were removed and placed into a separate eppendorf tube.  This solution was then 
centrifuged at 1000rpm for 6 minutes before carefully removing the PRP only and placing 
into a third tube.  To stop platelet aggregation occurring through the final spin, 1μl of 
prostacyclin (PGI2) was added to the PRP before centrifugation at 2800rpm for 6 minutes.  
The supernatant was then removed leaving a platelet pellet in the bottom of the tube, which 
was resuspended with tyrodes solution to a volume of 200μl.  Using a coulter counter 
(Becton Dickinson, USA), 2.5ul of the PRP solution was pipetted into 10mls of saline to give a 
platelet count per 1ml.  These platelets were then allowed to rest for 30 minutes before use 
in either in vivo or ex vivo experimentation.   
 
2.2.2. CFSE labelling of platelets 
The initial steps of this process follow the above platelet isolation protocol up to centrifuging 
the platelets at 2800rpm for 6 minutes.  The supernatant was then removed leaving the 
platelet pellet. This was then resuspended in 500μl of 10μM CFDA-SE solution and incubated 
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at room temperature for 20 minutes in the dark. CFDA-SE (5’6-carboxyfluorescein diacetate 
succinimidyl ester) is a non-fluorescent, cell permeable flourescein derivative, which is 
modified by intracellular esterases to render the molecule brightly fluorescent.  Modification 
by these intracellular enzymes also renders the modified molecule cell impermeant.  After 
this time had elapsed, 1μl of PGI2 was added to the PRP and spun again at 2800rpm for 6 
minutes. The supernatant was then removed leaving a platelet pellet in the bottom of the 
tube. This pellet was resuspended with tyrodes solution to a volume of 200μl. Using a coulter 
counter, 2.5μ of the PRP solution was pipetted into 10mls of saline to give a platelet count 
per 1ml. Dilutions, by the addition of tyrodes, were then undertaken to leave the required 
platelet count for specific experimentation. These platelets were then allowed to rest for 30 
mins before use in in vivo or ex vivo procedures.  For in vivo studies, these platelets were 
injected into a different mouse undergoing IR injury and were hence called donor platelets.   
 
2.2.3. Murine cardiac endothelial cell (MuCEC-1) culture 
Isolation of primary murine ECs is typically very difficult and requires elaborate and time 
consuming purification techniques (Marelli-Berg et al., 2000). Furthermore, overgrowth of 
contaminating cells often prevents long-term culture of these populations (Marelli-Berg et 
al., 2000).  As a result of the difficulties encountered with primary isolates, an immortalised 
murine cardiac EC line was used (MuCEC-1) (Bouis et al., 2001). MuCEC-1 cells were obtained 
locally from Dr. Patricia Lalor (University of Birmingham, UK).  Cells were grown to confluence 
in gelatin coated flasks.  MuCEC-1 cells are isolated from H-2Kb-tsA58 mice, which express a 
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thermoliable strain (tsA58) of the SV(40) large T antigen (tsA58 TAg) which allows production 
of conditionally immortalised cells (Lidington et al., 2002).  These ECs are characterised by 
their phenotypic cobblestone appearance and their ability to form tubes on an artificial 
extra-cellular matrix.  Furthermore, these cells were shown to be positive for ICAM-1 and 
VCAM-1, with selectin expression neglible (Lidington et al., 2002).  MuCEC-1 were maintained 
in DMEM containing 10% FBS, supplemented with 50U/ml penicillin, 50U/ml streptomycin 
and 2mM L-Glutamine and 10ng/ml mEGF. At confluence, cells were enzymatically 
dissociated using Trypsin-EDTA, washed in complete media and split 1 in 3. For static 
adhesion assays, a confluent flask of MuCEC-1 was enzymatically dissociated using Trypsin-
EDTA, washed in complete media and one third resuspended in 30ml of complete medium. 
1ml of the resulting cell suspension was then added to each well of a 24 well plate containing 
a pre-treated coverslip (Refer to Sections 2.6.2 and 2.6.3) and allowed to grow to confluence 
prior to use. 
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2.3. Monitoring platelet and leukocyte trafficking in vivo using intravital microscopy 
 
2.3.1 Animals 
Animal experiments were completed with prior approval of the local ethics committee and 
the United Kingdom Home Office, in accordance with the Animals (Scientific Procedures) Act 
of 1986 under Project Licence 40/2749 (Dr. Neena Kalia).  10-12 week old male C57Bl/6 wild-
type mice were obtained locally (Biomedical Services Unit, University of Birmingham, UK). 
Some experiments were conducted on P-selectin-/- mice, kindly provided by Professor Paul 
Hellewell (Sheffield University, UK).  P-selectin-/- mice were bred from heterozygotes on a 
C57Bl/6 background and then transported to Birmingham at least one week before 
experimentation. P-selectin-/- phenotype was confirmed by flow cytometric analysis of 
peripheral blood platelets.   FcR -chain and IIb 3 deficient mice were bred locally in colonies 
held by Professor Steve Watson (University of Birmingham).  Genotyping was undertaken to 
confirm absence of the knockout gene.  All animals had ad libitum access to food and water.  
 
2.3.2. Surgical preparation for in vivo studies 
Anaesthesia was induced by intraperitoneal administration of ketamine (100 mg/kg Vetalar; 
Amersham Biosciences and Upjohn Ltd., UK) and xylazine hydrochloride (10 mg/kg; 
Millpledge Pharmaceuticals, UK) delivered in 0.9% saline. The trachea and right common 
carotid artery was cannulated with polyethylene portex tubing (Smiths Medical, Hythe, UK) 
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to assist breathing and to allow administration of donor CFSE labelled platelets, function 
blocking antibodies and additional maintenance anaesthesia as required. 
 
Preliminary in vivo experiments were conducted whereby only 100μl of tyrodes solution 
containing 1 x 108 of donor CFSE labelled platelets were injected intra-arterially.  However, 
subsequent experiments combined introducing these donor labelled platelets with 
fluorescent labelling of all endogenous platelets with a fluorescent dye of a different 
wavelength.  This was achieved by injecting 40 l Alexa Fluor 594 conjugated to goat anti-rat 
antibody (2 mg/mL; Molecular Probes, Eugene, OR, USA) and 20 l rat anti-murine CD41 
(GPIIb) antibody (0.5 mg/mL; BD Biosciences Pharmingen, San Diego, CA, USA) via the carotid 
cannula.  For experiments conducted in GPIIb deficient mice, Alexa 594 was conjugated to a 
rat anti-muirine GPIb antibiody.  All endogenous platelets were labelled as the amount of 
antibody added per mouse was in excess of the total number of platelets (assuming a 
platelet concentration of about 1 ×109 per mL blood) by around 1,000-fold.  The brightness of 
individual endogenous platelets should be the same for each experiment as the same 
preparation of labeled antibody, and the same amount of antibody per gram of mouse is 
introduced. The antibody will dissolve in the blood as expected and since the Alexa-594 
fluorophore is strongly conjugated to the primary CD41 antibody, no free fluorescent label 
should be available to dissolve in the blood (Kalia et al., 2009).  Alexa 594/CD41 antibody 
and/or donor CFSE labelled platelets were introduced into the circulation after neck surgery 
was performed and given 30 minutes to circulate.   
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2.3.3. Induction of intestinal IR injury  
During this time, the animal was transferred onto a petri-dish and a midline laporotomy was 
performed by cutting along the linea alba, an avascular fibrous structure found between the 
left and right rectus abdominis muscles.  The proximal jejunum or the distal ileum of the 
small intestine was gently exteriorised and held in place using moist tissue paper. Tissue 
paper rather than surgical clips were used to limit the amount of injury.  The jejunum was 
orientated in a way that allowed for some length of the mesenteric arteriole supplying that 
segment to be positioned flat on the petri-dish surface.  Small intestinal ischaemia was 
induced by application of an atraumatic vascular clamp to the superior mesenteric artery 
(SMA) for 15, 30, 45 or 60 minutes.   This allowed ischaemia to be induced to the lower 
duodenum,  jejunum and ileum, but importantly did not lead to mortality during the 4 hour 
reperfusion period used for intravital imaging.  Visual evidence that ischaemia had been 
induced could be seen by the palor or change of colour within the intestinal tissue (Figure 
2.1).  The small intestine was reperfused by removal of the clamp and the animal was 
immediately prepared for intravital monitoring by laying it on its side within the petri-dish.  
 
The mesenteric artery supplying the exteriorised segment of the jejunum or the outer serosal 
wall microvessels within this region were monitored intravitally in some preliminary 
experiments.  However, the major focus of the research was the microcirculation of the 
lumenal mucosal villi in the jejunum and ileum.  In order to view the mucosa, it was exposed 
by cauterising 1-1.5cm along the anti-mesenteric border and kept open using moist tissue 
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paper.  Once exposed, the mucosal surface was carefully placed facing downward and 
wrapped in a single layer of tissue paper to limit peristaltic movement. Throughout the 
experiment, the preparation was continuously kept most by pipetting bicarbonate-buffered 
saline solution (36°C, pH 7.4).  Control sham mice underwent exactly the same procedure but 
the SMA was not clamped.  The petri-dish holding the mouse was then transferred to the 
stage of an inverted Olympus intravital microscope. 
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Figure 2.1. Visual evidence of ischaemic episode through SMA clamping. (a) A perfused 
tissue appeared a healthy pink colour.  (b) However, clamping of the superior mesenteric 
artery using a non-traumatic clamp led to an obvious tissue palor due to a lack of perfusion 
within the small intestine. 
Mesenteric 
Vessel 
Serosal 
Vessels 
Before 
During 
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2.4. Quantification of cell trafficking in vivo  
 
2.4.1.  Capture of intravital images from the jejunum and ileum 
Experiments were conducted using a motorized Olympus BX-61WI microscope (Middlesex, 
UK).  Simultaneous capture of brightfield and fluorescent images was achievable by rapidly  
alternating the illumination of the specimen between transmission light using a Uniblitz 
shutter (Vincent Associates, Rochester, NY, USA) and epi-fluorescent light using a Lambda 
DG-4 high speed wavelength changer (Sutter Instrument Company, Novato, CA, USA). Digital 
images were captured using a high resolution CCD camera .  All these components were 
controlled by a Dell workstation and imaging software (Slidebook, Intelligent Imaging 
Innovations, Denver, CO, USA) and stored as permanent digital images for subsequent off-
line analysis.  
 
Using the x20 objective, one intestinal serosal field of view or a mucosal field of view from 
the ileum and jejunum (413μm x 308μm) was pre-selected containing between 6 and 10 
individual villi structures in the jejunum or 12 to 16 in the ileum.  After 30 minutes 
reperfusion, 1 minute recordings were taken from the same pre-selected field of view every 
30 minutes for a period of 4 hours.  A brightfield image and two fluorescent images using the 
FITC and CY3 filter channels were captured simultaneously.  This allowed an image showing 
the architecture of the microvessels to be captured at the same time as a green image of the 
donor CFSE labelled platelets and a red image of the Alexa 595 labelled endogenous 
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platelets.  At the end of this monitoring period, an additional six fields of view were taken in 
order to ensure the events taking place in the pre-selected field of view represented those 
taking place in other regions of the ileal and jejunal mucosa.  These six regions were not 
randomly selected but followed a strict pre-determined pattern.  Six regions were selected 
relative to the position of the initial field (Figure 2.2).  Events in the pre-selected region were 
considered representative if the final level of cell adhesion was within two standard 
deviations of the mean of the six fields examined following the experiments. Two standard 
deviations are typically expected to contain around 95% of the statistical population.   
 
2.4.2.  Quantification of individual platelets and microthrombi within jejunum and ileum 
To quantitate individual green CFSE labelled donor platelet events, each platelet observed 
during the one minute recording was counted. Individual platelets were deemed either as 
adherent if situated in the field of view for ≥ 30 seconds or free flowing if ≤ 2 seconds.  Red 
Alexa 594 labelled microthrombi were quantitated according to their size (in pixels) or their 
fluorescent intensity. Data was presented as the sum of the size or fluorescent intensity of all 
microthrombi in the field of view.  A ‘mask’ was drawn over the thrombi and imaging 
software was used to calculate its size and intensity  (Figure 2.3a).  The background 
fluorescence intensity, predominantly due to freely circulating endogenous platelets, was 
determined using the image analysis software and subtracted from the fluorescence intensity 
of the thrombi.  This allowed the fluorescent intensity of only the microthrombus to be 
determined. 
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Figure 2.2. Selection criteria for fields of view to monitor for adhesive events intravitally. 
Six fields of view (green boxes) were selected at the end of the intravital experiment to 
ensure data obtained from the pre-selected field of view (yellow box) were representative of 
events across the whole exposed tissue. Events in the pre-selected region were considered 
representative if the final level of cell adhesion was within two standard deviations of the 
mean of the six fields examined following the experiments. Two standard deviations are 
typically expected to contain around 95% of the population. 
                    Edge of exposed tissue 
                 Abdominal area of animal 
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2.4.3. Quantification of freely flowing platelets within the mesenteric vessels  
The number of individual donor CFSE labelled platelets circulating within the mesenteric 
vessel supplying the exteriorised segment of the jejunum was determined by manually 
counting them.  However, in this large vessel, the numbers of donor platelets that could be 
visualised and the blood flow velocity was very high and so it was not possible to always 
distinguish individual platelets as they whizzed past in real time.  Hence, manually counting 
the individual platelets was likely to provide an underestimated value.  Therefore, to combat 
this problem a novel approach of measuring the fluorescent intensity within a 100μm 
x100μm square drawn over the vessel was determined.  The intensity passing through this 
square at a series of time points, during a 1 minute capture period was averaged 
automatically by the imaging software to provide a single intensity reading (Figure 2.3). 
 
2.4.4. Labeling of endogenous leukocytes and quantification in vivo 
For some experiments, endogenous leukocytes were labelled in vivo using the cell-permeable 
nucleic dye, Acridine orange (Sigma-Aldrich, Poole, UK). When bound to DNA, Acridine 
orange displays similar fluorescent spectra to FITC. To visualise leukocytes, animals were 
injected intra-arterially with 100μl of 200μg/ml Acridine orange.  After injection, the dye was 
allowed to circulate for 5 minutes only before image capture at either 1 hour or 4 hours 
reperfusion. Adherent leukocytes were quantitated using the same protocol for quantitating 
adherent platelets (refer to 2.4.2). 
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Figure 2.3. Quantification of microthrombi within the jejunum and ileum and freely flowing 
platelets within the mesenteric vessels. (a) Using a masking tool available in the imaging 
software, it was possible to quantify the sum of the pixel area and fluorescent intensity of a 
masked region representing the microthrombi in the whole mucosal field of view. (b) Free 
flowing platelets in mesenteric vessels were quantitating by drawing a 100μm x 100μm 
square over the vessel and getting the software to average the fluorescent intensity within 
within in over a period of one minute.  
 
Unmasked Masked 
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2.4.5. FITC-BSA production and quantification of macromolecular leakage 
At the end of all intravital experiments, 200 l of FITC-conjugated bovine serum albumin 
(FITC-BSA) was injected intra-arterially.  When introduced systemically, it is retained within 
the vasculature, thereby facilitating easy visualisation of the vasculature and confirming 
blood flow (Kalia et al., 2002).  However, when the integrity of the vessel is disturbed, it 
appears as a flare in the surrounding interstitium.  10% FITC on celite was conjugated to 
bovine serum albumin (both Sigma, Poole, UK) by mixing the FITC, BSA and 10ml of 
bicarbonate buffer (pH 9.0) overnight at 4°C. The resulting mixture was centrifuged at 10-
12,000rpm for 10 minutes and conjugated/unconjugated BSA separated by dialysis 
(12,000MW cut off; Spectrum Laboratories, CA, USA). Prepared FITC-BSA was frozen and 
stored until use in eppendorfs.  Macromolecular leakage was determined by measuring the 
fluorescent intensity within the field of view using gray levels.  Since a 16-bit camera was 
used to capture the images, it meant that it was able to distinguish between 65, 536 levels of 
grey with 0 being black and 65,535 being white and all values in between being different 
stages of grey.  Increasing values are directly proportional to increasing amounts of leakage.   
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2.5  Non-intravital methods for assessing injury 
 
2.5.1. Haematoxylin and eosin (H&E) tissue staining 
Haematoxylin and eosin (H&E) tissue staining was used to examine the severity of tissue 
damage in intestinal IR injured jejunum, ileum, liver and lungs. Mice were subjected to 
intestinal IR injury or sham surgery.  After 1 or 4 hours reperfusion, the animals were 
sacrificed and a 0.2cm piece of ileal and jejunal tissue, 1 liver lobe and both lungs were 
removed and placed into formalin for 12-14 hours.  The tissue was then processed through a 
series of dehydration and fixing steps using IMethylated spirits and xylene solutions.  After 
processing, the tissue was paraffin wax embedded before 10μm sections were cut on to a 
microslide using a HM 355 motorised microtome (Thermo Scientific, Walldorf, Germany).  
Sections were allowed to dry in a mini-oven for 10 minutes and then H&E stained using an 
automated histology stainer and mounted in DPX solution (Sigma, Poole, UK).  
 
2.5.2. Scanning electron microscopy (SEM) 
Ileum and jejunum was removed from IR injured or sham animals and pinned out on a 
corkboard to expose the mucosal villi structures. This was then placed in 2.5% 
glutaralderhyde to fix overnight.  Tissue preparation was kindly undertaken by colleagues 
within the Department of Metals and Metallurgy, University of Birmingham.  This included 
sectioning the tissue with glass blades and an incubation process that allowed a heavy metal 
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solution to be absorbed by the tissue allowing for contrast within the images.  A Philips 700XL 
SEM was used to scan and capture images from the mucosal surface.   
 
2.5.3. Liver alanine aminotransferase (ALT) levels following intestinal IR injury  
To biochemically confirm the presence of remote hepatic injury subsequent to intestinal IR 
injury, blood samples were obtained from mice subject to sham or IR procedures at 4 hours 
reperfusion.  Increased levels of serum ALT are directly proportional to the extent of liver 
injury.  Samples were analysed using an Olympus Au400 analyser. The automated analyzer 
facilitates ALT activity and monitors light absorbance at 340nm which is relative the level of 
enzyme in the sample.  Sampling was performed by the Department of Clinical Chemistry at 
the Birmingham Women’s Healthcare NHS Trust (Birmingham, UK). 
 
2.6. Quantification of platelet adhesion in vitro 
In addition to monitoring platelet adhesion in vivo, their adhesion to ECs (MuCEC-1) and 
collagen was also determined in vitro using a static or flow based adhesion assay 
respectively. 
  
2.6.1.  Static endothelial adhesion assays 
24 well plates for static assays were pre-treated with 5% gelatin to aid EC adhesion.  MuCEC-
1 were cultured to confluence over 2-4 days on the treated surfaces. Media was removed 
from the endothelial monolayers which were washed twice with 0.5ml warm PBS and then 
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treated with 10ng/ml TGFβ and 100U/ml TNFα or tyrodes solution for 4 hours. 500μl of 
activated, or resting, washed IR platelets at a concentration of 1 x 107/ml were then 
incubated with the endothelial cells for 45 mins at 37oC.  Proceeding this step, endothelial 
monolayers were washed with warm 0.1% PBS before fixing with 2% glutaraldehyde in PBS 
for 15 minutes at 37oC. The fixative was then washed away three times with 0.1% before 
mounting with medium. Slides were then read within 2 hours for analysis. CFSE labelled 
platelets were imaged using an Olympus differential interference contrast (DIC) microscope. 
6 separate fields were selected from each endothelial monolayer using a set pattern to 
ensure randomness (Figure 2.4).  Slides were analysed and cells counted using the slidebook 
software. 
 
2.6.2. Flow based adhesion assay over collagen 
Thin rubber tubing was attached to the three outlets on the valve labelled output, sample 
and wash. Tubing from the wash and sample outlets were attached to a 20ml syringe, 
containing tyrodes solution, and a 2.5ml syringe respectively.  The input tubing was 
connected up to the input duct of the glass capillary, which was placed on the stage of an 
inverted microscope (DM IRB: Leica, Milton Keynes, UK) for imaging.  A 50ml glass syringe 
was fixed securely to the automated pump and a 3-way valve.  Attached to this valve was 
another 20cm long piece of rubber tubing which fed into the output duct of the glass 
capillary tube to collect flown blood. A 20ml plastic syringe was also attached to this valve to 
allow for water to enter and fill the output rubber tubing.  Careful attention was taken to 
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allow the whole flow system to be full of water with no apparent air bubbles present. Air 
bubbles would have affected both flow velocities and the adhesiveness of collagen fibres.    
 
Glass capillary tubes (Camlab, Cambridge, UK) were coated with 100μg/ml type 1 collagen 
from equine tendon (Horm, Nycomed, munich, Germany) for 1 hour at room temperature. 
These capillaries were then washed with PBS and left overnight at room temperature. Once 
the capillary tube was fixed into position, within the flow assay set up, a single field of view 
was then chosen, to the far left of the slide, as our primary observation area.  500μl of anti-
coagulated (40μM P-PACK plus 5U/ml heparin) blood from either sham or IR experiments 
was then perfused over the chamber at a wall shear rate of 300 s-1.  Five additional random 
images were then taken, following the same imaging protocol as with the endothelial 
adhesion assay.  Images were analyzed off-line using ImageJ software. Platelet adhesion 
results are expressed as the percentage area covered by platelets. 
Chapter 2. Materials and Methods  
 
58 
 
 
       
       
Blood Flow 
input  
   
  
  Blood Flow 
Output 
       
       
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.4.  Selection criteria for fields of view to monitor for adhesive events in vitro.   5 
fields of view (green boxes) were selected at the end of the in vitro adhesion experiment to 
ensure data obtained from the preselected field of view (yellow box) were representative of 
events across the whole thrombogenic surface. Events in the pre-selected region were 
considered representative if the final level of cell adhesion was within two standard 
deviations of the mean of the six fields examined following the experiments. Two standard 
deviations are typically expected to contain around 95% of the population. 
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2.7. Methodology for receptor blocking studies 
 
2.7.1. Confirmation of adhesion molecule blockade 
The role of various platelet receptors in contributing to their adhesion to either activated 
endothelium or exposed subendothelial matrix proteins in vitro and in vivo was determined 
using specific function blocking antibodies.  However, prior to antibody use for blocking 
experiments, FACS based studies were used to confirm complete blockade of the receptor 
(Figure 2.5).  200μl (100μg) of blocking antibody was injected via the cannulated carotid and 
allowed to flow within the circulation for 30 mins.  The murine washed platelet protocol was 
then followed before dilution of platelets to a concentration of 2 x 107 / ml.  
50μl of this solution was then incubated with 5μl of FITC conjugated antibody to the same 
receptor for 15 mins in the dark.  After this incubation period, 450μl of tyrodes was added.  
Suspensions were loaded onto and analysed on a BD FACSCalibur flow cytometry system.  
The system has two available excitation lasers (488nm and 635nm) allowing the use of 
multiple coloured dyes, which can be detected on four different filters (FL1-4).  FL1 allows 
detection of dyes with an emission wavelength of around 530nm including fluorescein 
isothiocyanate (FITC). Fluorescent intensity was taken as the mean fluorescent intensity of 
10,000 platelets. 
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Figure 2.5. Determination of adequate function blocking concentrations for the anti-
adhesion molecule antibodies. Platelets were pre-treated with varying concentrations of 
blocking antibody.  Blocked platelets were subsequently treated with a fluorescently 
conjugated version of the blocking antibody.  Fluorescent antibody capture is proportional to 
free antigen available on the cell surface.   Dr Dean Kavanagh is gratefully acknowledged for 
the above figure.   
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2.7.2. Ex vivo platelet receptor blocking 
Following the washed platelet protocol, platelets were diluted to 2 x 108 in 1ml.  50μl of 
function blocking antibody was added to this suspension for 30 minutes and then washed by 
a centrifuge spin of 1000g for 6 minutes.  Platelets were then resuspended or 10ml for in 
vitro adhesion and FACS studies.  Donor CFSE labelled platelets were resuspended in 100μl of 
tyrodes solution prior to injection into the recipient mouse for in vivo intravital experiments.       
 
2.8. Cell interaction protocols 
 
2.8.1. FACS analysis of platelet-leukocyte interactions 
Whole blood was collected from sham or IR injured animals at 2 hours post-reperfusion from 
the descending aorta into a 1ml syringe containing heparin and 40μM PPAK.  50μl of blood 
was then placed into a FACS tube and allowed to incubate with 5μl of CD41 FITC-conjugated 
antibody (Emfret, Germany) for 15 minutes. After this incubation period, whole blood was 
diluted in 445μl of 37oC tyrodes solution and analysed using a Beckman flow cytometer. 
Platelet-leukocyte aggregates were studied by evaluating the gated leukocyte population for 
the binding of platelet specific anti-CD41 mAb, within the first 30,000 events. The percentage 
of platelet-leukocyte events was concluded by dividing 30,000 by the number of events 
present in the associated platelet-leukocyte peak.  
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2.8.2. Platelet aggregations 
For platelet aggregations, whole blood from sham or IR injured mice was sampled by uptake 
into a 1ml syringe containing 100ul of ACD.  Preparation of washed mouse platelets was then 
followed, as stated previously (refer to Section 2.2.1). The concentration of platelets was 
diluted to 2 x 108/ml with 400ul of this suspension been placed into an aggregometry tube. A 
metal stirrer was then placed into the tube and inserted into the 37oC compartment of the 
Chrono-Log aggregometer (Chrono-Log, Havertown, PA, USA) for 1 minute.  After this time 
elapsed, the tube was placed into the compartment labeled PRP and the 4ul of agonist 
(collagen or thrombin) was added.  Tracers were then observed for 4 minutes.  If post 
platelet counts were analyzed, results were obtained from 3 minutes after the initial 
stimulation. 
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3.0. Development and optimisation of an in vivo model to monitor platelets following 
intestinal ischaemia-reperfusion injury 
 
3.1. Introduction and hypotheses 
 
3.1.1. Introduction 
Platelet recruitment has been observed within the microcirculation of several organs 
following IR injury. Indeed, the beneficial effects of platelet depletion during pancreatic IR 
injury has been described (Kuroda et al., 1996).  Most studies demonstrating a role for 
platelets in IR injury have characterised the nature and molecular determinants of platelet-
endothelial cell interactions (Khandoga et al., 2002; Massberg et al., 1998). Massberg and 
colleagues provided the first evidence for a role for platelets in murine intestinal IR injury. 
Intravitally, they observed donor platelets rolling or firmly adherent to post-ischaemic 
activated endothelium via a mechanism dependent upon endothelial, rather than platelet, P-
selectin (Massberg et al., 1998).     Furthermore, these studies were conducted within the 
large mesenteric and submucosal arterioles supplying the SI (Massberg et al., 1998, 2003).   
 
However, despite the intestinal mucosal villi lining the luminal surface of the gut being the 
most susceptible to IR injury (Kalia et al., 2002), no studies have currently investigated the 
trafficking, recruitment or pathophysiological role of platelets within this area.  Also, 
recruitment of platelets due to exposure of subendothelial matrix proteins such as collagen, 
subsequent to endothelial denudation, has not been investigated following intestinal IR 
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injury.  Therefore, it is currently not known whether platelets are recruited to IR injured sites 
using specific platelet collagen receptors interacting with exposed collagen.  Interestingly, 
blockade of platelet receptors in large arteries has shown great insight into possible future 
drug targets to decrease vascular complications such as myocardial infarction (Massberg et 
al., 2002) and stroke (Zoppo 1998).  
 
This chapter therefore aimed to investigate whether murine intestinal IR injury led to 
exposure of subendothelial ECM and whether platelets subsequently formed thrombi on this 
surface. Initially, the recruitment of platelets to IR injured SI using the traditional method of 
fluorescently labelling only donor-derived platelets was investigated.  However, donor 
labelled platelets only represent approximately 5% of a normal murine circulating platelet 
population when re-introduced into a recipient mouse (Cooper et al., 2002).  This 
methodology allows individual platelet interactions with endothelium and free flowing 
individual platelets to be identified but does not identify aggregates of platelets or thrombi 
typically present after ECM exposure.  In order to quantitate the latter, all endogenous 
platelets of the mouse undergoing the ischaemic injury need to be labelled (Falati et al., 
2003).  We therefore introduced CFSE (green) fluorescently labelled donor platelets into a 
mouse in which all the IIb subunit of the endogenous platelets had been labelled with Alexa 
594 (red).  This methodology allows thrombi, free flowing platelets, and single platelets to be 
quantitated within the same in vivo experiment and thus substantially decreases the number 
of animals required.  The mucosal villi are most susceptible to ischaemic injury and hence 
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severe microcirculatory damage that will lead to endothelial denudation will most likely 
occur in this region.  Therefore, the studies have focused predominantly on monitoring 
platelet activity in this region of the gut.  Numerous studies have identified inflammatory 
leukocytes as the main effector cell in IR injury with leukocyte adhesion to vessel walls 
considered one of the most damaging events taking place during IR injury (Kiss et al., 2008).   
This chapter therefore compared leukocyte and platelet recruitment within the IR injured 
mucosal villi intravitally.   
 
3.1.2  Hypothesis 
For the work included in this chapter we hypothesized: 
1. The recruitment of platelets would be greatest within the mucosal villi due to the high 
susceptibility of this luminal surface to intestinal IR injury.   
2. The recruitment of platelets would be increased as the duration of ischaemia and 
reperfusion, and thus severity of injury, was increased.   
3. Platelet recruitment would manifest itself in the form of microthrombi forming on 
exposed ECM rather than just adhesion of individual platelets to activated 
endothelium. 
4. Circulating platelets would become activated when trafficking though the injured gut 
environment and become ‘primed’ or more likely to adhere to remote sites. 
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3.2. Methods 
The methods used in this chapter are described in detail in Chapter 2 and briefly below.   
 
3.2.1 Does fluorescently labelling donor platelets with CFSE or endogenous platelets with 
Alexa 594 lead to their inadvertent activation? 
Donor platelets were fluorescently labelled with CFSE and endogenous platelets with Alexa 
594 for intravital in vivo studies. To determine whether labelling with either of these 
fluorescent dyes could cause inadvertent platelet activation (which would lead to in vivo 
adhesion of platelets to vessel walls), in vitro platelet aggregations were undertaken.  The 
aggregatory response to collagen or thrombin of labelled and unlabelled platelets was 
determined and compared.  
 
3.2.2. Can the duration of ischaemia affect platelet recruitment?  
Experimental intestinal IR injury can be fatal and is thus associated with high mortality rates, 
especially if it involves the entire gut.  For this reason, most studies have focussed on 
segmental intestinal ischaemia whereby the blood vessel supplying a small segment (1-2cm) 
is occluded. However, this is not a frequent clinical occurrence and in most conditions, 
ischaemic injury to the whole of the SI occurs.  In order to identify a protocol for total IR 
injury which did not cause mortality within the intravital observation period, we performed 
experiments on 20-25g C57Bl/6 mice subjected to varying periods of ischaemia followed by 4 
hours reperfusion.  The aim was to identify a protocol that allowed for significant vascular 
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damage to occur without leading to mortality.  A long post-reperfusion period (4hrs) allowed 
platelet events to be monitored as the injury became progressively worse.  Intestinal 
ischaemia was achieved by clamping the superior mesenteric artery.  Animals were divided 
into 4 groups as shown below and assessed for survival.   
 
Duration of Ischaemia (mins) Duration of Reperfusion 
(mins) 
Number of animals 
15 240  5 
30 240 5 
45 240 5 
60 240 3 
Long durations of intestinal ischaemia were associated with a high mortality rate and were 
therefore unsuitable for continuous intravital monitoring.  Respiratory distress and mortality 
was observed in 100% of animals subjected to 60 min ischaemia either during the ischaemic 
phase or immediately upon reperfusion.  Survival throughout the 4 hr reperfusion phase was 
observed only in animals undergoing 15, 30 and 45min ischaemia and so some data is 
presented for mice undergoing ischaemia for these durations.  However, the majority of 
studies within this chapter, and all subsequent experiments within this thesis, were 
conducted on animals undergoing 45 minutes ischaemia and 4 hours reperfusion.  
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3.2.3. Intravital Microscopy 
The carotid artery and trachea were cannulated and the animal subjected to either sham or 
IR treatment.  Animals underwent 15, 30 or 45 min ischaemia followed by up to 4 hrs 
reperfusion. Preliminary experiments were conducted with only CFSE-labeled donor platelets 
administered via the carotid artery. Thereafter, we developed the methodology and 
conducted novel experiments combining ex vivo administration of CFSE-labeled donor 
platelets into animals in which endogenous platelets were labeled with Alexa 594.  This Alexa 
dye was systemically administered following conjugation with a non-blocking CY3 antibody 
that recognises the major platelet integrin CD41 / IIb (Falati et al., 2004). During reperfusion, 
a field of view from the proximal jejunum or the terminal ileum was pre-selected for 
continuous observation and platelet activity was analysed. Recordings were made every 30 
minutes.  Individual CFSE-labeled donor platelets were defined as adherent if they remained 
stationary in the field of view for >30 seconds, while remaining cells were classified as free 
flowing if they were present for <2 seconds.  The size and fluorescent intensity of CD41/Alexa 
594-labeled microthrombi was determined using image analysis software as previously 
described (Chapter 2, Section 3.2). 
The systemic administration of FITC-BSA allowed vascular macromolecular leakage to be 
quantitated.  Leakage is used as an indicator that the integrity of the vessel wall has been 
disturbed.  Increased fluorescent intensity outside the microvessels, which can be 
quantitated, is directly proportional to macromolecular leakage.  Histological haematoxylin 
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and eosin (H&E) staining was used to visualise mucosal villi in sham and IR injured small 
intestine.   
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3.3 Results 
 
3.3.1. Fluorescently labeling platelets with CFSE or Alexa 594 does not lead to inadvertent 
activation as determined in vitro 
In vitro aggregation analysis of collagen and thrombi stimulated CFSE and Alexa 594-labelled 
platelets showed no significant effect on platelet activatory function in comparison with 
sham washed platelets (Figures 3.1a and 3.1b). These findings coincide with (Cooper et al., 
2003) who showed similar results when labelling with CFSE.   
 
3.3.2 Singular CFSE-labelled platelet adhesion increases and free flowing platelet number 
decreases in the ileum as intestinal IR injury is intensified  
The adhesion of individual CFSE labelled donor platelets increased within the ileal mucosal 
villi as the ischaemic duration increased from 15 to 45 minutes (Figure 3.2a).  At 1 hour 
reperfusion, significantly increased platelet adhesion was observed with 45 minutes 
ischaemia when compared to sham controls (p<0.001).  At 4 hours reperfusion, significantly 
increased platelet adhesion was observed with 30 (p<0.001) and 45 (p<0.001) minutes 
ischaemia when compared to sham controls.  Furthermore, the numbers of adherent 
platelets was greater at 4 hours reperfusion when compared to 1 hour reperfusion (p<0.001 
for animals undergoing 30 minutes ischaemia).   
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Numbers of free flowing platelets significantly decreased as ischaemic period increased.  At 1 
hour reperfusion, significantly decreased numbers were observed only with 45 minutes 
ischaemia (p<0.001) when compared to sham controls.  At 4 hours reperfusion, significantly 
decreased numbers were only observed with 45 minutes ischaemia when compared to sham 
controls (p<0.001).  Furthermore, numbers of free flowing platelets demonstrated a trend to 
decrease at 4 hours reperfusion in mice undergoing 30 and 45 minutes ischaemia compared 
to 1 hour reperfusion (Figure 3.2b).  This decrease could be due to either the increase in 
platelets adherent to vessel walls limiting the numbers of circulating platelets, or simply due 
to a decrease in blood flow rates within the injured gut.  The lack of adherent platelets 
witnessed in sham animals provided futher evidence that the CFSE labelling technique did 
not pre-activate platelets, but also that the surgical manipulation of the gut was insufficient 
to cause vessel wall activation.  
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Figure 3.1. Fluorescently labeling platelets with CFSE and Alexa 594 does not lead to 
inadvertent activation as determined in vitro. Washed unlabelled and labeled (both CFSE 
and CD41/Alexa 594) platelets (2 x108/ml) were stimulated with (a) 0.1U/ml Thrombin or (b) 
3 g/ml collagen and the change in optical density indicative of aggregation recorded (arrow 
head is when agonist was added). The images are from one experiment that is representative 
of three.  
80 % 
80 % 
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Figure 3.2. Singular CFSE-labelled platelet adhesion increases and free flowing platelet 
number decreases in the ileum as intestinal IR injury is intensified.  Recruitment of CFSE 
labelled donor platelets to the microcirculation of the ileal mucosal villi was examined 
intravitally.  Platelets (1 x 108 platelets, 10μM CFSE) derived from wild-type mice were 
introduced prior to IR injury. (a) Donor platelet adhesion was significantly increased as the 
ischaemic episode and duration of reperfusion was increased. (b) Numbers of free flowing 
platelets significantly decreased as the ischaemic period and duration of reperfusion 
increased.  Representative images of CFSE labelled donor platelets adherent within ileal villi 
at 60 minutes post-reperfusion in (c) sham and (d) 45 minutes ischaemia + reperfusion. Plots 
in panels a and b are representative of mean + SEM of at least 5 separate experiments; Black 
bars = 1 hour reperfusion ;  white bars = 4 hours reperfusion.  ***p<0.001 when compared 
using a one way ANOVA followed by Bonferroni post test to determine points of significance. 
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3.3.3. Singular CFSE-labelled platelet adhesion increases in jejunum more so than in ileum  
Interestingly, we observed that intestinal IR injury was associated with a difference in the 
degree of singular platelet adhesion within different sites of the SI.  Numbers of adherent 
platelets were almost 3 fold higher within jejunal mucosal villi when compared to ileal 
mucosal villi (Fig 3.3a).  Within the ileum, more platelets adhered as the reperfusion period 
increased.  However, within the jejunum, there was no significant difference in the numbers 
of adherent platelets at 1 and 4 hours reperfusion. Interestingly, platelet adhesion within 
larger serosal and mesenteric vasculature was limited with adherent numbers not exceeding 
between 1-2 cells throughout reperfusion (Figure 3.3b).  Free flowing platelets in these larger 
vessels, assessed either through manually counting (serosa; Figure 3.4a) or by measuring 
their intensity (mesentery; Figure 3.4b), significantly decreased at 1 and 4 hours post-
reperfusion, indicative of platelet becoming adherent elsewhere.  The fate of free flowing 
platelets within the jejunum after IR injury will be described later in Section 3.2.5. 
 
DUAL LABELLING STUDIES 
 
3.3.4. Alexa 594-labelled microthrombi are observed in the jejunum more so than in the 
ileum 
Since 45 minutes ischaemia followed by 4 hours reperfusion gave rise to the greatest number 
of CFSE labelled individual platelets adhering within the ileum and jejunum, the formation of 
microthrombi was investigated in mice undergoing this injury protocol.  The total size and 
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fluorescent intensity of all Alexa 594-labelled microthrombi was determined within the 
jejunum and ileum.  No microthrombi were observed in sham controls in any region.  
However, significantly increased numbers of microthrombi of high intensity were observed in 
the jejunum (Figure 3.5a-b) relative to the ileum (Figure 3.5c-d).  Furthermore, they were 
also much larger.  
 
3.3.5. IR injury of the jejunum is associated with complete cessation of blood flow  
As already stated in sections 3.2.2 and 3.2.3, individual CFSE-labelled platelet adhesion was 
greater in the jejunum compared to the ileum.  Figures 3.6a (jejunum) and 3.6c (ileum) 
present this data again but this time as a continuous graph over the 4 hour reperfusion 
period (Figures 3.6a and c).  No free flowing platelets were observed in the jejunum, 
indicating no blood flow and complete flow occlusion in this region of the small intestine 
(Figure 3.6b).  As already stated in section 3.2.2 the numbers of free flowing CFSE-labelled 
donor platelets within the ileum was reduced but not abolished suggesting there was still 
blood flow within the ileum (Figure 3.6d)   
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Figure 3.3. Singular CFSE-labelled platelet adhesion increases in the jejunum more so than 
in the ileum.  Donor platelets (1 x 108 CFSE labelled platelets) derived from wild-type mice 
were introduced prior to IR injury. (a) Donor platelet adhesion to the microcirculation of ileal 
villi was significantly increased at 1 and 4 hrs compared to sham.  Donor platelet adhesion to 
the microcirculation of the jejunal villi was significantly increased compared to sham.  More 
adherent with jejunum than ileum.  (b)  Only sparse recruitment of 1-2 platelets was 
observed within the larger vessels of the jejunum serosa and mesentery.  Representative 
images are shown of donor platelet recruitment at 60 minutes post-reperfusion within 
jejunal  villi (c) mesentery (d) and serosa (e). Plots in panel a and b are representative of 
mean + SEM of at least 5 separate experiments, *p<0.05, **p<0.01, ***p<0.001 when 
compared using a one way ANOVA followed by Bonferroni post test for points of significance.  
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Figure 3.4. Singular CFSE-labelled free flowing platelet number decreases in serosal and 
mesenteric vessels during intestinal IR injury.  Recruitment of CFSE labelled donor platelets 
to the circulation of the jejunal serosa and mesentery was examined intravitally.  Platelets (1 
x 108 platelets, 10μM CFSE) derived from wild-type mice were introduced prior to IR injury. 
Numbers of free flowing platelets or the average intensity of slowing platelets significantly 
decreased during intestinal IR injury in both the (a) serosa and (b) mesenteric vasculature.  
Plots in panels a and b are representative of mean + SEM of at least 5 separate experiments; 
Black bars = 1 hour reperfusion;  white bars = 4 hours reperfusion). *p<0.05, **p<0.01, 
***p<0.001 when compared using a one way ANOVA followed by Bonferroni post test to 
determine points of significance. 
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Figure 3.5. Alexa 594-labelled platelet microthrombi are observed in the jejunum more so 
than in the ileum.  The formation of microthrombi (20μl GPIIb ab conjugated to 40 μl Alexa 
594 introduced prior to IR injury) within the jejunal and ileal mucosal villi was examined 
intravitally. The size (represented as pixels) and fluorescent intensity of the microthrombi 
were significantly increased at all time points in IR mice within both the (a-b) jejunum and (c-
d) ileum when compared to sham controls.  For all figures, the grey line = sham controls; 
black line = IR injured animals.  Figures represent mean + SEM of at least 5 separate 
experiments; ***p<0.001 when compared using a two way ANOVA followed by Bonferroni 
Post Test for points of significance. 
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Figure 3.6. Singular CFSE-labelled platelet adhesion increases in the jejunum more so than 
in the ileum.  Furthermore, no free flowing platelets are observed in the jejunum. Donor 
platelets (1 x 108 platelets, 10μM CFSE) derived from wild-type mice were introduced prior to 
IR injury. (a) Donor platelet adhesion to the microcirculation of the jejunal villi was 
significantly increased compared to sham jejunum. (b)  No free flowing platelets were 
observed in the jejunum at any time point indicative of no flow in this region. (c) Donor 
platelet adhesion was also increased within the ileum but less so than the jejunum. (d) 
Numbers of free flowing platelets decreased within the ileum over time.  For all figures, the 
grey line = sham controls;  black line = IR injured animals.  Figures represent mean + SEM of 
at least 5 separate experiments; **p<0.01, ***p<0.001 when compared using a two way 
ANOVA followed by Bonferroni Post Test for points of significance.   
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3.3.6. Dual labelling allows individual platelets and microthrombi to be observed in the 
same animal at the same time 
The CFSE-labelled individual donor platelets could be seen both adherent within, and thus 
associated with a microthrombus, but also on their own.  When not associated with a 
thrombus, they appeared green and those out of focus appeared larger than the very small 
ones in the focal plane. Those associated with a microthrombus appeared yellow due to the 
mixture of fluorescence from green individual platelets and red microthrombi (Figures 3.7a-
b). We observe the same sized green fluorescent areas flowing freely through the 
vasculature. This suggests that these platelets are inactive and consequently of single 
formation. However, though highly unlikely, it cannot be ruled out that these green 
fluorescent areas may consist of more than one platelet   
 
3.3.7.  The proximal jejunum is more susceptible to intestinal IR injury than the ileum 
As described above, greater levels of individual platelet adhesion and microthrombus 
formation as well as complete cessation of blood flow was observed within the jejunum 
rather than the ileum.  In the ileum, limited microthombus formation was observed and the 
blood flow to this region of the gut was maintained. These microscopic observations were 
paralleled by a difference in the degree of macroscopic injury observed within these two 
regions.  The jejunum underwent severe injury, especially with 45 minutes ischaemia, and 
appeared haemorrhagic, severely congested and swollen upon reperfusion.  In contrast, the 
terminal ileum looked relatively normal grossly (Figures 3.8a-b).    
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Figure 3.7. Intestinal IR injury was associated with both increased adhesion of singular 
CFSE-labelled donor platelets as well as the formation of microthrombi within the villous 
microcirculation.  (a)  Only singular green CFSE-labelled donor could be observed adherent 
within both sham controls. (b) Singular green CFSE-labelled donor and red Alexa 594-labelled 
endogenous microthrombi could be observed within the jejunum.  Singular platelets were 
either adherent on their own as illustrated in (a) or contained with a microthrombus, and 
thus appearing yellow, as illustrated in (b).  Representative images are shown of sham and 
jejunal microcirculation at 60 minutes post reperfusion.  
50µm 
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Figure 3.8. Intestinal IR injury was associated with a difference in the degree of 
macroscopic injury in the jejunum and the terminal ileum.  (a)  The ileum appeared 
relatively healthy after 45 minutes ischaemia and 4 hours reperfusion.  (b) The proximal 
jejunum underwent severe injury, especially with 45 minutes ischaemia, and appeared 
haemorrhagic, severely congested and swollen upon reperfusion.  Representative images are 
shown of IR injured ileal and jejunal segments at 4 hours post-reperfusion. 
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3.3.8. Increased vascular macromolecular leakage is observed within the jejunal mucosa 
and not the ileal mucosa. 
Significantly (p<0.001) increased macromolecular leakage was observed within the jejunal 
mucosa at 4 hours post-reperfusion when compared to sham jejunum (Figure 3.9).  This is 
often used as an indicator to suggest the integrity of the endothelial barrier is disturbed.  It 
was frequently observed that almost the whole field of view appeared fluorescent within the 
IR injured jejunum.  Although there was some increase in macromolecular leakage from the 
ileal mucosa, this did not reach significance when compared to sham ileum (Figures 3.9 and 
3.10a-d).   
 
 
3.3.9. Increased injury, as determined histologically and using SEM, is observed within the 
jejunum compared to the ileum 
The villi from sham jejunal mucosa, sham ileal mucosa and IR injured ileal mucosa were 
healthy looking finger-like structures (Figure 3.11a-b). However, the villi within the IR injured 
jejunal mucosa after 4 hours reperfusion showed a distinct decrease in jejunal villous length, 
mucosal sloughing and with areas of inflammation visible around the crypt areas (Figure 
3.11c).  Scanning electron microscopy (SEM) of this region clearly showed exposure of the 
ECM through the visualisation of collagen fibres.  Platelet microthrombi, apparently adherent 
to the ECM collagen fibres, were also observed (Figure 3.11d). This was not observed in sham 
tissue or in IR injured ileal tissue. 
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Figure 3.9.  Increased vascular macromolecular leakage is observed within the jejunal 
mucosa and not the ileal mucosa.  Leakage was analysed by systemically administering FITC-
BSA at 4 hours reperfusion.  The fluorescent intensity within a field of view was determined 
using the slidebook software. A significant increase was seen in fluorescent intensity to the 
jejunal villi during IR injury. A small and insignificant increase in vascular leakage was 
observed within the ileum.       Plots in are representative of mean + SEM of at least 5 
separate experiments, ***p<0.001 when compared using a one way ANOVA followed by 
Bonferroni Post Test for points of significance.   
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Figure 3.10.  Increased vascular macromolecular leakage is observed within the jejunal 
mucosa and not the ileal mucosa.  Leakage was analysed by systemically administering FITC-
BSA at 4 hours reperfusion. Representative images are shown of vascular leakage at 4 hours 
reperfusion within (a) sham jejunum (b) sham ileum (c) IR ileum and (d) IR jejunum 
a b 
c d 
35µm 
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Figure 3.11. Histological damage to jejunal villi in IR injured mice (magnification x200 for 
light microscopy images and x22942 for SEM).  C57BL/6 mice were subjected to small 
intestinal IR injury.  At 4 hours reperfusion, the jejunum was removed for histological analysis 
and H&E staining. Representative images from (a) sham jejunal mucosa and (b) ileal mucosa 
seen in sham and IR.  The villous structures are healthy, with no sloughing of epithelial cells 
observed at the tips of the villi.  (d) In contrast, severe jejunal mucosal villous damage with 
inflamed crypts was observed in seen in mice undergoing 45 minutes ischaemia and 4 hours 
reperfusion. (d) Representative SEM image of an IR injured jejunal mucosal villous 
microcirculation which shown an area where the ECM is exposed and platelet microthrombi 
are observed on the collagen fibres.   
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3.3.10. Platelets derived from IR injured mice do not aggregate in response to collagen nor 
do they aggregate on collagen under in vitro flow conditions 
Having demonstrated the development of microthrombi within the injured jejunal 
microcirculation, we postulated whether the circulating platelets that traffic through injured 
gut, but do not actually adhere, were potentially capable of adhering to injured remote extra-
digestive sites as a result of becoming activated or ‘primed’ in the gut.   We therefore, 
removed platelets from sham and IR injured mice and investigated their aggregatory 
response to collagen and thrombin.  Furthermore, their adhesion to collagen in an in vitro 
flow assay was also determined.  Sham and IR platelets aggregated in response to the agonist 
thrombin.  However, a significant (p<0.001) reduction in the aggregation of IR platelets was 
observed in response to collagen when compared to sham platelets (Figure 3.12a). A 
significant (p<0.001) reduction in the ability of platelets derived from animals 2 hours post-
reperfusion to aggregate on collagen coated capillary tubes under flow conditions was also 
observed compared to platelets derived from sham animals (Figure 3.12b-d).   
 
3.3.11.  Leukocyte recruitment is only increased within the ileal and not the jejunal villi 
Endogenous leukocytes were labelled with acridine orange injected via the carotid artery and 
observed intravitally. The number of leukocytes significantly increased within the ileal villi 
after both 1 (p<0.001) and 4 (p<0.001) hours post-reperfusion when compared to sham 
controls, with more observed as the duration of reperfusion increased.  However, no 
increase in leukocyte numbers was observed within the jejunum (Figure 3.13a-e).  
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Figure 3.12. Platelets derived from IR injured mice do not aggregate in response to collagen 
in an aggregometer nor do they aggregate on collagen under in vitro flow conditions.  (a) 
Washed sham (blue bars) and IR platelets (black bars) (2 x108/ml) were stimulated with 
0.1U/ml thrombin or 3ug/ml collagen and the change in optical density indicative of 
aggregation was analysed at 2 mins post agonist administration. A significant decrease was 
only witnessed when activating IR platelets with collagen. (b) 500ul of  mouse blood anti-
coagulated with P-Pack and heparin was perfused through collagen coated microslides at a 
shear rate of 300s-1. After washing for 3 mins, 5 random images were then taken using an 
Olympus digital camera. Representative images of demonstrating adhesion to collagen of 
platelets derived from (c) sham and (d) IR mice are shown. The graphical data represents 
mean  SEM of at least 5 separate experiments; ***p<0.001 when compared using a one 
way ANOVA followed by Bonferroni post-test for points of significance.       
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Figure 3.13. Leukocyte recruitment is only significantly increased within the ileal and not 
the jejunal villi. Recruitment of Acridine orange labelled leukocytes to the microcirculation of 
the ileal and jejunal mucosal villi was examined intravitally.  (a) A significant increase was 
seen in adherent leukocytes to the ileal villi during IR injury. No significant change was 
observed within the jejunal villi. (white bars = 1 h reperfusion ; black bars = 4 h reperfusion). 
Representative images are shown of leukocyte recruitment at 4 hours reperfusion within (b) 
sham ileum, (c) sham jejunum, (d) IR ileum and (e) IR jejunum.  Note the disturbed 
architecture of the jejunal villi and the congestion within the villous microcirculation.  Data 
are presented as mean + SEM of at least 5 separate experiments. *** p < 0.001 when 
compared using a two way ANOVA followed by Bonferroni Post Test for points of 
significance.  
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3.4. Discussion 
 
 
The most commonly used procedure for monitoring platelets within the microcirculation in 
vivo has relied on ex vivo labeling of platelets from donor mice and injecting them into the 
experimental mouse. This methodology achieves a labeled fraction in the recipient mouse of 
approximately 5% of all circulating platelets which can be monitored intravitally.  Platelet-
endothelial interactions or monolayer formation has been demonstrated in numerous 
experimental models of IR injury including the retina, liver and lungs using this method 
(Nishijima et al., 2001; Khandoga et al., 2002).  Although in larger diameter vessels 
undergoing severe FeCl3 injury, thrombus formed has also been observed made up of 
labelled donor platelets, (Renne et al., 2005), we did not observe any microthrombi formed 
primarily of CFSE-labeled donor platelets.  This may be due to the smaller diameters of the 
villous microvessels studied in which numbers of circulating donor platelets was far smaller 
than that observed in larger vessels.  However, we did demonstrate that intestinal IR injury 
led to the adhesion of singular platelets within the ileal and the jejunal villous 
microcirculation, with significantly more in the latter.  Furthermore, we were able to 
demonstrate that numbers of free flowing platelets in the ileum decreased, partly indicative 
of reduced blood flow in this region.  Within the jejunum, we were unable to monitor any 
free flowing platelets, which was due to complete cessation of blood flow within this area.  
The activity of platelets within the intestinal mucosal villous microcirculation has not 
previously been monitored and so this new data demonstrated that platelets can be 
recruited to this lumenal surface and adhere to activated endothelium.   
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Unfortunately, this methodology doe not take into account platelet events that may be 
taking place due to the aggregation of unlabelled endogenous platelets.  Therefore, it is 
possible that previous studies using this methodology have underestimated the role of 
platelets in IR injury models. Hence we performed additional studies using a novel method of 
combining the fluorescent labeling of donor platelets with the labeling of all endogenous 
platelets in the recipient mouse. Considering the sheer numbers of platelets, labelling all of 
them red made it impossible to identify individual platelets and compromised quantification 
of freely flowing platelets and their interaction with endothelium.  But in combination with 
introducing  green donor platelets, we were able to quantitate three platelet activities – 
thrombus formation, individual platelet adhesion and circulating platelet numbers.   Overall, 
we have demonstrated that using only a single labelling methodology alone significantly 
underestimates the role of platelets in intestinal IR injury and it is only when using the dual 
labelling method have we been able to monitor platelet recruitment to areas of activated 
endothelium and exposed ECM. 
 
It is possible that the microthrombi observed were simply due to mechanical hindrance of 
the platelets.  Leukocyte retention in capillaries often results from mechanical hindrance of 
leukocyte transit through narrow capillary segments (Kuebler et al., 2000).  However, 
platelets are much smaller discoid cells with diameters of 2-3 µm.  Since capillaries have an 
approximate diameter of 5-6µm, mechanical hindrance of platelet transit and subsequent 
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platelet sequestration is unlikely.  More importantly, the electron microscopy studies 
demonstrated the presence of microthrombi within the microvasculature overlying areas of 
exposed collagen fibres.  These observations provide the first evidence to suggest platelet 
recruitment to IR injured intestinal vasculature could also occur through mechanisms other 
than interactions with activated endothelium.  The microthrombi and exposed collagen fibres 
were identified only within the jejunal capillaries and central arteriole of villi and not within 
the ileal, serosal or mesenteric macrovessles.  Also, the next chapter of this thesis provides 
further evidence that thrombosis occurs due to platelet-collagen interactions, as a function 
blocking antibody to GPIb, which links platelets to collagen via vWF, significantly inhibited 
microthrombus formation.  It is well documented that inhibition of platelet recruitment via 
interactions with exposed ECM, following IR injury, has positive effects on tissue and vascular 
damage. However, these studies have taken place within larger vessels such as the cerebral 
and mesenteric arteries, with little experimentation undertaken to show how platelet 
inhibition may benefit microvascular beds when ECM is exposed rather than just activated 
endothelium.   
 
Previous studies have focused only on the role of individual adherent platelets following 
intestinal IR reperfusion (Cooper et al., 2003; Massberg et al., 1998; Massberg et al., 1999). 
The numbers of platelets observed adherent in these studies appears to be higher than the 
numbers identified within the current study.  However, it is difficult to make direct 
comparisons.  For example, Massberg and colleagues demonstrated that approximately 400 
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platelets adhered within the serosa of the jejunum in their study (Massberg et al., 1998; 
Massberg et al., 1999).  However, they induced segmental ischaemia for 1 hour which most 
likely induced a greater degree of injury to that particular area than our study.  
Unfortunately, total intestinal ischaemia for this same duration resulted in 100% mortality 
either during the ischaemic phase or immediately upon reperfusion in our study.  
Furthermore, the observations of Massberg and colleagues were made in large submucosal 
arterioles and venules whereas the current observations were made in the relatively smaller 
villous microcirculation.  However, we did not observe such high numbers of platelets 
adherent within the large mesenteric or serosal vessels, but this could be due to their 
resistance to IR injury and higher flow rates and wall shear rates. 
 
The involvement of platelets was dependent upon the severity of ischaemic injury and, to a 
certain extent, the duration of reperfusion.  This was demonstrated by the observation that 
adhesion of individual platelets within the ileal microcirculation significantly increased with 
increased ischaemia.   The numbers of adherent platelets and the development of 
microthrombi, particularly within the jejunum, occurred immediately upon reperfusion and 
neither platelet event became significantly more severe with time.  Our earliest observation 
was within 30 minutes of reperfusion.  This suggests that endothelial activation (leading to 
adhesion of individual platelets) and endothelial denudation (leading to microthrombus 
formation) occurs either during the ischaemic phase or immediately upon reperfusion.  This 
has significant clinical importance when developing therapeutic regimens targeting platelets 
Chapter 3. Intestinal IR injury and platelets in vivo 
95 
 
during intestinal IR injury.   
 
It is possible that maximal platelet activity takes place early post-reperfusion and actually 
cannot be increased any further.  We demonstrated that the ability of platelets derived from 
IR injured mice to aggregate in response to collagen, either in an aggregometer or under flow 
conditions, was lost after 2 hours post-reperfusion i.e. IR injury platelets demonstrated a 
hypoaggregatory response.  Furthermore, Mr Rui Wu (intercalating BMedSci undergraduate 
project student) demonstrated that platelets derived from mice undergoing intestinal IR 
injury had normal adherent ability on collagen and endothelial cells in vitro under flow 
conditions at 10 mins post-reperfusion but lost this ability by 2 hours (Wu et al., 2010).  
Collectively, this may explain why we did not observe increased platelet adhesion with time.  
It is therefore possible that platelets present within the circulation of IR injured mice become 
irreversibly activated to a level incapable of undergoing secondary activation through weak 
to medium strength agonists.  Interestingly, IR injured platelets at 2 hours post-reperfusion 
were still able to aggregate in response to the strongest platelet agonist thrombin.  Similarly, 
Aydemir-Koksoy and colleagues also demonstrated significantly reduced aggregation of 
platelets isolated from rabbits undergoing intestinal IR injury platelet to collagen whereas 
platelets taken from animals undergoing only ischaemia were still able to aggregate 
(Aydemir-Koksoy et al., 1999). 
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Platelets are amongst the most vulnerable cells to oxidative injury due to their low anti-
oxidant reserve (Ambrosio et al., 1994).  Following IR injury, numerous systemic 
inflammatory mediators are released including oxygen free radicals (eg. H2O2), arachidonic 
acid products, cytokines and nitric oxide.  Platelets can become inactivated by these 
mediators and become hypoaggregatory in response to agonists such as collagen. Additional 
mechanisms have been reported to account for this platelet dysfunction, such as platelet 
membrane damage, alterations in platelet receptors and release of platelet granule contents 
(Boldt et al., 1996).  Indeed, reversible platelet dysfunction with impaired aggregation is a 
well known phenomenon associated with cardiopulmonary bypass surgery (Jung et al., 1995).  
Approximately 10% to 20% of patients undergoing cardiac operations exhibit inadequate 
haemostasis varying in its duration and severity and platelet transfusions are required to stop 
internal bleeding complications after surgery.    
It is interesting that the ileum is better at ‘coping’ with IR injury than the jejunum as was 
determined macroscopically, histologically and electron microscopically.  Only platelet-
endothelial interactions and limited vascular leakage was observed in the ileum even after 
high ischaemic episodes. This phenomenon has been investigated previously in pigs, in which 
similar observations to our own were witnessed (Chan et al., 1998).  The same group went on 
to show that basal nitric oxide levels are higher in the ileum than the jejunum in rats and 
decreased upon reperfusion of ischaemic regions (Chan et al., 1998(2)). This may provide one 
explanation for the segmental differences in susceptibility to injury. 
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Having identified platelets within the mucosal villous microcirculation, the critical question 
that remains is whether they have a pathophysiological role in intestinal IR injury. Several 
groups consider leukocytes as being primarily responsible for injury (Brown et al., 1990; Beuk 
et al., 2008).  Indeed, our in vivo observations within the ileal vasculature demonstrate a 
higher number of leukocytes rather than platelets within the ileum. However, adherent 
individual platelets and microthrombi were predominantly observed in the more severely 
injured jejunum.  Furthermore, less leukocytes were observed within this area when 
compared to the ileum.  These results suggest platelets may be the primary cell responsible 
for inducing injury within the jejunum microvasculature.  In order to determine whether 
platelets have a pathological role in intestinal IR injury, the remainder of this thesis will 
identify strategies to inhibit both platelet-endothelial and microthrombus formation and 
determine whether this confers any macroscopic and microscopic benefit. 
 
In conclusion this chapter has presented data obtained using a novel dual labeling 
methodology for platelets.  This method allows individual, aggregated and freely circulating 
platelets to be quantitated in vivo and will further permit their pathophysiological role to be 
determined.  We have also demonstrated that platelet recruitment varies in different sites of 
the gut and that recruitment is directly proportional to the severity of injury.  This may 
dictate which parts of the intestine would be better suited to act as a graft for procedures 
such as small bowel transplantation.  The transplanted graft undergoes a period of ischaemia 
when excised from the donor, and then reperfusion injury upon transplantation.   Therefore, 
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the terminal ileum may be a better choice of graft than the jejunum.  Interestingly, intestinal 
IR injury has a detrimental effect on circulating platelets as evidenced by their inability to 
aggregate in response to collagen both in an aggregometer and under flow conditions. This 
may be of beneficial event which could theoretically prevent the adhesion of activated 
platelets in remote extra-digestive sites.   
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4.0. Investigating the roles of GPIb  and P-selectin in mediating platelet recruitment to 
intestinal IR injured microvasculature 
4.1. Introduction and hypotheses 
4.1.1. Introduction 
The previous chapter presented novel data demonstrating that platelet recruitment within 
the IR injured gut manifests in two different forms.  Individual platelets were observed within 
the proximal jejunum and the terminal ileum, but less so in the latter region.  Furthermore, 
microthrombi were observed predominantly within the jejunum which also underwent the 
most severe injury.  It is likely that the microthrombi within the villous capillaries exacerbate 
or contribute to the development of tissue injury within the jejunum through the occlusion of 
microvessels and recruitment of inflammatory leukocytes.  Indeed, congested blood 
capillaries and lack of blood flow was observed in the jejunal mucosa.  This chapter aimed to 
investigate the molecular adhesive mechanisms governing platelet recruitment to the jejunal 
and ileal villous microcirculation, and determine whether inhibiting individual platelet 
recruitment and/or microthrombus formation conferred benefit to the gut.   
 
Most studies that have determined a critical role for platelets in IR injury have identified a 
critical role for P-selectin in permitting platelet-endothelial interactions (Massberg et al., 
1998).  Leukocyte adhesion has also been demonstrated to be dependent upon leukocyte 
PSGL-1 interacting with endothelial and platelet P-selectin (Cooper et al., 2003).  The 
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development of microthrombi has been attributed to the exposure of ECM matrix proteins, 
especially collagen, which leads to the subsequent adhesion, activation and aggregation of 
platelets (Vandendries et al., 2004).  It is therefore likely in our model, that in addition to P-
selectin, an additional mechanism is responsible for platelet recruitment and may involve 
platelet receptors that adhere to and become activated by exposed collagen.  Platelet 
adhesion under hydrodynamic shear stress is mediated by a number of receptors including 
GPIb-IX-V, GPVI and the integrins IIb 3 (GPIIb-IIIa) and 2 1 (GPIa/IIa).  As well as controlling 
haemostasis after vessel injury, these same receptors also contribute to mediating 
pathological processes involving platelets such as heart disease and stroke (Kleinschnitz et 
al., 2007).  The contributory role of collagen receptors will be investigated later, but the 
current chapter will present data obtained with regards the role of GPIb-IX-V, particularly the 
GPIb  subunit. 
 
GPIb-IX-V, constitutively expressed on platelets, is a complex of GPIb  disulphide-linked to 
GPIb  and non-covalently associated with GPIX and GPV in the ratio of 2:2:2:1 (Sachs et al., 
2003).  There are approximately 25,000 copies of GPIb  per platelet and it is the major sub-
unit which binds to vWF immobilised on exposed collagen at the site of injury.  This is 
commonly accepted as the first step in the formation of a haemostatic plug (Nieswandt et al., 
2003).  However, GPIb  also plays a key role in the process of platelet tethering or rolling on 
activated endothelium (Andre et al., 2000; Theilmeier et al., 2002).  This allows for their 
activation and subsequent adhesion.  Since both individual platelets and microthrombi were 
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observed within the IR injured gut, it is likely that the former is due to endothelial activation 
and the latter collagen exposure.  Therefore, GPIb  has the potential to be the major platelet 
receptor responsible for all types of platelet adhesion within the intestinal vasculature of this 
disease model.  Indeed, GPIb  has been shown to play a key role in platelet recruitment to 
cardiac and cerebral vessels in murine models of disease (Lowenberg et al., 2010).   
 
4.1.2 Hypothesis 
This chapter therefore aimed to investigate the roles of P-selectin and GPIb  in mediating 
platelet recruitment to the intestinal IR injured microvasculature.  Since we observed both 
platelet events (microthrombus formation and individual platelet adhesion) taking place in 
the jejunum, we predominantly focused on this region for this study.  For the work included 
in this chapter we hypothesized: 
 
1. Recruitment of individual platelets would be dependent upon P-selectin. 
2. Recruitment of microthrombi to the jejunum would be dependent upon GPIb . 
3. Reducing platelet recruitment, either through a P-selectin or a GPIb  dependent 
mechanism, would confer intravital, histologic and macroscopic benefit to the 
jejunum. 
4. Reducing platelet recruitment, either through a P-selectin or a GPIb  dependent 
mechanism, would also reduce leukocyte recruitment to the mucosa of the jejunum. 
 
Chapter 4.  Individual blockade of GPIb  and P-selectin
103
4.2. Methods 
Initially, FACS analysis was performed to allow us to demonstrate that the function blocking 
antibody concentration was sufficient to cause GPIb  receptor blockade of over 90%.   Donor 
platelets and endogenous platelets were blocked separately to increase confidence of GPIb 
inhibition. Receptor inhibition was not required for P-selectin investigations as knockout 
mice, with a C57Bl/6 background, were used. These mice were originally from the Jackson 
labs and the colony they originated from were the C57Bl/6J-Selptm1Bay colony. These mice 
were a generous gift from Professor Paul Hellewell (University of Sheffield, UK).    Fluorescent 
IVM was performed on male 20-25g wild-type C57Bl/6 mice or P-selectin-/- mice, receiving 
wild-type or P-selectin-/- donor platelets respectively.   All intestinal IR intravital 
investigations within this chapter used periods of 45 minutes ischaemia followed by 4 hours 
of reperfusion.  The carotid artery and trachea were cannulated and the animal subjected to 
either sham or IR treatment.  During reperfusion, the ileum and jejunum was monitored 
intravitally.  Free flowing platelets, individual adherent platelets and microthrombi were 
quantitated.  The systemic administration of FITC-BSA and Acridine orange allowed vascular 
macromolecular leakage and leukocyte adhesion to be quantitated.  Histological 
haematoxylin and eosin (H&E) staining was used to visualise mucosal villi.  In vitro adhesion 
assays were conducted to determine the role of GPIb and P-selectin in allowing adhesion of 
platelets to collagen under flow conditions and endothelial cells under static conditions.  
Flow cytometry was also performed to demonstrate the presence of circulating 
platelet/leukocyte aggregates. 
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4.3. Results 
4.3.1. Anti-GPIb  antibody does not affect systemic platelet numbers  
The first line of critical experimentation was to analyse the percentage receptor occupancy of 
the GPIb  function blocking antibody and also determine whether it’s systemic 
administration had any detrimental effects on platelet number.  Optimum antibody 
concentrations for complete receptor blockade were determined after injection of C57Bl/6 
mice with varying amounts of Xia B2 (anti-GPIbα antibody).  The antibody was allowed to 
circulate in the vasculature for 30 mins, after administration through the cannulated carotid 
artery.  50μl of blood was then incubated with 5ul of FITC conjugated Xia B2 and flow 
cytometry was used to detect the minimal amount of the necessary to achieve saturating 
GPIbα receptor binding in vivo.  Kleinschnitz and colleagues, who used a similar antibody for 
in vivo studies, used a concentration of 100ug to gain >90% inhibition (Kleinschnitz et al., 
2007).  Our receptor binding studies also proved that a concentration of 100ug was more 
than sufficient to achieve receptor occupancy of approximately 95% (Table 4.1).  Platelet 
counts in antibody-treated mice were not statistically different from the rat IgG control 
(Table 4.1). 
 Wt (no antibody) Rat IgG Anti-GPIb  IgG 
 
Receptor Occupancy % 
 
0 
 
0 
 
>95 
Platelet Count (x10
9
)/L 1254 ± 123 1318 ± 45 1156 ± 110 
    
Table 4.1.  The anti-GPIb  antibody achieves receptor occupancy of approximately 95% 
and does not affect circulating platelet number.  Values are mean  SD with p<0.05, 
unpaired Student t test).
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4.3.2. Individual platelet adhesion is not significantly decreased in the ileum of anti-GPIb  
mAb pre-treated or P-selectin-/- mice.   
Individual platelet recruitment was unaffected in either anti-GPIb  mAb treated or P-
selectin-/- mice (Figure 4.1a).  Free flowing platelets were also unaffected and did not 
increase in these mice (Figure 4.1b). The effects of an IgG control antibody on numbers of 
free flowing platelets was also determined in the ileum but no difference was observed 
(Figure 4.1c.).   
 
4.3.3. Microthrombus formation, but not individual platelet adhesion, is significantly 
decreased in the jejunum of anti-GPIb  mAb pre-treated animals.  Neither platelet event 
was reduced in P-selectin-/- mice.   
The formation of microthrombi in wild-type animals receiving the anti-GPIb  mAb was 
significantly (p<0.001) reduced when compared to un-treated sham animals undergoing 
intestinal IR injury (Figure 4.2a and 4.3b).  This reduction was observed at all time points 4 
hours post-reperfusion.  No decrease in the numbers of adherent individual platelets was 
observed, although during the early stages of reperfusion there was an insignificant decrease 
which reached similar numbers to those seen in wild-type animals 4 hours post-reperfusion 
(Figure 4.2b).  In contrast, formation of microthrombi in P-selectin-/- mice was not reduced 
when compared to un-treated animals undergoing intestinal IR injury (Figure 4.2a).  Again, 
no decrease in the numbers of adherent individual platelets was observed in P-selectin-/- 
(Figure 4.2b).   Free flowing platelets were only significantly increased in anti-GPIb  pre-
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treated animals during the early stages post-reperfusion up to 150 minutes post-reperfusion.  
However, during the later stages of reperfusion, no free flowing platelets were observed 
suggesting vascular occlusion was still occurring even though microthrombi formation had 
been inhibited (Figure 4.2c).  Furthermore, the IgG antibody did not have any effects on the 
formation of microthrombi in the jejunum as determined by quantitating their fluorescent 
intensity (Figure 4.2d). This evidence, along with other IgG controls stated within several in 
vitro adhesion, aggregatory and FACS experiments throughout this thesis, gives us the 
confidence that the internal effect of antibody administration in this model is negligible. 
 
4.3.4.  Marked macroscopic improvement of the jejunum was observed in anti-GPIb  mAb 
pre-treated animals during early reperfusion but this effect was not long lasting.  No 
benefit is observed in P-selectin-/- animals. 
As stated previously (Chapter 3, Section 3.2.7), the proximal jejunum in un-treated mice 
underwent severe injury following 45 minutes ischaemia and appeared haemorrhagic, 
severely congested and swollen upon reperfusion. This area had greater levels of individual 
platelet adhesion, microthrombus formation and complete cessation of blood flow.  
However, in anti-GPIb  mAb pre-treated mice, microthrombus formation was significantly 
reduced and despite significant individual platelet adhesion (Figure 4.3b), the jejunum 
appeared relatively healthy for about 3 hours post-reperfusion (Figure 4.4b).  However, this 
remarkable beneficial effect was not observed at 4 hours reperfusion.  No macroscopic 
benefit was observed in P-selectin-/- mice undergoing intestinal IR injury. 
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Figure 4.1. Individual platelet adhesion is not significantly decreased in the ileum of anti-
GPIb  mAb pre-treated or P-selectin-/- mice at 4 hours reperfusion.  Recruitment of CFSE-
labelled donor platelets to the microcirculation of ileal mucosal villi in sham, IR injured, 
GPIbα blocked or P-selectin-/- mice was examined intravitally. Wild-type, GPIbα blocked or P-
selectin-/- treated labelled platelets (Donor: 1 x 108 platelets, 10μM CFSE) were introduced 
prior to IR injury. (a) CFSE-labelled donor platelet recruitment was not significantly reduced 
in GPIbα blocked or P-selectin-/- mice.  (b) Free flowing platelets were not significantly 
increased in GPIb  blocked or P-selectin-/- mice in comparison to sham animals. (c) Free 
flowing platelets are unaffected by the administration of IgG antibodies in sham animals at 2 
hours reperfusion. Plots are representative of mean + SEM of at least 5 separate 
experiments. **p<0.01, ***p<0.001 when compared using a one way ANOVA followed by 
Bonferroni Post Test for points of significance. 
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Figure 4.2. Microthrombus formation is significantly decreased in the jejunum of anti-
GPIb  mAb pre-treated animals.  Neither platelet event was reduced in P-selectin-/- mice.  
Recruitment of CFSE-labelled donor and Alexa 594-labelled endogenous platelets to 
microcirculation of jejunal villi in wild-type, GPIbα blocked or P-selectin-/- mice was examined 
intravitally. Wild-type, GPIbα blocked or P-selectin-/- treated labelled platelets (Donor: 1 x 108 
platelets, 10μM CFSE; Endogenous: 20 μl GPIIb ab/ 40 μl Alexa 594) were introduced prior to 
IR injury. (a) Alexa 594-labelled endogenous microthrombi formation was only significantly 
reduced in GPIbα blocked mice. (b) CFSE-labeled donor platelet recruitment was not 
significantly reduced in GPIbα blocked or P-selectin-/- mice. (c) Free flowing platelets were 
significantly increased in GPIb  blocked animals during the early stages of reperfusion. (d) 
Microthrombi intensity was un-affected by the IgG antibody in IR animals at 2 hours 
reperfusion. Plots are representative of mean + SEM of at least 5 separate experiments. 
**p<0.01, ***p<0.001 when compared using a one way ANOVA followed by Bonferroni Post 
Test for points of significance.  
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Figure 4.3. Microthrombus formation, but not individual platelet adhesion, within the 
jejunum is significantly decreased in anti-GPIb  mAb pre-treated animals.  (a)  Singular 
green CFSE-labelled donor and red Alexa 594-labelled endogenous microthrombi could be 
observed within the jejunum of an un-treated animal undergoing IR injury.  Singular platelets 
were either adherent on their own or contained with a microthrombus, and thus appeared 
yellow.  (b) Alexa 594-labelled endogenous microthrombi formation was significantly 
reduced by pre-treatment with an anti-GPIbα mAb but CFSE labelled individual platelets are 
still observed. Representative images are shown of un-treated and GPIb  treated jejunal 
microcirculation at 4 hours post reperfusion 
75µm 
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Figure 4.4. Marked macroscopic improvement of the jejunum was observed in anti-GPIb  
mAb pre-treated animals during early reperfusion but this effect was not long lasting.  No 
benefit is observed in P-selectin-/- animals. (a) The proximal jejunum underwent severe 
injury following 45 minutes ischaemia and appeared haemorrhagic, severely congested and 
swollen upon reperfusion in wild-type animals. A representative image is shown of the 
jejunum at 4 hours post-reperfusion.  (b) The jejunum appeared relatively healthy after 45 
minutes ischaemia and 1 hour reperfusion in mice receiving the anti-GPIb  mAb.  A 
representative image is shown of the jejunum at 1 hour post-reperfusion.  However, this 
remarkable beneficial effect was not observed at 4 hours reperfusion (not shown). 
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4.3.5. Macromolecular leakage from the jejunum was significantly reduced in anti-GPIb  
mAb pre-treated animals during early reperfusion but this effect was not long lasting.  No 
benefit is observed in P-selectin-/- animals. 
The jejunum showed a significant (p<0.001) decrease in vascular leakage in anti-GPIb  mAb 
pre-treated mice at 1 hour reperfusion when compared to wild-type animals undergoing IR 
injury (Figure 4.5).  However, this decrease was not observed at 4 hours post-reperfusion at 
which point similar interstitial fluorescence was recorded to that of IR injured wild-type mice 
observed.  No change in leakage was observed in P-selectin-/- mice at any point post-
reperfusion (Figure 4.5).  
 
4.3.6. No histological improvement of the jejunal mucosal villi was observed in anti-GPIb  
mAb pre-treated animals or in P-selectin-/- at 4 hours post-reperfusion. 
No improvement in the histology of the jejunal mucosa was observed in wild-type mice pre-
treated with an anti-GPIb  mAb or in P-selectin-/- at 4 hours reperfusion (Figure 4.6).  
Unfortunately, histology was not performed on specimens from animals pretreated with 
anti-GPIb  mAb at 1 hour reperfusion.   
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Figure 4.5. Macromolecular leakage from the jejunum was significantly reduced in anti-
GPIb  mAb pre-treated animals during early reperfusion but this effect was not long 
lasting.  No benefit is observed in P-selectin-/- animals. Macromolecular leakage was 
analysed by systemically administering FITC-BSA, at 4 hours post-reperfusion.  The increased 
fluorescence per field of view was monitored intravitally. (a) Significant increases in 
fluorescent intensity to the jejunal villi was observed in wild-type mice after 1 hour post-
reperfusion and also in animals receiving the anti-GPIb  mAb at 1 and 4 hours post-
reperfusion and in P-selectin-/- mice.  Representative images are shown of vascular leakage 
from (b) wild-type animals 4 hours post-reperfusion IR jejunum (c) anti-GPIb  mAb pre-
treated animals at 1 hour post-reperfusion and (d) 4 hours post-reperfusion. Data is 
representative of mean + SEM of at least 5 separate experiments. **p<0.01, ***p<0.001 
when compared using a one way ANOVA followed by Bonferroni post test for points of 
significance. 
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Figure 4.6. No histological improvement of the jejunal mucosal villi was observed in anti-
GPIb  mAb pre-treated animals or in P-selectin-/- at 4 hours post-reperfusion 
(magnification x200).  (a) Sections from wild-type shams showed healthy jejunal mucosa. (b) 
Sections from IR injured mice and from those (c) receiving the anti-GPIb  mAb demonstrated 
severe mucosal sloughing and inflamed crypt areas at 4 hours post-reperfusion.  (d) Similar 
results were also observed in P-selectin-/- mice at 4 hours post-reperfusion.  
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4.3.7. Individual platelet adhesion was significantly increased in the jejunum in anti-GPIb  
mAb pre-treated animals.  This was only demonstratable once the numbers within and 
outside the microthrombi were analysed.  
As mentioned above, individual platelet adhesion did not change in animals receiving the 
anti-GPIb  mAb.  However, on closer inspection, we identified that some of the individual 
platelets were actually contained within the microthrombi but had been quantitated as 
singular platelets (appeared yellow – Figure 4.3a). We therefore re-counted the numbers of 
individual CFSE-labelled green platelets within the microthrombi and those located outside 
the microthrombi at 4 hours post-reperfusion.   On doing so, we observed that anti-GPIb  
mAb pre-treated mice showed a significant (p<0.01) decrease in platelets inside the 
microthrombi at 4 hours post-reperfusion (Figure 4.7). Furthermore, we were also able to 
demonstrate that individual platelets outside of the thrombus, even though of an increased 
trend, were statistically unaltered i.e. the ‘genuine’ singular platelets, in mice receiving the 
anti-GPIb  mAb (Figure 4.7).  
 
4.3.8. Platelets derived from IR injured mice do not adhere to collagen under flow 
conditions in vitro but platelets derived from IR injured mice pre-treated with an anti-
GPIb  mAb do adhere. 
Murine whole blood containing wild-type platelets, wild-type IR platelets, wild-type platelets 
+ anti-GPIb   mAb or wild-type IR platelets + anti-GPIb  mAb was flowed over collagen 
coated capillary tubes in vitro.  Wild-type anti-GPIb  mAb pre-treated platelets showed an 
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expected significant (p<0.001) decrease in adhesion when compared to wild-type controls 
(Figure 4.8a).  This decreased adhesion was not as great as the complete inhibition previously 
described for platelets derived from IR animals (Figure 4.8a, but initially described in Section 
3.3.10 and Figure 3.12).  Hence IR injury inhibited the adhesion of platelets to collagen more 
strongly than the anti-GPIb  mAb.  Interestingly, the adhesion of platelets derived from 
animals undergoing IR injury but receiving an anti-GPIb mAb was not the same as IR animals.  
Indeed, a significant (p<0.01) increase in platelet adhesion was observed in wild-type mice 
undergoing IR injury pre-treated with an anti-GPIb  mAb when compared to non-treated IR 
mice (Figure 4.8a). 
 
4.3.9. Platelets derived from IR injured mice do not adhere to activated endothelium under 
static conditions in vitro but platelets derived from IR injured mice pre-treated with an 
anti-GPIb  mAb do adhere.  
At 2 hours post-reperfusion, 500ul of mouse blood were incubated on endothelial coated 
coverslips for 45 minutes. After washing 3x with PBS, coverslips were mounted and 5 random 
images were then taken using an Olympus digital camera. Treatment of both TGF  and TNF  
induced a significant (p<0.001) increase in platelet adhesion (Figure 4.9a).  This was 
significantly (p<0.05) reduced by pre-treatment with an anti-GPIb  mAb but was not as great 
as the reduction observed with platelets derived from IR animals.  Hence IR injury inhibited 
the adhesion of platelets to endothelium more strongly than the anti-GPIb  mAb.  
Interestingly, the adhesion of platelets derived from animals undergoing IR injury but 
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receiving an anti-GPIb mAb was not the same as IR animals.  Indeed, a significant (p<0.01) 
increase in platelet adhesion was observed in wild-type mice undergoing IR injury pre-
treated with an anti-GPIb  mAb when compared to non-treated IR mice (Figure 4.9a). 
 
4.3.10. Leukocyte-endothelial and circulating leukocyte-platelet interactions following IR 
injury increase significantly in anti-GPIb  mAb pre-treated mice  
As previously presented in Chapter 3, leukocyte adhesion after IR injury did not increase in 
the jejunum when compared to sham controls, and the only leukocyte increase was observed 
in the ileum (as previously described in Figure 3.13a).  However, a significant (p<0.001) 
increase in leukocyte adhesion in the jejunum was observed at 4 hours post-reperfusion in IR 
injured mice pre-treated with an anti-GPIb  antibody when compared to untreated IR 
injured mice (Figure 4.10). We further investigated in vitro by FACS analysis, the interaction 
of circulating leukocytes with platelets.  Circulating numbers of platelet-leukocytes 
aggregates were significantly (p<0.01) increased at 4 hours post-reperfusion in IR injured 
mice pre-treated with a anti-GPIb  mAb when compared to untreated IR injured mice 
(Figure 4.11).  Investigation into leukocyte recruitment or circulating platelet-leukocyte 
aggregates in P-selectin-/- mice undergoing IR injury was not performed as no benefit from IR 
injury was observed in these mice.   
A summary of the major findings from this chapter are presented in Table 4.2.  The data has 
been obtained from the jejunum following IR injury as both microthrombus formation and 
adhesion of individual platelets was observed in this region.  
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Figure 4.7. Individual platelet adhesion was significantly increased in the jejunum in anti-
GPIb  mAb pre-treated animals.  This was only demonstratable once the numbers within 
and outside the microthrombi were analysed.  Black bars = IR injury in wild-type mice; grey 
bar = IR injury in wild-type type mice with receiving the anti-GPIbα mAb.  Data is 
representative of mean + SEM of at least 5 separate experiments, **p<0.01 when compared 
using a one way ANOVA followed by Bonferroni post test for points of significance. 
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Figure 4.8. Platelets derived from IR injured mice do not adhere to collagen under flow 
conditions in vitro but platelets derived from IR injured mice pre-treated with an anti- 
GPIb  mAb do adhere.  At 2 hours reperfusion, 500ul of mouse blood, anti-coagulated with 
P-Pack and heparin, was perfused through collagen coated microslides at a shear rate of 
300s-1. After washing for 3 mins, 5 random images were then taken using an Olympus digital 
camera. (a) A significant increase in platelet adhesion was observed in wild-type mice 
undergoing IR injury pre-treated with an anti-GPIb  mAb when compared to non-treated IR 
mice. Representative images of adhesion to collagen of platelets derived from (b) IR injured 
wild-type mice and (c) IR injured wild-type mice pre-treated with anti-GPIb  mAb.  Data is 
representative of mean + SEM of at least 3 separate experiments. **p<0.01, ***p<0.001 
when compared using a one way ANOVA followed by Bonferroni Post Test for points of 
significance.
b C 
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Figure 4.9. Platelets derived from IR injured mice do not adhere to activated endothelium 
under static conditions in vitro but platelets derived from IR injured mice pre-treated with 
an anti-GPIb  mAb do adhere.   At 2 hours reperfusion, 500ul of mouse blood were 
incubated on endothelial coated coverslips for 45 minutes. After washing 3x with PBS, 
coverslips were mounted and 5 random images were then taken using an Olympus digital 
camera. (a) A significant increase in platelet adhesion was observed with platelets derived 
from in wild-type mice undergoing IR injury pre-treated with an anti-GPIb  mAb when 
compared to platelets derived from non-treated IR mice. Representative images of platelet 
adhesion to endothelium derived from (b) IR injured wild-type mice and (c) IR injured wild-
type mice pre-treated with GPIb . Data is representative of mean + SEM of at least 3 
separate experiments. **p<0.01 when compared using a one way ANOVA followed by 
Bonferroni Post Test for points of significance.
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Figure 4.10. Leukocyte-endothelial interactions following IR injury increase significantly in 
the jejunum of anti-GPIb  mAb pre-treated mice.  Leukocyte adhesion did not increase in 
the jejunum when compared to sham controls when observed intravitally. However, in IR 
injured mice pre-treated with the anti-GPIb  mAb, a significant increase in leukocyte 
adhesion was observed.  Data is representative of mean + SEM of at least 5 separate 
experiments.  ***p<0.001 when compared using a one way ANOVA followed by Bonferroni 
Post Test for points of significance. 
Chapter 4.  Individual blockade of GPIb  and P-selectin
121
 
IgG (sham) IgG (IR) GPIb (IR)
0
10
20
30
***
**
Pe
rc
en
ta
ge
 b
in
di
ng
%
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.11. Circulating leukocyte-platelet interactions following IR injury increase 
significantly in anti-GPIb  mAb pre-treated mice.  FACS analysis was performed on 50ul 
blood samples taken from IR injured mice at 2 hours reperfusion. Platelet-leukocyte 
interactions were not increased in wild-type mice undergoing IR injury compared to sham 
controls.  However, in IR injured mice pre-treated with the anti-GPIb  mAb, a significant 
increase in leukocyte-platelet interactions were observed.  Data is representative of mean + 
SEM of at least 5 separate experiments.  **p<0.01, ***p<0.001 when using a one way 
ANOVA followed by Bonferroni Post Test for points of significance. 
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alone 
 
IR injury in  
anti-GPIb  mAb  
pre-treated mice  
 
 
IR injury in  
P-selectin-/- mice   
 
Microthrombus formation 
 
 
 
 
 
No change 
 
Individual platelet adhesion 
 
 
 
 
Initially goes down.  
No change by 4 hrs 
 
No change 
 
Free flowing platelets 
 
 
 
Initially goes up.  
No change by 4 hrs 
 
 
No change  
 
Macromolecular leakage 
 
 
 
Initially goes down.  
No change by 4 hrs 
 
 
No change 
 
Macroscopic and histological 
appearance 
 
Very poor  
 
Initially improves.   
No change by 4 hrs 
 
No change 
 
Platelet adhesion to collagen 
under flow conditions in vitro 
 
 
Poor 
 
 
Significant 
improvement in 
ability to adhere 
 
 
 
Not investigated 
 
 
Platelet adhesion to 
activated endothelium under 
static conditions in vitro 
 
 
 
 
 
 
Significant 
improvement in 
ability to adhere 
 
 
Not investigated 
 
Leukocyte recruitment to 
endothelium 
 
Not much 
(more in ileum) 
 
Significantly  
increased  
 
Not investigated 
 
Platelet-Leukocyte 
aggregates  
 
 
None 
 
 
Significantly  
increased 
 
 
Not investigated 
Table 4.2.  Summary of the effects of inducing intestinal IR injury within wild-type mice, 
mice pre-treated with the GPIb  antibody and in P-selectin-/- mice.  Although the major 
benefits were observed in GPIb  pre-treated mice, these effects were short-lived and were 
not observed at 4 hours post-reperfusion.  
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4.4. Discussion 
Platelet recruitment to sites of vascular injury is mediated predominantly by exposure of 
ECM proteins such as collagen and also by adhesion to activated endothelium.  We initially 
described in Chapter 3 that both events takes place in the small intestine following IR injury 
with both microthrombi as well as individual adherent platelets being observed.  In the 
current chapter, we have demonstrated that the formation of microthrombi are dependent 
upon the platelet receptor GPIb .  However, the adhesion of individual platelets was not 
dependent upon GPIb  as their adhesion within the jejunum and ileum did not decrease on 
blockade of this receptor during IIR injury.   It was anticipated that the adhesion of individual 
platelets would be inhibited in the P-selectin-/- mice.  However, quite surprisingly, we did not 
observe any difference in platelet activity when IR injury was induced in these knockout 
mice.  By preventing the formation of microthrombi in anti-GPIb  mAb pre-treated mice, we 
were also able to reduce the macromolecular leakage from the villous microcirculation.  This 
suggests that the integrity of the microvessels is intact in these mice.  Furthermore, GPIb  
pre-treatment also conferred macroscopic and histological benefit. We demonstrated that 
blood flow within the jejunum improved in anti-GPIb  mAb, as evidenced by the presence of 
free flowing platelets trafficking through this region.  However, it was interesting to observe 
that although these positive effects were elicited, they were short-lived.  By 4 hours post-
reperfusion, blood flow decreased and macroscopic and histological injury became apparent 
again.  Enhanced leukocyte adhesion and the formation of circulating leukocyte-platelet 
aggregrates in IR injured mice pre-treated with the GPIb  antibody  was also observed. 
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It was surprising that no in vivo platelet activity, especially individual platelet adhesion, was 
reduced in P-selectin-/- mice. P-selectin has been shown to be involved in key mechanisms 
allowing for platelet adhesion to occur at sites of vessel wall injury as well as stabilizing 
thrombus formation (Yokoyama et al., 2005).  It allows for platelets to initially role on the 
endothelium leading to subsequent activation and adhesion (Gawaz et al., 2005).  P-selectin 
has also been shown to play a key role in several models of IR injury, including intestinal IR 
injury but these observations were undertaken within the mesenteric vessels rather than 
those in the more vulnerable mucosa.  Indeed, preliminary data from the Kalia lab has 
demonstrated that the adhesion of activated platelets to activated endothelium can be 
inhibited under static and flow conditions using a P-selectin antibody (unpublished data).  
However, it is possible that due to the lower shear stresses associated with mucosal villous 
microcirculation a role for P-selectin in platelet rolling and activation may not be required.  
The presence of rolling leukocytes may also hinder the free flow of platelets.  Although we 
did not anticipate P-selectin to have a role in preventing microthrombus formation, previous 
findings have suggested that platelet P-selectin is also involved in the maintaining the 
stability of a developing thrombus.  However, these studies are inconclusive, with 
publications showing both a significant decrease in thrombi formation (Yokoyama et al., 
2005) to negligible differences on inhibition of this receptor (Patel et al., 2008).   
 
P-selectin is located within the Weibel-Palade bodies of endothelial cells as well as in the 
alpha granules of activated platelets.  However, P-selectin deficient mice do not express this 
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receptor on either the endothelium or the platelets.  In the current study, donor platelets 
were derived from P-selectin KO mice, and so these would also have been deficient in P-
selectin.  Had a role for P-selectin been identified, further studies would have been 
conducted to determine whether endothelial P-selectin or platelet P-selectin,  was important 
by assessing interaction of wild-type donor platelets in P-selectin deficient mice and 
interaction of P-selectin-deficient donor platelets in wild-type mice.  Although most studies 
have strongly implicated platelet P-selectin, Frenette and colleagues were the first to 
demonstrate that platelet-endothelial interactions could also be dependent upon endothelial 
P-selectin (Frenette et al., 1995).  Indeed, an important role for endothelial P-selectin in 
governing platelet-endothelial cell interactions within hepatic pre-sinusoidal arterioles and 
post-sinusoidal venule following IR injury has been demonstrated (Khandoga et al., 2002). 
Platelet-endothelial cell interactions were nearly absent in arterioles and venules of mice 
lacking endothelial P-selectin and sinusoidal perfusion failure was ameliorated.   
 
The blocking of GPIbα inhibited the formation of microthrombi throughout the 4 hour 
reperfusion duration and most likely contributed to the inhibition of vessel occlusion during 
the early stages of reperfusion.  GPIb  predominantly plays a critical role in aiding the initial 
tethering/rolling of platelets on collagen exposed in injured vessels at high shear rates as 
observed in large arterioles.   Therefore, blocking GPIb  abolishes platelet adhesion to sites 
of vascular damage and could explain the lack of microthrombus formation.  However, the 
shear rates within the microvessesls of the villi are not high and therefore it was surprising to 
Chapter 4.  Individual blockade of GPIb  and P-selectin
126
observe a critical role for GPIb .  The involvement of GPIbα in promoting platelet tethering 
at low shear appears to contradict previous findings demonstrating that thrombus growth on 
type 1 fibrillar collagen under low shear conditions occurs independent of both vWf and 
GPIbα (Wu et al., 1996).  However, Kulkarni and colleagues were also able to identify a 
critical role for the GPIb -vWF interaction in mediating platelet capture from blood at 
arteriole (high) and venular (low) shear rates, suggesting it is not implausible for GPIb to play 
a role in low shear vessels such as the intestinal villous microvessels (Kulkarni et al., 2000).  
 
GPIb  can also bind platelets to vWF expressed on activated endothelium (Clemetson et al., 
2008).  It is therefore possible that the microthrombi we have observed are just aggregates 
of platelets attached to intact endothelium, not exposed collagen, or formed due to platelet 
stagnation within the small capillary vessels.  Indeed, we did demonstrated that blocking 
GPIb  could significantly reduce the adhesion of platelets to TNF /TGF  stimulated 
endothelial cells in vitro.  However, in vivo we did not observe a decrease in individual 
platelet adhesion, only microthrombus formation. Quite surprisingly, the former was 
increased in anti-GPIb  antibody pre-treated mice (though not to a significant level).  
Furthermore, SEM images also provided evidence that within the jejunum, microthrombi 
were present on collagen surfaces within the mucosal vasculature.  This suggests that the 
microthrombi that were formed, were most likely due to platelet interactions with 
subendothelial collagen. 
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It is also possible that the lack of thrombus formation in the current study is not just due to 
inhibition of platelet tethering and capture, but also due to the inability of platelets to 
actually aggregate following introduction of an antibody to GPIb .  Indeed, recent evidence 
has supported the possibility that GPIbα can also support the platelet-platelet interactions 
required for thrombus formation. Bergmeier and colleagues studied thrombus formation in 
transgenic mice in which the extracellular domain of GPIb  was replaced by that of human 
IL-4 receptor (IL4R /GPIb -tg mice).  They demonstrated that platelet aggregration, as well 
as adhesion to ferric chloride-treated mesenteric arterioles, was completely inhibited in the 
IL4R /GPIb -tg mice when compared to wild-type mice (Bergmeier et al., 2006).  Indeed, the 
authors stated that this defect was the strongest the group had observed in this injury model 
and even more severe than that of mice deficient in IIb 3 (GPIIb-IIIa), the major integrin 
mediating platelet aggregation.  This finding was consistent with in vitro studies 
demonstrating that GPIb-vWF interactions also played a role in platelet thrombus formation 
ie. the adhesion of platelets not just to subendothelial collagen but also to already adherent 
platelets (Kulkarni et al., 2000)  
 
Although GPIb  had a beneficial effect during early reperfusion as evidenced by the lack of 
thrombus formation, decreased macromolecular leakage, improved histological and 
macroscopic appearance, these events did not persist throughout reperfusion and by 4 
hours, tissue injury was again apparent.  These results suggest inhibiting the mechanisms 
responsible for platelet-collagen (and possibly platelet-platelet) interactions are only 
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sufficient to prevent injury during early reperfusion.  The adhesion of individual platelets was 
not affected and indeed increased in animals pre-treated with the anti-GPIb  antibody and 
these increased numbers of platelets may be responsible for recruitment of inflammatory 
leukocytes.  This is evidenced by the observation that leukocyte adhesion and circulating 
numbers of platelet-leukocyte aggregates increased in GPIb  blocked mice undergoing IR 
injury.   It is also possible, that since flow is initially restored, more circulating leukocytes and 
platelets gain entry to the jejunum and thus adhere within the microvessels.   
 
Furthermore, we previously observed in Chapter 3 that platelets isolated from animals that 
had undergone intestinal IR injury were unable to adhere to collagen in vitro under flow 
conditions. In the current chapter we described a similar phenomenon on activated 
endothelial cells.  Fascinatingly, platelets derived from IR animals pre-treated with an anti-
GPIbα antibody were now able to adhere to collagen and to activated endothelium. This may 
also partly contribute to the enhanced adhesion of individual platelets observed throughout 
the 4 hours reperfusion. It is possible that IR injury leads to some phenotypic or functional 
damage to platelets which is why circulating ones derived from IR injured mice were unable 
to adhere to collagen in vitro.  Several mechanisms may cause decreased platelet 
aggregation. Porte and colleagues reported that following liver transplantation, platelet 
activation occurred upon reperfusion, and these platelets lacked most of their secretory 
granules and microtubules (Porte et al., 1994). Because platelets became non-functional 
after losing their granules, the finding of agranular platelets was compatible with decreased 
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platelet aggregation.   However, in the current studies where reduced IR damage was 
observed as a result of anti-GPIb  antibody pre-treatment, we suggest that less platelet 
activation occurs and this explains why these platelets retain their aggregatory ability.  
Indeed, Himmelreich and colleagues also demonstrated that intra-operative infusion of 
prostaglandin E1 not only attenuated liver IR injury but also reduced the associated 
impairment in platelet aggregation (Himmelreich et al., 1993).  
 
Overall, these novel results demonstrate that platelets play a key role in induction of 
microcirculatory and tissue damage following intestinal IR injury. The inhibition of 
microthrombus formation decreased both microvasculature occlusion and vessel leakage 
during the early stages of reperfusion. These results do raise the possibility of using GPIb 
antagonists or antibodies therapeutically to limit the tissue or transplanted graft injury that 
takes place immediately following reperfusion.  IIb 3 / GPIIbIIIa antagonists are currently 
used extensively in the clinic (their role in this injury model will be investigated later) 
(Scarborough et al., 2008).  Although effective pharmacologically at inhibiting platelet 
aggregation, they are not able to prevent platelet adhesion and activation because both of 
these processes occur earlier than aggregation.  Since GPIb  receptors allow the initial 
capture of platelets from flow at sites of damaged vasculature, their blockade is a potential 
mechanism to block platelet adhesion and activation upstream of aggregation.  Indeed, a 
monoclonal antibody directed against GPIb  has been used in baboons effectively to reduce 
injured femoral artery injury without increasing bleeding time (Fontayne et al., 2008).  
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Unfortunately, in the current study, the initial benefit of blocking platelet recruitment 
through inhibiting GPIbα, decreases as reperfusion prolongs towards 4 hours. Indeed, 
macroscopic, histological and FITC-BSA leakage analysis showed no improvement at 4 hours 
reperfusion.  It is possible that enhanced leukocyte and platelet recruitment in this scenario 
may play a vital role in contributing to this secondary injury.  It therefore seems that a dual 
therapy that can prevent both microthrombus formation and prevent the recruitment of 
potentially detrimental individual platelet and leukocyte recruitment may confer more longer 
lasting protection within the gut following intestinal IR injury.  This will be investigated in the 
next chapter.   
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5.0.  Effects of preventing platelet and leukocyte recruitment to intestinal IR injured 
microvasculature by dual blockade of GPIb  and P-selectin  
 
5.1. Introduction and hypotheses 
5.1.1. Introduction 
In Chapter 4 we demonstrated a beneficial effect following intestinal IR injury in anti-GPIb  
antibody pre-treated mice and, quite surprisingly, no benefit in P-selectin-/- mice.  However, 
inhibiting microthrombus formation alone was not sufficient to permit sustained blood flow 
within the most severely affected area of the small intestine, throughout the 4 hour 
reperfusion period.  One of the most interesting and potentially important consequences of 
anti-GPIb  antibody pre-treatment was the significant increase in the number of leukocytes 
that were observed intravitally.  It is possible microthrombi adhering to either endothelial 
cells or subendothelial matrix proteins occupy or cover receptors that would normally sustain 
the adhesion of leukocytes (or individual platelets).  Therefore, in the absence of 
microthrombi, more surface area of endothelial receptors becomes available for circulating 
leukocytes.  Similar observations were made by Vowinkel and colleagues who demonstrated 
that neutropaenia led to a remarkable increase in the number of platelets that could directly 
bind to venular endothelial cells in an experimental murine model of colitis (Vowinkel et al., 
2007).  This study, and ours, suggests that inhibiting the adhesion of one cell type enhances 
the adhesion of the other. 
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 We also observed a remarkable increase in the number of circulating platelet-leukocyte 
aggregates in anti-GPIb  antibody pre-treated mice.  The presence of circulating platelet-
leukocyte aggregates has been identified as a more sensitive marker of in vivo platelet 
activation than platelet surface P-selectin expression (Michelson et al., 2001).  These 
aggregates form when platelets are activated and undergo degranulation, after which they 
adhere to circulating leukocytes.  Platelets and leukocytes do not normally interact with each 
other in the circulation.  However, enhanced platelet-leukocyte interactions occur in vivo in 
inflammatory processes, such as unstable angina (Ott et al., 1995) acute myocardial 
infarction, stroke (Zellar et al., 2005), and diabetes (Jawahar et al., 1992) as well as during 
vascular surgical procedures such as cardiopulmonary bypass (Faraday et al., 2001) and aortic 
valve surgery (Leguyader et al., 2006). Upon platelet activation, P-selectin is released and 
expressed on its surface. It is probable that platelet activation, within our intestinal IR injury 
model, is caused by the associated changes in homeostatic conditions within the vasculature. 
Decreases in nitric oxide and prostaglandin production, as described previously, are 
frequently associated with IR injury and allow for platelet activation within injured vessels. 
Binding of P-selectin to its ligand PSGL-1, constitutively expressed on all leukocytes, mediates 
the formation of platelet-leukocyte aggregates in the circulation and on damaged vascular 
surfaces (Yokoyama et al., 2005). This association leads to increased expression of 
CD11b/CD18 (Mac-1) on leukocytes (Neumann et al., 1999) which itself supports interactions 
with platelets, possibly through fibrinogen linking this integrin with platelet IIb 3 (GPIIb/IIIa; 
Gawaz et al., 1991).   
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The formation of platelet-leukocyte aggregates plays an important role in the initiation of 
inflammation (and also thrombosis by causing microembolism in capillaries).  Adhesion of 
platelets to leukocytes has been shown to regulate various leukocyte actions such as inducing 
monocyte cytokine (Neumann et al., 1997) and chemokine synthesis (Weyrich et al., 1996).  
In light of the data obtained from Chapter 4, it is therefore likely that leukocytes, potentially 
recruited by individually attached or activated platelets, could be mediating the ‘secondary’ 
vessel occlusion and the subsequent tissue damage observed in anti-GPIb  antibody pre-
treated mice during late reperfusion.  Since the main interaction binding platelets to 
leukocytes is P-selectin/PSGL-1 dependent, we undertook studies to identify the beneficial 
effects of combining anti-GPIb  antibody pre-treatment in P-selectin knockout mice.   
 
5.1.2. Hypotheses 
This chapter therefore aimed to investigate the effects of inhibiting GPIb  in P-selectin-/- mice 
on platelet, leukocyte and platelet-leukocyte interactions. We predominantly focused on the 
jejunum for this study, although some additional studies were also conducted in the ileum.  
For the work included in this chapter we hypothesized: 
 
1. Recruitment of individual platelets, leukocytes, microthrombus formation  and 
platelet-leukocyte interactions in the jejunum would be decreased in P-selectin-/- mice 
pre-treated with an anti-GPIb  antibody. 
2. Reducing all these events would confer intravital, histologic and macroscopic benefit  
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even at 4 hours post-reperfusion, within the jejunum. 
3. Any remote organ damage, particularly to the liver and lungs, associated with 
intestinal IR injury would be inhibited  in P-selectin-/- mice pre-treated with an anti-
GPIb  antibody. 
 
5.2. Methods 
Donor platelets, from P-selectin-/- mice, and endogenous platelets were both blocked with 
the anti-GPIb  antibody introduced into P-selectin-/- mice.  Fluorescent IVM was performed 
as described previously following 45 minutes ischaemia followed by 4 hours of reperfusion.  
The carotid artery and trachea were cannulated and the animal subjected to either sham or 
IR treatment.  During reperfusion, the jejunum and ileum was monitored intravitally.  Free 
flowing platelets, individual adherent platelets and microthrombi were quantitated.  The 
systemic administration of FITC-BSA and Acridine orange allowed vascular macromolecular 
leakage and leukocyte adhesion to be quantitated.  Histological haematoxylin and eosin 
(H&E) staining was used to visualise mucosal villi.  In vitro adhesion assays were conducted to 
determine the role of GPIb and P-selectin in allowing adhesion of platelets to collagen under 
flow conditions and endothelial cells under static conditions.  Flow cytometry was performed 
to demonstrate the presence of circulating platelet/leukocyte aggregates. 
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5.3.  Results 
 
5.3.1. Leukocyte adhesion in the jejunum and circulating leukocyte-platelet aggregates 
significantly decrease following IR injury in P-selectin-/- mice pre-treated with an anti-
GPIb  mAb at 4 hours post-reperfusion 
Leukocyte recruitment in the jejunum was significantly (p<0.05) reduced in IR injured P-
selectin-/- + anti-GPIbα antibody mice when compared to  IR injured wild-type + anti-GPIbα 
mAb mice at 4 hours post-reperfusion (Figures 5.1a and 5.2).  However, it was interesting to 
observe that the adhesion of individual platelets within the jejunum was not reduced 
although there was a slight trend for this number to fall (Figure 5.1b). Furthermore, blood 
sustained flow was apparent within the jejunum in IR injured P-selectin-/- + anti-GPIbα mAb 
mice as demonstrated by a significant (p<0.05) increase in the number of freely flowing 
donor platelets when compared to  IR injured wild-type + anti-GPIbα antibody mice (Figure 
5.1c).  This dual blockade was the only combination that led to the observation of free 
flowing platelets at 4 hours post-reperfusion.  
 
We further investigated, by FACS analysis, the interaction of circulating platelets with 
leukocytes.  Platelet-leukocyte interactions were significantly (p<0.05) reduced in IR injured 
P-selectin-/- + anti-GPIbα mAb mice when compared to IR injured wild-type + anti-GPIbα mAb 
mice (Figure 5.3).   
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Figure 5.1.  Leukocyte adhesion significantly decreased in the jejunum of IR injured P-
selectin-/- mice pre-treated with an anti-GPIb  antibody at 4 hours reperfusion. 
Recruitment of leukocytes and platelets to the jejunal microcirculation were examined 
intravitally.  (a) Leukocyte recruitment was significantly reduced in IR injured P-selectin-/- + 
anti-GPIbα antibody mice when compared to  IR injured wild-type + anti-GPIbα antibody 
mice.  (b) Individual platelet recruitment is also reduced under these conditions but not to a 
significant level.  (c) Furthermore, a significant increase in the number of freely flowing 
platelets (1 x 108 platelets, 10μM CFSE) was observed in IR injured P-selectin-/- + anti-GPIbα 
antibody mice compared to  IR injured wild-type + anti-GPIbα antibody mice.  Data 
represents mean + SEM of at least 5 separate experiments. *p<0.05, *** p<0.001 when 
compared using a one way ANOVA followed by Bonferroni post test for points of significance.  
Only yellow bars represent new data – blue, black and grey bars are presented in Chapter 4.   
 Sham mice 
 IR injury in WT mice 
 IR injury in WT + anti-GPIbα mAb pre-treatment  
 IR injury in P-sel-/- + anti-GPIbα mAb pre-treatment  
Chapter 5.  Dual blockade of GPIb  and P-selectin 
138
a 
 
 
 
 
 
b 
 
 
 
 
 
c 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.2.  Leukocyte adhesion significantly decreased in the jejunum of IR injured P-
selectin-/- mice pre-treated with an anti-GPIb  mAb at 4 hours reperfusion.   Individual 
platelet recruitment is also reduced under these conditions but not to a significant level.    
Representative images of leukocyte adhesion in (a) sham wild-type (b) IR injured wild-type 
and (c) IR injured P-selectin-/- + anti-GPIb  mAb mice are presented.   
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Figure 5.3.  Circulating leukocyte-platelet interactions significantly decreased in IR injured 
P-selectin-/- mice pre-treated with an anti-GPIb  mAb at 4 hours reperfusion.  FACS analysis 
was performed on 50ul blood samples, taken from IR injured mice at 4 hours reperfusion. 
Platelet-leukocyte interactions were significantly reduced in IR injured P-selectin-/- + anti-
GPIbα mAb mice when compared to IR injured wild-type + anti-GPIbα antibody mice (5.3a).  
Data represent mean + SEM of at least 5 separate experiments.  Representative FACS plots 
are also presented with regions outlined in red indicating platelet-leukocyte aggregates 
(5.3b).  *p<0.05, ***p<0.001 when compared using a one way ANOVA followed by 
Bonferroni post test for points of significance. Only yellow bars represent new data – blue, 
black and grey bars are presented in Chapter 4.   
 Sham mice 
 IR injury in WT mice 
 IR injury in WT + anti-GPIbα mAb pre-treatment  
 IR injury in P-sel-/- + anti-GPIbα mAb pre-treatment  
Cell
Number
FITC-CD41 staining PBMC decorated with platelets 
Sham IR (GPIb / P-selectin) 
IgG control  IR (GPIb) 
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5.3.2. Leukocyte and individual platelet adhesion did not decrease in the ileum of IR injured 
P-selectin-/- mice pre-treated with an anti-GPIb  mAb at 4 hours post-reperfusion  
It was interesting to observe that although leukocyte and platelet adhesion decreased in the 
jejunum in P-selectin-/- + anti-GPIb  mAb mice, similar events were not observed within the 
terminal ileum when compared to IR injured wild-type + anti-GPIbα mAb mice (Figure 5.4).   
 
5.3.3. Marked macroscopic, microscopic and histological improvement as well as a 
decrease in macromolecular leakage was observed in the jejunum of IR injured P-selectin-/- 
mice pre-treated with an anti-GPIb  mAb at 4 hours post-reperfusion 
The proximal jejunum appeared healthy when observed grossly throughout the 4 hour 
duration of reperfusion (Figure 5.5).  H&E staining revealed a distinct improvement to villus 
length and the apparent lack of an inflammatory response around the crypt areas (Figure 
5.6).  Furthermore, a significant (p<0.001) decrease in vascular leakage of FITC-BSA was 
observed in IR injured P-selectin-/- + anti-GPIbα mAb mice compared to  IR injured wild-type + 
anti-GPIbα mAb mice at 4 hours post-reperfusion in the jejunum (Figure 5.7).  These results 
suggest that dual receptor blockade is required to significantly decrease microvasculature 
injury caused by platelet and inflammatory cell recruitment during intestinal IR injury. 
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Figure 5.4.  Leukocyte and individual platelet adhesion did not decrease in the ileum of IR 
injured P-selectin-/- mice pre-treated with an anti-GPIb  mAb at 4 hours post-reperfusion.  
Recruitment of leukocytes and platelets to the ileal microcirculation was examined 
intravitally.  (a) Leukocyte recruitment was not significantly reduced in IR injured P-selectin-/- 
+ anti-GPIbα mAb mice.  (b) Individual platelet recruitment was also not reduced under these 
conditions. Representative images of ileal leukocyte adhesion from (c) sham wild type (d) IR 
injured wild type.  Data represents mean + SEM of at least 5 separate experiments.  p<0.05, 
**p<0.01, ***p<0.001 when compared using a one way ANOVA followed by Bonferroni post 
test for points of significance. Only the yellow bars represent new data – blue, black and grey 
bars are  presented in Chapter 4.   
 Sham mice 
 IR injury in WT mice 
 IR injury in WT + anti-GPIbα mAb pre-treatment  
 IR injury in P-sel-/- + anti-GPIbα mAb pre-treatment  
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Figure 5.5. Marked microscopic improvement of the jejunum was observed in IR injured P-
selectin-/- + anti-GPIbα mice compared to wild-type + anti-GPIbα mAb mice at 4 hours post-
reperfusion in the jejunum when viewed using brightfield intravital imaging.  (a) The 
proximal jejunal mucosa appeared haemorrhagic, severely congested and swollen after 4 
hours reperfusion in IR injured wild-type + anti-GPIbα mAb mice.  (b) The jejunum remained 
healthy in IR injured P-selectin-/- + anti-GPIbα mAb mice throughout the 4 hour reperfusion 
duration.  Representative images are shown of the jejunum at 4 hours post-reperfusion.  
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Figure 5.6.   Histological improvement of the jejunal villi in IR injured P-selectin-/- mice pre-
treated with an anti-GPIb  mAb was observed at 4 hours reperfusion (magnification x200).  
(a) No sloughing and healthy villi structures were observed in sham models.  (b) Severe 
mucosal sloughing and inflamed crypt areas were seen in IR injured mice. (c) An increase in 
villous length and very little inflammation to the lower mucosa was observed in  P-selectin-/- 
mice + anti-GPIb  mAb. 
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Figure 5.7.  Vascular leakage significantly decreased jejunally in IR injured P-selectin-/- + 
anti-GPIbα mAb mice when compared to  wild-type + anti-GPIbα antibody mice at 4 hours 
post-reperfusion. Macromolecular leakage was analysed by systemically administering FITC-
BSA, at 4 hours reperfusion, and observing increased fluorescence intravitally.  (a) A 
significant decrease in fluorescent intensity was observed in P-selectin-/- + anti-GPIb  mAb 
mice compared to IR injured mice.   Representative jejunal images are shown of vascular 
leakage from IR injured (b) wild-type mice and (c) P-selectin-/- + anti-GPIb  mAb mice at 4 
hours post-reperfusion. Data is representative of mean + SEM of at least 5 separate 
experiments.  **p<0.01, ***p<0.001 when compared using a one way ANOVA followed by 
Bonferroni post test for points of significance.  Only the yellow bar represents new data – 
other bars are presented in Chapter 4.   
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5.3.4. Platelets derived from IR injured mice do not adhere to collagen under flow 
conditions but platelets derived from P-selectin-/- + anti-GPIbα mAb mice do 
Platelets from IR injured P-selectin-/- + GPIb  mAb mice demonstrated a significant  (p<0.05) 
increase in their ability to adhere to collagen under flow conditions when compared to IR 
injured wild-type platelets (Figure 5.8).  However, the extent of the adhesion was not 
different to that observed with IR injured + GPIb  mAb mice.   
 
5.3.5. Reduced remote organ injury to the liver and lungs was observed in IR injured P-
selectin-/- + anti-GPIbα mAb mice at 4 hours post-reperfusion  
Since this dual therapy markedly improved the gut, the effects on remote organ injury was 
also assessed.  Histological analysis of lung tissue from animals undergoing intestinal IR injury 
revealed collapsed alveoli, thickened interstitial walls and a dense neutrophilic infiltrate 
(Figure 5.9).  Capillaries were often congested with red blood cells and a marked neutrophilic 
infiltrate was apparent.  Occasionally, neutrophils and red blood cells were observed within 
the alveolar spaces, indicating haemorrhage.  However, relatively small areas of cell infiltrate 
were present in aerated and distended lungs of IR injured P-selectin-/- + anti-GPIb  mAb mice 
which appeared similar to control lungs (Figure 5.10). Hepatic histology revealed very little in 
the way of tissue damage in animals undergoing intestinal IR injury.  However, biochemical 
analysis of plasma alanine transferase (ALT) levels demonstrated  a significant increase in ALT 
levels at 4 hours reperfusion. This was significantly (p<0.05) reduced in IR injured P-selectin-/- 
+ anti-GPIbα mAb mice and similar to levels observed in sham mice (Figure 5.10). 
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Figure 5.8. Platelets derived from IR injured mice do not adhere to collagen under flow 
conditions in vitro but platelets derived from P-selectin-/- mice pre-treated with an anti-
GPIbα mAb do adhere.  At 2 hours reperfusion, 500ul of mouse blood anticoagulated with P-
Pack and heparin was perfused through collagen coated microslides at a shear rate of 300s-1. 
After washing for 3 mins, 5 random images were then taken using an Olympus digital camera. 
Although not much of an increase was observed when IR injured P-selectin-/- + anti-GPIbα 
mAb mice were compared to IR injured mice + anti-GPIb  mAb mice, a significant increase 
was observed when compared to IR injured mice.  Representative images of adhesion to 
collagen of platelets derived from (b) IR injured wild-type and (c) IR injured + GPIb  mAb 
mice.  Data represents mean + SEM of at least 3 separate experiments. *p<0.05, **p<0.01 
when compared using an unpaired student t test for points of significance. Only the yellow 
bar represents new data – other bars are presented in Chapter 4.   
**
Chapter 5.  Dual blockade of GPIb  and P-selectin 
147
a 
 
 
 
 
 
b 
 
 
 
 
 
c 
 
 
 
 
 
 
 
 
 
Figure 5.9.   Histological improvement to lung tissue in IR injured P-selectin-/- mice pre-
treated with an anti-GPIb  mAb (magnification x200).  At 4 hours reperfusion, the lungs 
were removed for histological analysis and H&E stained. (a) Healthy structures were 
observed in sham mice.  (b) Collapsed alveoli, thickened interstitial walls and a dense 
neutrophilic infiltrate were observed in intestinal IR injured mice animals.  (c) However, 
relatively normal histology, with numerous aerated alveoli and thin alveolar walls, was 
observed in IR injured P-selectin-/- + anti-GPIb  mAb mice. 
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Figure 5.10. Although the livers of mice undergoing intestinal IR injury did not demonstrate 
histological injury, plasma levels of ALT suggested damage occurred at the cellular level.  
This was significantly decreased in IR injured P-selectin-/- mice pre-treated with an anti-
GPIb  antibody.  Healthy hepatic tissue was observed in (a) sham mice (b) IR injured mice 
and (c) IR injured P-selectin-/- + anti-GPIb  antibody mice. After 4 hours reperfusion 100ul of 
blood was removed from each mouse and placed in a heparin coated haematological 
screening tube. Samples were then sent to the haematology department at the Queen 
Elizabeth Hospital, Birmingham, for enzyme analysis (d). Data represents mean + SEM of at 
least 3 separate experiments.  *p<0.05, **p<0.01 when compared using an unpaired student 
test for points of significance.  
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5.4. Discussion 
 
As demonstrated in Chapter 4, the use of anti-GPIb  mAb therapy was associated with an 
improvement in tissue and microcirculatory viability during early reperfusion.  However, this 
was not long lasting and could possibly be linked to the concomitant significant increase in 
leukocyte adhesion and circulating platelet-leukocyte interactions and the trend for 
individual platelet adhesion to increase.  In the current chapter we provide novel data 
demonstrating that inhibition of both leukocyte adhesion and thrombosis formation is 
essential in order to preserve tissue and microcirculatory integrity for longer periods of time. 
This was achieved by a ‘dual therapy’ relying on the absence of  P-selectin and GPIb .  We 
did not conduct detailed studies to determine whether platelet and/or endothelial P-selectin 
was important and this would be worthy of future investigation. Furthermore, remote as well 
as local tissue integrity was preserved.  Previous pharmacological studies have demonstrated 
that it is difficult to completely preserve microvessel integrity following intestinal IR injury, as 
evidenced by persistence of macromolecular leakage of labelled albumin (Kalia et al., 2005).  
However, by inhibiting platelet and leukocyte recruitment, it was also possible to improve 
this microcirculatory disturbance. 
 
We initially anticipated that the individual platelet adhesion observed in the ileum and 
jejunum of IR mice would be decreased in the P-selectin knockout mice.  This is because 
platelet P-selectin binds via its high-affinity counter-receptor PSGL-1 on endothelium and 
mediates platelet-endothelial interactions during thrombo-inflammatory reactions.  
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However, as demonstrated in Chapter 4, no effect on individual platelet adhesion was 
observed in the P-selectin deficient mice.  Nor were these interactions decreased in the dual 
therapy mice.  However, we did observe a significant decrease in leukocyte adhesion and 
circulating leukocyte-platelet interactions in the latter mice.  This suggests that although 
individual platelet adhesion is not P-selectin dependent, leukocyte adhesion to platelets or 
endothelium is.  Hence, leukocytes must be interacting via PSGL-1 expressed on their surface 
with endothelial or platelet P-selectin.  Interestingly, the antagonism of P-selectin has 
previously been observed to accelerate thrombolysis and enhance the anti-aggregatory 
effects of IIb 3 (GPIIb/III)a inhibitors (Theoret et al., 2006).  Theoret and colleagues 
demonstrated that P-selectin antagonism using rPSGL-Ig delayed the aggregation process, 
which was more efficiently inhibited with dual antagonism of P-selectin and IIb 3.  However, 
no previous studies have demonstrated that in combination with anti-GPIb  therapy, 
microthrombus formation, leukocyte adhesion and platelet-leukocyte interactions can be 
significantly inhibited.  
 
It was interesting to note that although leukocyte adhesion (and to a lesser extent individual 
platelet adhesion), decreased within the jejunum in dual therapy mice, this response was not 
mirrored to the ileum.  This suggests that different molecular adhesive mechanisms operate 
to recruit circulating cells within the severely injured jejunum compared to the mildly injured 
ileum, with neither leukocyte or individual platelet recruitment to ileal endothelium being 
GPIb  or P-selectin dependent.  Leukocyte recruitment can be bought about by a number of 
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alternative and well characterised mechanisms. Activated endothelium, leading to leukocyte 
recruitment can be initiated by several stimuli including cytokines such as TNFα. Once 
endothelium is activated, leukocytes are able to firstly roll on this surface through selectin 
mediated processes including E and P-selectin. Subsequent leukocyte activation occurs via 
two distinct mechanisms. The first mechanism involves β1 and β2 activation, initiated by 
cytokine release, which allows for these integrins to bind with their associated endothelial 
ligands ICAM-1/2 and VCAM-1. The second involves the selectins, associated with the initial 
leukocyte rolling, which independently activate the β2 integrins. Firm adhesion and 
transmigration of leukocytes through the activated endothelium completes the recruitment 
process. (Ravi et al., 2007).  It is possible that these mechanisms may be involved in 
mediating leukocyte recruitment in the ileum in the current study.  
Bombeli and colleagues conducted one of the earliest studies investigating the various 
mechanisms by which platelets could adhere to intact endothelium (HUVECs) in vitro.  They 
demonstrated no role for endothelial VCAM-1, E-selectin, or P-selectin. However, a 
significant decrease in platelet binding was observed when HUVECs were treated with 
monoclonal antibodies to ICAM-1, αvβ3 integrin, as well as GPIbα, or when platelets were 
treated with an anti- IIb 3 antibody. (Bombeli et al., 1998).  The greatest inhibition (50%) was 
found when HUVECs were treated with the mAb 2D5, which blocks the fibrinogen-binding 
site of ICAM-1. It was noteworthy that in their study they also demonstrated that platelet 
adhesion was not affected by blockade of platelet P-selectin.   It is therefore possible that 
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one of these alternative mechanisms may also contribute to the recruitment of platelets to 
the activated endothelium of ileal and jejunal villi.   
The benefits of the dual therapy used in the current chapter were not just confined to the 
intestine.  Indeed, the lungs and liver also demonstrated a structural or biochemical 
improvement.  Damage to remote extra-digestive sites is a common sequel of intestinal IR 
injury.  Intestinal IR injury is associated with high levels of cytokines, activated complement 
fragments (Gibbs et al, 1996) eicosanoids, neutrophils (Simpson et al, 1993) and endotoxin 
within the systemic circulation (Grootjans et al, 2010).  The liver is the first port of call for 
blood from the small intestine, which carries with it all the soluble inflammatory mediators 
released by the IR injured gut.  Hence neutrophil sequestration, reduced bile (Nakamura et 
al., 2001) and hepatic blood flow rates and impaired hepatocyte metabolism are often 
observed in such livers (Savas et al., 2003).  Furthermore, cardiac contractile dysfunction and 
acute lung injury characterized by neutrophil sequestration, microvascular dysfunction, and 
ultrastructural evidence of endothelial cell injury has been reported previously (Cui et al., 
2009).  However, our histological studies demonstrated an apparent decrease in pulmonary 
damage in IR injured mice undergoing dual therapy.  Although in our studies, the liver 
showed very little histological damage in IR untreated mice, in comparison to sham samples, 
we still demonstrated that injury was present at the cellular level and that this could also be 
reduced in dual therapy mice.   
In summary, this chapter highlights the importance of targeting both the platelet and the 
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leukocyte in order to attain longer lasting benefits from intestinal IR injury.  The importance 
of targeting both of these cell types was also demonstrated by Ishikawa and colleagues in a 
murine model of stroke induced by middle cerebral artery occlusion followed by reperfusion 
(Ishikawa et al., 2004).  Previous studies had demonstrated that ICAM-1-bound fibrinogen on 
endothelial cells recruited platelets via IIb 3 and endothelial P-selectin recruited leukocytes 
via ICAM-1.  Hence Ishikawa and colleagues hypothesised that IIb 3 blockade would be 
effective in reducing the IR-induced recruitment of platelets and the blockade of either 
endothelial or platelet-associated P-selectin would blunt both leukocyte and platelet 
recruitment responses to IR injury.  Indeed, this is what they observed.  Although the latter 
observations differ slightly from our own, certainly this study highlights the importance of 
blocking the interactions of both of these cell types for effective treatment of ischaemic 
disorders.  Although this chapter has identified an effective strategy to treat intestinal IR 
injury, we further compared the benefits observed with targeting additional platelet 
receptors.  This will be discussed in Chapter 6.   
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6.0.  Investigating the roles of GPVI, α2β1, αIIbβ3 and PLC 2 in mediating platelet 
recruitment to intestinal IR injured microvasculature 
 
6.1. Introduction and hypotheses 
 
6.1.1. Introduction 
 
This chapter will look at the possibilities of further inhibiting platelet recruitment to IR 
injured vessel walls through alternative mechanisms dependent upon the inhibition of GPVI, 
α2β1 and αIIbβ3.  It is possible that a single therapy targeting one platelet receptor may be as 
effective as the dual therapy described in Chapter 5.  Amongst the numerous collagen 
receptors expressed in platelets, GPVI is of central importance for platelet activation and 
subsequent firm arrest.  Its inhibition in several in vivo experimental models of thrombosis, 
involving physical and chemical vessel damage, has proved to be of great benefit. 
Furthermore, a critical role has been identified for GPVI in experimental models of 
myocardial infarction (Kleinschnitz et al., 2007).  Takaya and colleagues demonstrated that 
the myocardial infarct size was significantly smaller in FcR -/- mice (therefore GPVI deficient) 
subjected to occlusion and reperfusion of the coronary artery than in control FcR +/+ mice 
(Takaya et al., 2005).  
 
The same beneficial effects have been observed for the highly expressed receptor αIIbβ3 
(GPIIb/IIIa).  Binding of platelets to soluble fibrinogen is the terminal step in platelet 
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aggregation, but this integrin also plays a key role in platelet adherence to both collagen and 
endothelium as demonstrated in vitro using flow assays (Auger et al., 2005; Tull et al., 2006).  
Adhesion to endothelium can occur via interactions with αvβ5 and also ICAM-1. Therefore, 
αIIbβ3 presents a highly likely candidate for investigation following intestinal IR injury where 
both collagen is exposed and endothelium is activated in the jejunum or ileum.  However, 
post-vessel injury bleeding has been a constant problem associated with targeting this 
receptor.  Nevertheless, it has been observed to be beneficial in murine models of cerebral 
ischemia when blockers are used at a low dose that does not produce clinically significant 
haemorrhage (Abumiya et al., 2000).
 
Inhibiting the integrin α2β1 (GPIa/IIa) may also show positive effects in the IR injured gut as it 
has a critical role in maintaining thrombus stabilisation. It is the major collagen receptor on 
platelets that mediates stable adhesion on collagen following platelet activation.  However, 
previous in vitro studies have shown great variability in the effectiveness of blocking this 
integrin and in vivo studies investigating the role of this integrin in thrombosis have been 
limited.  He and colleagues were the first to generate a knockout mouse in which the 
expression of the α2β1 integrin was eliminated, and demonstrated that a delay in thrombus 
formation was observed following carotid artery injury in vivo (He et al., 2003).   
 
In addition to surface proteins, this chapter will also investigate the role of intracellular PLC 2 
following intestinal IR injury.  PLC 2-dependent signalling plays an essential part in platelet 
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activation and could represent an attractive target for treatment of thrombotic diseases.  It 
lies downstream of adhesion receptors such as integrins α2β1 and αIIbβ3,
 GPIb-V-IX and GPVI, 
with impaired activation observed to vWF and collagen in PLC 2 deficient platelets.   
Currently, no in vivo studies have investigated the role of PLC 2 in a pathological injury such 
as intestinal IR injury.  However, an interesting in vitro study by Leoncini and colleagues 
showed platelets could be activated by oxygen free radicals and also homocysteine, an amino 
acid found in blood, with PLC 2 phosphorylation playing a key role in this process (Leoncini et 
al., 2007). Since free radicals and homocysteine increase following intestinal IR injury, PLC 2 
may play a critical role in activating platelets in this situation (Gradman et al., 2001).  A study 
by Nonne et al showed that PLC 2 played a key role in thrombus formation in mild laser-
induced lesions within mesenteric vessels, but interestingly, this specific phospholipase 
played no significant role as the severity of injury increased (Nonne et al., 2005).  
 
6.1.2. Hypothesis. 
The roles of these four platelet surface and intracellular proteins have not previously been 
investigated in intestinal disease or even in many other models of ischemic disorders.  Since 
GPVI and α2β1 have been associated with platelet recruitment to collagen, their role was 
investigated within the jejunum where collagen exposure and thrombus formation was 
observed.  The roles of αIIbβ3 and PLC 2 were investigated within the jejunal and ileal 
mucosa. For the work included in this chapter we hypothesized: 
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1. Microthrombus formation and individual platelet recruitment in the jejunum would 
be decreased in FcR -chain-/- (non-functioning GPVI) and αIIbβ3
-/- mice and in mice 
administered an anti-α2β1 antibody. 
2. Individual platelet recruitment in the jejunum would be decreased when using PLC 2-
/- donor platelets.  
3. Individual platelet recruitment in the ileum would be decreased when using αIIb
-/- or 
PLC 2-/- donor platelets. 
 
 
6.2 Methods 
Initially, FACS analysis was performed to allow us to demonstrate that the function blocking 
antibody (SAM.G4 – Emfret) concentration was sufficient to cause blockade of over 90% of 
the 2 subunit (CD49d/GPIa) of the 2 1 integrin. Donor and endogenous platelets were 
blocked separately to increase confidence of inhibition. Receptor inhibition was not required 
for αIIbβ3
 investigations as αIIb
 deficient mice were used. To determine the role of GPVI, FcR -
chain-/- mice were used.  The FcR -chain is the critical signaling element of the GPVI-FcR -
chain complex and is also essential for GPVI expression on the platelet surface.  Therefore 
lack of it essentially creates a non-functioning GPVI mouse.  To investigate the role of PLC 2, 
donor platelets were derived from PLC 2-/- mice and administered into a wild-type mouse, 
which allowed individual platelets to be quantitated. Unfortunately, we did not have 
sufficient knockout mice to monitor the role of PLC 2 in the development of microthrombi, 
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so all endogenous platelets in mice undergoing IR injury were still PLC 2+/+ (i.e. wild-type 
mice platelets).  Since previous studies (Nonne et al., 2005) had demonstrated that a role for 
PLC 2 was dependent upon the severity of injury, we investigated its role in the ileum and 
the jejunum where varying degrees of injury severity were observed.  There was no 
difference in circulating platelet counts in the knockouts that were used when compared to 
controls (data not presented).  Some experiments were conducted on thrombocytopenic 
mice which were obtained by injecting 2ug/g body of IgG platelet depletion antibody (Emfret, 
R300) through the carotid artery cannula.  After one hour, full blood counts were performed 
on 120ul of blood and IR injury was induced thereafter.  Fluorescent IVM was performed on 
male 20-25g wild-type C57Bl/6, knockout or thrombocytopenic mice.  All intestinal IR 
intravital investigations within this chapter used periods of 45 minutes ischaemia followed by 
4 hours of reperfusion.  The carotid artery and trachea were cannulated and the animal was 
subjected to either sham or IR treatment.  During reperfusion, the ileum and jejunum was 
monitored intravitally.  Free flowing platelets, individual adherent platelets and 
microthrombi were quantitated.   
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6.3.  Results 
 
6.3.1 Anti- 2 antibody does not affect systemic platelet numbers 
Optimum antibody concentrations for complete receptor blockade were determined after 
injection of C57Bl/6 mice with varying amounts of SAM.G4.  The antibody was allowed to 
circulate in the vasculature for 30 mins, after administration through the cannulated carotid 
artery. 50μl of blood were then incubated with 5ul of FITC conjugated SAM.G4 (1:10 dilution) 
and flow cytometry was used to detect the minimal amount of the necessary to achieve 
saturating α2 binding in vivo.  Our receptor binding studies demonstrated that a 
concentration of 100ug / 200µl was more than sufficient to achieve receptor occupancy of 
approximately 95%.  Also, platelet counts in SAM.G4 antibody-treated mice were not 
statistically different from the rat IgG control (Table 6.1).  However, using the anti-GPIb 
antibody caused a significant depletion in platelet number and thus generated the 
thrombocytopenic mice (Table 6.1).   
 Wt (no ab) Rat IgG β  IgG IgG 
(Depletion) 
 
Receptor 
Occupancy % 
 
 
0 
 
0 
 
>95 
 
n/a 
 
 
Platelet Count 
(x10
9
)/L 
1254 ± 123 1318 ± 45 1039  ± 140 2.9* ± 3.1 
     
 
Table 6.1.  The anti- 2 antibody achieves receptor occupancy of approximately 95% and 
does not affect circulating platelet number.  The anti-GPIb antibody depletes circulating 
platelet numbers and thus generated the thrombocytopenic mice.  Values are mean  SD 
with *p<0.05 when compared using an unpaired Student t test.
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6.3.2. Microthrombus formation and individual platelet adhesion was not significantly 
decreased in the jejunum of IR injured FcR -chain-/- and anti-α2β1 antibody pre-treated 
mice.   
The formation of microthrombi or the adhesion of individual platelets in FcR -chain-/- 
animals or in wild-type animals receiving the anti-α2β1 mAb was not significantly reduced 
when compared to un-treated animals undergoing intestinal IR injury (Figure 6.1a and 6.1b).  
Furthermore, free flowing platelet numbers did not increase either indicating that blood flow 
was not apparent in the jejunal microcirculation of these mice (Figure 6.1c).   
 
6.3.3. Microthrombus formation and individual platelet adhesion was significantly 
decreased in the jejunum of IR injured αIib
-/- mice.   
A significant decrease in microthrombus formation (p<0.001) and individual platelet adhesion 
(p<0.01) was observed within the jejunal mucosa of IR injured αIIb
-/- mice when compared to 
un-treated sham animals undergoing intestinal IR injury (Figures 6.2a-b). The antibody used 
to label endogenous platelets was usually a CD41 (GPIIb) derivative. To observe the effect of 
this integrins inhibition this was obviously an unsuitable option. Platelets were instead 
labelled with the Alexa dye and a CD42b (GPIb) which showed no difference in intensity 
measuresurements. Furthermore, free flowing platelets were present within the observed 
field of view, indicating blood flow was also maintained within the jejunum of these mice.  
However, an increased bleeding from the mucosal surface (see later) was also observed in 
these mice and this made it technically difficult to analyse this event quantitatively. 
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a                                          b 
 
 
c 
Figure 6.1. Microthrombus formation and individual platelet adhesion was not significantly 
reduced in the jejunum of IR injured FcR -chain-/- or anti-α2β1 mAb pre-treated mice. 
Recruitment of endogenous (20 μl GPIIb ab + 40 μl Alexa 594)  and donor (1 x 108 platelets, 
10μM CFSE) platelets to the microcirculation of the jejunal mucosal villi in wild-type, α2β1 
blocked and FcR -chain-/- mice was examined using intravital microscopy.  Wild-type, FcR -
chain-/- or anti-α2β1 mAb pre-treated donor platelets were introduced prior to IR injury. (a) 
Microthrombus formation and (b) individual adherent platelets were not significantly 
reduced in any of the above knockout or antibody treated mice. (c)  Numbers of free flowing 
platelets did not increase indicating there was no improvement on flow either.   All data are 
representative of mean + SEM of at least 5 separate experiments. ***p<0.001 when 
compared using a one way ANOVA followed by Bonferroni Post Test for points of 
significance. 
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a                                      b 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.2. Microthrombus formation and individual platelet adhesion was significantly 
decreased in the jejunum of IR injured αIIb
-/- mice. Recruitment of endogenous (20 μl GPIIb 
ab + 40 μl Alexa 594)  and donor (1 x 108 platelets, 10μM CFSE) platelets to the 
microcirculation of the jejunal mucosal villi in wild-type or αIIb
-/- mice was examined using 
intravital microscopy. Wild-type or αIIb
-/- donor platelets were introduced prior to IR injury. 
(a) Microthrombus formation and (b) numbers of individual adherent platelets was 
significantly reduced in the αIIb
-/- mice. All data are representative of mean + SEM of at least 5 
separate experiments. **p<0.01, ***p<0.001 when compared using a one way ANOVA 
followed by Bonferroni Post Test for points of significance. 
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6.3.4. Individual platelet adhesion was also significantly decreased in ileum of IR injured 
αIIb
-/- mice.   
Since the severity of injury varied between the jejunum and ileum, the effects of the absence 
of αIIbβ3
 on individual platelet adhesion within the ileum was also determined.  Individual 
platelet adhesion was significantly (p<0.05) decreased in ileal villi in αIIb
-/- mice when 
compared to wild-type animals undergoing intestinal IR injury (Figure 6.3a). Furthermore, 
freely flowing platelets could also be observed at 30 minutes post-reperfusion, indicating 
that blood flow was still apparent, although this was not significantly increased (Figure 6.3b).  
 
6.3.5. No histological improvement in FcR -chain-/-, anti-α2β1 antibody pre-treated or αIIb
-/- 
mice after IR injury. 
No improvement in histological appearance was observed in the FcR -chain-/- or anti-α2β1 
antibody pre-treated mice after IR injury when compared to wild-type mice undergoing IR 
injury. Despite a reduction in microthrombus formation and individual platelet adhesion in 
the αIIb
-/- mice, interestingly, no histological improvement was observed in these mice (Figure 
6.4). In fact, it did seem as if the injury was worse in these mice after IR injury with villous 
structures often missing from the jejunal mucosa.  Furthermore, increased bleeding from the 
mucosal surface was also quite visible which led to mice undergoing distress as bleed loss 
increased (Figure 6.4). IR injured thrombocytopenic mice also demonstrated similar 
histological and macroscopic disturbances as those observed in the αIIb
-/- mice.   
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Figure 6.3. Individual platelet adhesion was also significantly decreased in the ileum of IR 
injured αIIb
-/- mice.  Recruitment of donor (1 x 108 platelets, 10μM CFSE) platelets to the 
microcirculation of the ileal mucosal villi in wild-type or αIIb
-/- mice was examined using 
intravital microscopy. Wild-type or αIIb
-/- donor platelets were introduced prior to IR injury.  
(a) Numbers of individual adherent platelets was significantly reduced in the αIIb
-/- mice.  (b)  
There was still sufficiently high enough numbers of freely flowing platelets observed in this 
region suggesting blood flow was still maintained.  All data are representative of mean + SEM 
of at least 5 separate experiments.  *p<0.05, **p<0.01, ***p<0.001 when compared using a 
one way ANOVA followed by Bonferroni Post Test for points of significance. 
 Sham mice 
 IR injury in WT mice 
 IR injury in αIIb
-/- mice 
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Figure 6.4. No histological improvement in FcR -chain-/-, anti-α2β1 antibody pre-treated or 
αIIb
-/- mice was observed after intestinal IR injury (magnification x200).  (a/d/g) Wild-type 
shams showed healthy jejunal mucosa both histologically, grossly and when viewed 
intravitally. (b/e/h) IR injured mice and (c/f/i) αIIb
-/- (and also thrombocytopenic) mice 
demonstrated severe mucosal sloughing and inflamed crypt areas at 4 hours post-
reperfusion histologically. Indeed, within the αIIb
-/- mice, villous structures were often missing 
from the mucosa of the jejunum.  Excessive bleeding was also witnessed from the mucosal 
surface in αIIb
-/- (and thrombocytopenic) mice. 
a b c 
d e f 
g h i 
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6.3.6. Individual PLC 2-/- donor platelet adhesion was significantly decreased in the ileum 
of IR injured wild-type mice.  No difference was observed in the jejunum. 
In these experiments, only the donor platelets were PLC 2-/-.  We did not have sufficient 
knockout mice for the recipient IR injured mice to also be PLC 2 deficient.  Therefore, the 
small intestine in these animals still manifested the detrimental microcirculatory effects 
associated with ischemia and subsequent reperfusion.  However, by using donor platelets 
derived from PLC 2-/- mice, we were able to demonstrate a significant (p<0.01) reduction in 
the adhesion of individual platelets in the ileum when compared to wild-type platelets being 
monitored in an IR injured wild-type mouse (Figure 6.5a). Since microthrombus development 
still occurred in the jejunum, it was no surprise that individual platelet adhesion of PLC 2-/- 
donor platelets was unaffected in this region (Figure 6.5b).  Evidently, free flowing platelets 
did not significantly increase either (Figure 6.5c). 
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Figure 6.5. Individual PLC 2-/- donor platelet adhesion was significantly decreased in the 
ileum of IR injured wild-type mice.  No difference was observed in the jejunum. 
Recruitment of PLC 2-/- donor (1 x 108 platelets, 10μM CFSE) platelets to the microcirculation 
of the ileal and jejunal mucosal villi in wild-type mice was examined using intravital 
microscopy.  Wild-type or PLC 2-/- donor platelets were introduced prior to IR injury.  (a) 
Numbers of individual adherent platelets was significantly reduced in the ileum but not in the 
(b) jejunum.  (c) Free flowing platelets were observed in the ileum but were not significantly 
increased above IR injured mice.  All data is are representative of mean + SEM of at least 5 
separate experiments.  **p<0.01, ***p<0.001 when compared using a one way ANOVA 
followed by Bonferroni Post Test for points of significance.  
 Sham mice 
 IR injury in WT mice 
 IR injury in PLC 2-/- mice 
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6.4 Discussion 
In this chapter, the most effective strategy at preventing both microthrombus formation and 
the adhesion of individual platelets was demonstrated by using mice deficient in the platelet 
αIIb sub-unit.  In these knockout mice, a significant reduction in microthrombi was observed in 
the jejunum and individual platelet adhesion was reduced in both the jejunum and the ileum.  
Furthermore, blood flow was apparent within the jejunum and ileum of these mice.  The use 
of the IIb deficient mice was far more effective than the anti-GPIb antibody used in P-
selectin-/- mice as described in Chapter 5.  However, despite these striking anti-platelet 
effects, induction of intestinal IR injury in IIb deficient mice was associated with significant 
bleeding from the injured gut mucosa, as well as no improvement in tissue morphology as 
observed histologically. We did not pursue further experiments to quantitate 
macromolecular leakage or leukocyte adhesion in these mice as the sustained bleeding from 
the mucosal surface made it impossible to obtain sufficiently clear intravital images. 
Furthermore, this mucosal bleeding was associated with increased distress to the animal as 
blood loss increased, which also limited further experimentation.  Interestingly, despite 
observing collagen exposure electron microscopically, as described in Chapter 3, no anti-
platelet or beneficial effect was observed in FcR -chain-/- mice (lacking GPVI) or in mice pre-
treated with an anti- 2 1 antibody.   
 
The results from this chapter and Chapter 5 are somewhat conflicting.  We demonstrated 
that by using an anti-GPI  strategy we could reduce the platelet recruitment at sites of of 
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microvessel injury and that this was beneficial.  However, using a far more effective anti-
platelet strategy, through inhibiting IIb, caused increased bleeding.  The importance of 
having some platelet recruitment was also demonstrated by the increased bleeding and poor 
histological improvement observed following IR injury in the thrombocytopenic mice 
(achieved by administration of an anti-mouse depleting GPIb  antibody).  This phenomenon 
of increased bleeding in response to a lack IIbβ3 or platelets has not previously been 
demonstrated in the gut following intestinal IR injury, most likely because previous studies 
have not focussed on the events taking place in the mucosal surface.   However, Kleinschnitz 
and colleagues also witnessed similar bleeding events in their in vivo model of experimental 
stroke whereby cerebral haemorrhage was a frequent observation of αIIbβ3 inhibition 
(Kleinschnitz et al., 2007). They also demonstrated that blockade of GPIb could decrease 
infarct size to a greater extent than GPVI – these results again mirror those presented in the 
current study.   
 
These collective observations suggest that some platelets are required in ischemic sites to 
prevent bleeding (i.e. to cause haemostasis), but the complete blockage of blood flow that 
occurs as a result of platelet-platelet interactions during reperfusion is not required.  Indeed, 
IIbβ3 antagonists were developed on exactly this basis with the hypothesis that their lack of 
effect on other platelet adhesion receptors would theoretically allow a single layer of 
platelets to contribute to haemostasis, whereas the anti- IIbβ3 effect would greatly diminish 
platelet thrombus formation (Coller et al, 2008). 
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To further demonstrate that some level of platelet recruitment is necessary in IR injured gut, 
further studies were conducted in thrombocytopenic mice.  Again, a severe bleeding 
phenomenon was observed highlighting the importance of some platelet recruitment being 
necessary.  Recent research from the Wagner group in Boston investigated the effects of 
thrombocytopenia in models of dermatitis (irritant contact and immune complex–mediated), 
lung inflammation (intranasal endotoxin) and following stroke (Goerge et al., 2008).  In all 
injury models, massive bleeding into the skin, lungs and brain tissue was visible but only in 
the thrombocytopenic mice.  In platelet-depleted mice undergoing skin injury, the first 
microscopic appearance of bleeding or petechiae was visible at 20 minutes post-injury with 
bleeding increasing by 2 hours and still present after 6 hours. This mirrors the observations 
within the current study in the gut where animals began to demonstrate serious distress in 
response to the sustained bleeding. Collectively, these experiments indicate that platelets 
secure the integrity of the injured microcirculation during inflammatory challenge.  However, 
interestingly, this group further demonstrated that the actual adhesion and of the platelets 
themselves was not required to prevent the hemorrhage following injury.  They speculated 
that platelet storage granules were important in the prevention of inflammatory 
haemorrhage through release of an array of vasoactive molecules that could regulate 
vascular junctions, permeability and endothelial migration such as serotonin, sphingosine-1P 
and angiopoietin-1.  Hence, platelets could be required to deliver such agents to the site of 
inflammation and, in this way, secure vascular integrity rather than through haemostasis 
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dependent mechanisms.   
We anticipated IIbβ3 to play a critical role in platelet-platelet interactions and therefore 
thrombosis and this was indeed the case.  However, we also demonstrated that IIbβ3 played 
an important role in mediating platelet-endothelial interactions, as single platelet adhesion 
was reduced in the jejunum and, also for the first time, in the ileum.  A number of previous 
studies have demonstrated a critical role for  
IIbβ3 in supporting platelet adhesion to 
activated endothelium.  Li and colleagues 
demonstrated that thrombin, found in high 
concentrations at sites of injury, was able to 
significantly enhance platelet adhesion to 
endothelial cells in vitro (Li et al., 1996).  Bombeli 
et al further provided a more detailed model (see diagram) to explain the pathways by which 
platelet IIbβ3 could lead to the interaction of platelets with activated endothelial cells via 
fibrinogen, vWF, and fibronectin (Bombeli et al., 1998).  These proteins are either present in 
plasma or secreted by the platelets themselves.  Furthermore they demonstrated that the 
endothelial counter-receptors responsible were αvβ3 integrin, (binding fibronectin, fibrinogen 
or vWF), ICAM-1 (binding fibrinogen) or endothelial GPIb  (binding vWF). These same 
endothelial counter-receptors are known to be increased following IR injury and so it is likely 
that these mechanisms may also explain the adhesion of platelets to endothelial cells in the 
current study.   
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Interestingly, we did not observe any beneficial role for GPVI in the current study.  This is 
despite the fact that collagen exposure within the mucosal microcirculation was 
demonstrated in Chapter 3.  The mechanism of collagen-platelet interactions is complex. It 
involves direct or indirect binding of collagen to several platelet receptors including the GPIb-
IX-V, 2 1, GPIV and GPVI which leads to both adhesion and activation steps. Initially platelet 
adhesion at high shear occurs via GPIb-IX-V binding to collagen-bound vWF.  Platelets 
become fully arrested by direct interaction between collagen and 2 1 with strengthening of 
platelet attachment occurring after platelet activation predominantly via GPVI.  Therefore, 
the platelet collagen receptor GPVI has been considered an attractive therapeutic target to 
treat cardiovascular diseases.  However, Mangin and colleagues were amongst the first to 
demonstrate that loss of GPVI did not produce the anticipated dramatic effect when 
thrombosis was induced in vivo within arterioles in mice (Mangin et al., 2006). They 
demonstrated a functional overlap between thrombin and GPVI in which reduction in the 
platelet activating properties of one mechanism can be partially compensated by the other. 
Their study suggested a greater functional redundancy for GPVI in thrombogenesis than 
previously recognized and speculated that the full anti-thrombotic potential of GPVI 
inhibitors in vivo would require concurrent administration of anti-coagulant agents.  
Furthermore, mice deficient in the GPVI only show a minor increase in bleeding times 
(Nieswandt et al., 2001), which again suggests that other matrix proteins play a role in 
promoting thrombus formation and can thereby compensate for the absence of GPVI. 
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The integrin α2β1 is a major collagen receptor predominantly activated after GPVI-collagen 
interactions to a high-affinity state via "inside-out" signals, enabling the platelet to establish 
firm adhesion that resists shear forces in the bloodstream.  Since no role for GPVI was 
observed following intestinal IR injury, initially the role of α2β1 was not going to be 
investigated.  However, studies have demonstrated that it can also be activated by G 
protein–coupled receptor agonists independently of GPVI. Indeed, the intracellular signaling 
cascade used by α2β1 shares many of the features of the GPVI signaling cascade, including 
participation of Src kinases and PLCγ2 (Inoue et al., 2003) Grüner and colleagues also used 
intravital fluorescence microscopy to examine the dynamic process of platelet accumulation 
at sites of vascular injury in the carotid artery of 2- and 1-deficient
 mice (Grüner et al., 
2003).They also found that platelet adhesion and thrombus growth on the exposed 
extracellular matrix of the arterial wall were unaffected in the absence of 2 1 or indeed all 
1 integrins
 on platelets.  They concluded that multiple integrin-ligand interactions could 
synergize shear-resistant platelet adhesion at sites of arterial injury in vivo and that there 
was a high degree of functional redundancy amongst them.  Interestingly, they did state that 
this integrin could have a significant function in more pathophysiologic processes or disease 
models.  However, in the current model of intestinal IR injury, no role for α2β1 was 
demonstrated, but its role in other experimental models of disease is still currently lacking.   
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PLC 2 also appears to be a particularly good target following IR injury in that it lies 
downstream of the integrins α2β1 and αIIbβ3 and GPVI. Furthermore, Nonne and colleagues 
demonstrated a severe impairment of thrombus formation in PLC 2-/- mice in vivo after a 
superficial and mild laser-induced lesion in mesenteric arteries but no role following a severe, 
occlusive injury (Nonne et al., 2005). Unfortunately, due to a shortage of PLC 2 deficient 
mice, we were unable to determine whether it also had an important role in mediating 
jejunal thrombosis following intestinal IR injury.  Interestingly, PLC 2-/- mice are often 
accompanied by spontaneous gastrointestinal and intraperitoneal bleeding, which may have 
made it difficult to monitor the gut intravitally.  However, the finding that lack of intracellular 
PLC 2 could affect individual platelet interactions with endothelium was both novel and 
exciting. The surface expression of platelet receptors such as GPVI, GPIb , α2β1 and in 
particular αIIbβ3 is not altered on the donor PLC 2
-/- platelets and so decreased endothelial 
interactions cannot be explained by this (Mangin et al., 2003).  A role for PLC 2 in mediating 
platelet-endothelial interactions has not previously been investigated and is certainly worthy 
of further investigation both in vivo and in vitro. 
 
In summary, we have demonstrated that while platelets may plug the flow of blood in the 
mucosal villous microcirculation and also promote recruitment of inflammatory cells, they 
are also essential in preventing the deleterious consequences of inflammation on the 
vasculature that lead to haemorrhage and subsequent tissue damage.  Although IIb 3 had 
the most strongest anti-platelet effect in this model of intestinal IR injury, it was not tissue 
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protective.  However, a role for anti-thrombotic agents targeting this integrin should not be 
ruled out completely for intestinal IR injury, as it could be possible to identify a lower dose of 
an antagonist which may be beneficial.   
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7.0.  General Discussion 
 
7.1. Summary of the main findings  
Among the internal organs, the small intestine is probably the most sensitive to IR 
injury (Granger et al., 1986; Yamamoto et al., 2001).  Unfortunately, intestinal IR is a 
potentially life-threatening condition, quite often leading to a systemic inflammatory 
response and the potential development of the multiple organ dysfunction 
syndrome.  It can develop in both surgical and trauma patients when there is 
interruption of blood flow to the gut.  Surgically, abdominal aortic aneurysm repair, 
cardiopulmonary bypass, strangulated hernias, neonatal necrotizing enterocolitis 
and intestinal transplantation are associated with IR injury but it also occurs in septic 
and hypovolemic shock (Mallick et al., 2004).  Despite several promising 
interventions both pharmacological and physical in nature, including anti-oxidant 
therapy, hypothermia and pre-conditioning, there are currently no clearly 
established methods available to prevent intestinal IR injury (Kalia et al., 2002; 
Mallick et al., 2004).  Increasing our understanding of the complex process of 
ischaemia and reperfusion will allow us to find novel targets to develop new 
strategies to combat this serious injury.   
 
Although recent studies have begun to implicate platelets in IR injury, their 
pathophysiological role in IR injury of the gut is not fully understood, particularly 
their role in contributing to mucosal injury.  Platelet adhesion and aggregation at 
sites of vascular injury is essential for the cessation of bleeding.  However, excessive 
accumulation of platelets at sites of injuries can lead to severe pathologies.  Indeed, 
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after atherosclerotic plaque rupture, arterial thrombotic occlusion can lead to acute 
myocardial infarction and stroke (McCullagh et al., 1980).  Collagen is among the 
most powerful activators of platelets and plays a major role in promoting platelet 
thrombus formation in vivo.  Recently, there has been increased focus on collagen 
receptors as potential anti-thrombotic targets.  This is due not only to the fact that 
collagen plays an important role in atherothrombosis, but also because inhibitors 
targeting platelet collagen receptors can produce an anti-thrombotic effect in vivo 
(Nieswandt  et al., 2001; Massberg et al., 2003; Massberg et al., 2004).  Furthermore, 
platelet collagen receptor deficiency only leads to a relatively mild bleeding tendency 
(Arai et al., 1996).  Therefore, the role of direct and indirect platelet collagen 
receptors in mediating platelet recruitment following intestinal IR injury was 
investigated. 
 
This thesis initially presented data that platelet recruitment does indeed occur 
following intestinal IR injury, but this is confined specifically to the villous 
microcirculation with very little recruitment in the larger vessels of the serosal wall 
or the mesentery.  This recruitment varied not only in its nature but also in its 
location.  Individual platelets were primarily observed within the lesser injured ileum 
and microthrombus formation observed within the severely injured jejunum.  It was 
only possible to identify these two different types of platelet events within the small 
intestine by using a novel dual platelet-labelling methodology.  Simultaneous, real-
time capture of different populations of platelets labeled with dyes of distinct 
excitation wavelengths was only possible using a rapid wavelength filter switcher 
attached to the intravital set-up.   Previous studies have only demonstrated platelet-
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endothelial interactions following IR injury.  Therefore, an important aspect of the 
current research has been the development of a novel methodology that allows 
individual adherent and free flowing platelet events to be quantitated as well as 
thrombus formation.  Using this methodology, we were able to highlight that the 
traditional method for monitoring platelet trafficking in vivo, using only donor 
injected platelets, quite significantly underestimates the involvement of platelets in 
this injury model.   
 
The subsequent studies, presented in Chapter 4-6, demonstrated that the formation 
of microthrombi was predominantly dependent upon platelet GPIb  and IIb 3.  
Inhibiting thrombus formation was associated with a significant improvement in 
tissue and microcirculatory integrity.  However, inhibition of the IIb 3 integrin was 
associated with increased bleeding from the mucosal surface, despite it’s anti-
thrombotic effects, which may limit its therapeutic use clinically.   Lack of IIb 3 was 
also associated with a reduction in the adhesion of individual platelets within the 
jejunum and ileum.  However, an interesting finding from this study was that the 
intracellular enzyme, PLC 2, also appeared to have a role in contributing to platelet-
endothelial interactions, a mechanism of platelet adhesion which so far has been 
sparsely investigated.  Finally, this thesis demonstrated that targeting only the 
platelets following intestinal IR injury did not confer a sustained benefit to the 
jejunum despite restoration of blood flow to this region.  Although platelets seemed 
to be the ‘first on the scene’ and the primary instigators of tissue damage, inhibiting 
their adhesion did not prevent subsequent leukocyte recruitment which contributed 
to a secondary injury to the gut.   Indeed, enhanced leukocyte recruitment was 
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observed in animals receiving the anti-GPIb  antibody and some explanation as to 
why this may have happened will be provided later on (refer to Section 7.4 and 
Figure 7.1).   A longer lasting protection was only observed in animals in which both 
platelet and leukocyte recruitment was inhibited by blocking GPIb  in P-selectin 
deficient mice.  Future studies on recovery animals are required in order to 
determine how lasting the benefit of targeting these two cells types is following 
acute intestinal IR injury and whether this therapeutic strategy has any potential for 
use in animals undergoing more chronic intestinal pathologies.   
 
7.2.  The nature of platelet recruitment is dependent upon the regional severity 
of intestinal IR injury 
The mucosal surface is most susceptible to ischaemic injury.  There is substantial 
evidence that the mucosa of the intestine becomes the site for the production of 
various acute-phase proteins (Molmenti et al., 1993; Wang et al., 1998), gut 
hormones (Zamir et al., 1992) and cytokines (Mester et al., 1993; Meyer et al., 1995) 
following injury.  Indeed, the enterocyte itself, or the epithelial cells of the villi, 
produce increased amounts of cytokines during IR injury.  These not only influence 
the intestine but also affect the function and integrity of distant organs.  Maintaining 
the integrity of this mucosal surface is essential in order to prevent bacterial 
translocation into the bloodstream.  Indeed, up to 55% of small bowel transplant 
recipients die from sepsis-related complications due to a breakdown in the mucosal 
integrity of the graft lining (Browne et al., 1992).  However, it is surprising that all 
studies to date investigating vascular disturbances and the role of circulating cells in 
contributing to IR injury have focussed on the larger outer wall or mesenteric vessels 
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of the gut (Massberg et al., 1998; Copper et al., 2003).  The current study is the first 
to demonstrate the substantial recruitment of platelets within the mucosal villous 
microcirculation.   
 
Thrombosis, blood flow occlusion and subsequent injury was confined to the jejunal 
mucosa during the 4 hour duration of the experiment.  From a transplantation point 
of view, this is interesting data as it suggests that this region may not be best suited 
for use as a graft and the ileum may be more appropriate.  However, it is important 
to identify strategies that can improve the outcome of the of jejunum as it is damage 
to this area that seems to most affect morbidity and mortality following intestinal IR 
injury in non-transplant related scenarios.  Furthermore, longer durations of 
ischaemia and / or longer periods of reperfusion affect the ileum, with the injury 
dependent upon similar platelet events to those observed in the jejunum. Hence 
strategies that are beneficial in the jejunum may also have benefit in a more severely 
compromised ileum. 
 
7.3.  Platelets lead to tissue damage in the jejunum following their aggregation 
on exposed subendothelial matrix  
Platelets can be recruited to sites of vascular injury either by activated endothelium 
or following exposure of ECM collagen, with the latter event taking place as the 
severity of vessel damage increases.  However, previous studies have demonstrated 
intestinal IR injury is associated with platelet adhesion to activated endothelium 
only, primarily via P-selection / PSGL-1 interactions (Massberg et al., 1998; Copper et 
al., 2003).  There are two reasons why these previous studies have never 
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demonstrated thrombosis formation dependent upon platelet-subendothelial 
interactions.  Firstly, the injury sustained by the larger vessels following intestinal IR 
injury is not as great as that observed in the the villous microcirculation and this 
latter region has not been the focus of previous studies in vivo.  Secondly, the 
recruitment of endogenous platelets has not been easy to investigate.   
 
We clearly demonstrated that ECM collagen, underlying the villous microvessels 
becomes exposed only in the jejunum following IR injury.  This supports the 
suggestion that the formation of microthrombi are probably not due to aggregates 
forming on activated endothelial cells and that platelet GPIb  most likely interacts 
with vWF immobilised on collagen.  These microthrombi contribute to the occlusion 
of the vasculature within the jejunum which leads to no-reflow and resultant tissue 
damage.  However, recent evidence has supported the possibility that the vWF 
ligand GPIbα not only plays a critical role in the initial rolling to injured vessels but 
also mediates the platelet-platelet interactions required for thrombus (Bergmeier et 
al., 2006).  It is therefore possible that the key role of GPIbα within our IR model is 
either to mediate the initial rolling of platelets to exposed collagen or lead to 
secondary activation and subsequent aggregation of platelets, or both.  Regardless, 
inhibiting GPIb  has beneficial effects in this model.  It is possible the shear rates 
associated with the villous microvasculature may pre-empt the requirement for 
platelet rolling i.e. this event may not be as critical for platelet capture as it is in the 
faster flowing, larger vasculatures.  Hence the predominant role of this receptor at 
this injury site may be in promoting thrombus growth.  It is also possible that the 
indirect collagen receptor, GPIb  is mediating platelet-endothelial interactions 
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rather than platelet-collagen or platelet-platelet interactions (Andre et al., 2000; 
Theilmeier et al., 2002).  However, if this was the case, we would have anticipated all 
platelet events to have been inhibited and not just thrombus formation in the anti-
GPIb  antibody pre-treated mice.  Interestingly, individual platelet adhesion 
demonstrated a trend to increase and not decrease following inhibition of GPIb . 
 
The importance of platelet collagen receptors in mediating platelet recruitment in 
clinically relevant models of ischaemic and non-ischaemic injury is gaining interest.  
(Meyer et al,) recently presented data that binding of vWF to both collagen and GPIb 
were mandatory steps in stroke development.  Furthermore they demonstrated that 
vWF- IIb 3 interactions were not critical which could explain the ineffectiveness of 
IIb 3 blockade in experimental and clinical models of stroke (De Meyer et al., 2010).  
They further suggested that inhibition of vWF-mediated platelet adhesion could 
provide a novel therapeutic option in stroke management.   It is encouraging that 
several anti-thrombotic compounds blocking vWF-collagen or vWF-GPIb  
interactions are currently being developed (De Mayer et al., 2009; Vanhoorelbeeke 
et al., 2007), which may prove to have beneficial effects in the treatment of intestinal 
IR injury.   
 
7.4.  Inhibiting GPIb  alone does not afford long lasting tissue protection -
platelet and leukocyte inhibition is critical 
Historically, IR in various organs has been attributed to the recruitment of 
inflammatory leukocytes to the activated endothelium, with neutrophils which 
accumulate when the tissue is reperfused demonstrated to be the primary instigator 
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of the injury (Welbourn et al., 1991; Carden and Granger, 2000).  Once adherent to 
endothelium, neutrophils mediate damage by secretion of additional reactive oxygen 
species as well as proteolytic enzymes, in particular elastase.   However, in the 
current study, only small numbers of leukocytes were observed adherent following 
IR injury in wild-type mice, both in the jejunum and ileum, with the most immediate 
event being thrombus formation.   
 
Leukocyte recruitment did increase after microthrombus development was inhibited 
using the anti-GPIb  antibody. It was hypothesised that recruitment of these 
inflammatory cells may be responsible for mediating the secondary injury, which 
interestingly only took place in the jejunum and not in the ileum.  One possible 
explanation for this increased leukocyte adhesion in GPIb  blocked mice may be the 
fact that by preventing microthrombus formation and enabling blood flow within the 
jejunal microvessels, leukocytes were able to to gain entry and become adherent to 
activated endothelium. This is supported by the observation that inhibiting 
microthrombus formation using an anti-GPIb antibody in P-selectin deficient mice, 
was able to inhibit thrombus formation and prevent the adhesion of leukocytes that 
gained entry in the jejunal microcirculation (Figure 7.1).  Only by decreasing 
adhesion of both cell types was vessel occlusion inhibited, blood flow maintained 
and tissue histology improved throughout the 4 hour duration of the experiment.  
Although inhibition of both platelet and leukocyte events seems to confer the 
longest lasting benefit to the gut, there are obvious limitations associated with 
developing therapies that target both the inflammatory and haemostatic cells.   
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Figure 7.1.  Proposed mechanisms by which platelets and leukocyte could confer injury 
within the jejunum following intestinal IR injury in wild-type mice, mice pre-treated with 
an anti-GPIb  antibody and in IIb 3
-/- mice.  (a) IR injury in wild-type mice was associated 
with endothelial denudation and subsequent microthrombus formation. This led to blood 
flow occlusion within the microvessels and subsequent tissue injury. Minimal leukocyte 
adhesion was observed due to the lack of blood flow limiting their entry to this site.  (b) Pre-
treating mice with an anti-GPIb mAb prevented microthrombus formation, and so blood flow 
was restored upon reperfusion.  However, this meant leukocytes could gain entry to the 
activated endothelium and either adhere to it directly or via adherent platelets.  This also 
lead to tissue injury. (c) Induction of IR injury in IIb 3 deficient mice was a very effective 
anti-platelet strategy but was associated with blood loss from the mucosal surface 
suggesting some platelet recruitment was essential.       
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7.5.  Some platelet recruitment is necessary to prevent mucosal bleeding 
following intestinal IR injury 
The data obtained from the use of IIb deficient mice and from conducting studies in 
thrombocytopenic mice was very interesting.  In the former, no microthrombus 
formation or individual platelet adhesion was observed either in the jejunum or the 
ileum, indicating that this was a very effective anti-platelet strategy.  However, 
progressive bleeding was observed throughout late stage ischaemia and reperfusion 
in both IIb deficient and thrombocytopenic mice.  These results lead us to the 
conclusion that some degree of platelet recruitment is required at sites of vessel 
injury to counteract bleeding related problems. (Figure 7.1).   The risk of excessive 
bleeding associated with an effective anti-platelet therapy needs to be balanced 
against the risk of thrombosis and vessel occlusion associated with insufficient anti-
platelet therapy.  This is true not only following intestinal IR injury, but for almost all 
diseases where platelets are pathological (Yan et al., 2006).   
 
Several anti-platelet therapies have been shown to be effective in reducing 
thrombosis and vessel occlusion in complications such as myocardial infarction and 
other vascular ischaemic injuries.  Blockade of αIIbβ3 by abciximab or integrillin 
(which inhibits the associated peptide) have been shown to have a positive effect on 
decreasing thrombotic incidents. However, the side effects of internal bleeding, 
haemorrhage and thrombocytopenia suggest that blockade of this integrin may not 
be the best strategy clinically (Suleiman et al, 2003; Kleinschnitz et al, 2007).  
Clopidogrel is an antagonist of the P2Y12 / ADP receptor which is essential for αIIbβ3 
activation.  It is administered mostly in patients with coronary artery disease as it is 
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proven to decrease the risk of cardiovascular death by 20%.  However, incidents of 
gastrointestinal haemorrhage and thrombocytopenia have also been reported with 
use of clopidigrel but the numbers are particularly low (Caruana, 2007). 
 
Interestingly, Nocito and colleagues similarly demonstrated that neither inhibition of 
platelet function nor platelet depletion led to a reduction of hepatic IR injury.  
However, liver regeneration and repair were significantly impaired in platelet-
depleted animals, suggesting platelets mediate tissue repair and liver regeneration. 
Furthermore, platelet-derived serotonin was identified as the mediator of 
hepatocyte proliferation in the post-ischaemic liver (Nocito et al., 2007).  The role of 
platelets in tissue repair and regeneration is an area of research that will most likely 
grow as increasing evidence suggests these cells are sources of valuable growth 
factors and could be instrumental in guiding stem cells to sites of injury  (de Boer et 
al., 2006; Andrae et al., 2008).   
 
7.6. Major collagen receptors do not have a role to play in intestinal IR injury 
Considerable progress has been made over the last few years in elucidating the roles 
of the two major collagen receptors, glycoprotein VI (GPVI) and integrin 2 1, in 
promoting platelet adhesion and thrombus growth (Nieswandt and Watson 2003).   
The evidence that GPVI is of central importance for collagen activation of platelets is 
strong and recent studies have suggested that 2 1 also plays a key role in promoting 
primary platelet adhesion on collagen.  However, in the current study no important 
role for either of these direct collagen receptors was identified.  This suggests that 
although an important role for these proteins has been identified in animal models 
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of thrombosis in vivo, it does not follow that they will also have a critical role in 
clinically relevant models of disease.  Localised injuries such as the laser injury or the 
FeCl3 injury, used extensively to monitor thrombosis in vivo, do not mimic the 
environment that surrounds tissues that have undergone IR injury or perturb the 
microcirculation in a similar manner (Dubois  et al., 2006).  Furthermore, in vivo 
models of thrombosis most often revolve around inducing injury to a large arteriole 
or venule such as mesenteric or cremasteric arterioles or the carotid artery.  
However, the shear stresses the platelets are subject to in these vessels are 
considerably different to those found within the villous microcirculation.  It is 
therefore unsurprising that the mechanisms of platelet recruitment and thrombus 
formation rely on different platelet receptors in models of thrombosis compared to 
IR injury.   
 
7.7. Future Directions 
Even though the body of literature on platelet recruitment to injured or diseased 
tissues is expanding, there are still questions which remain to be answered. 
Therefore the work detailed in this thesis could be expanded in a number of ways.  
 
It would be interesting to determine whether the tissue protection afforded to the 
gut by an anti-GPIb  and P-selectin strategy lasts longer than 4 hours.  We did not 
monitor the bowel beyond 4 hrs and so it is unclear whether other mechanisms 
come into play to recruit platelets or leukocytes beyond this time point.  Mortality 
can occur within 48 hrs of experimental intestinal IR injury in rats and mice due to 
respiratory distress or through loss of gut barrier function.  It is also not clear 
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whether internal bleeding complications could arise in these dual therapy treated 
mice after several days, so this would require further investigation.   
 
Similar studies could be conducted in different organ beds to determine the role of 
platelets, and specifically platelet collagen receptors, in mediating injury.  It would be 
interesting to determine whether a similar dual receptor blockade is beneficial.  It 
may be that GPIb  is effective in the villous microcirculation because of the shear 
stresses and blood flow kinetics specific to this microcirculatory bed.  The liver 
sinusoidal capillaries, for example, have much lower rates of blood flow and so the 
recruitment of platelets in this tissue may vary when compared to the gut.  Certainly 
no studies to date have compared the mechanisms involved in recruitment of 
platelets and microthrombus formation in different microcirculatory beds 
undergoing clinically relevant acute or chronic injuries.  Furthermore, the role of 
platelets in other disease models or organs may be limited to activating the 
inflammatory cascade and recruiting other nuclear cells such as neutrophils and 
lymphocytes rather than occlusion of blood flow through microthrombus formation.   
 
Due to the shortage of PLC 2 deficient mice, it was not possible to determine 
whether this enzyme had a role in microthrombus formation within the jejunum, but 
this is worthy of future experimentation.  Also, the interesting observation that 
platelet-endothelial interactions could be inhibited in PLC 2-/- mice needs to be 
developed further as this has never been previously described in vitro or in vivo. 
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It is well accepted that platelets can recruit inflammatory leukocytes following IR 
injury.  However, recent evidence demonstrates that surface-adherent platelets can 
also support circulating stem cell recruitment in vivo via P-selectin and IIb 
dependent mechanisms (de Boer et al., 2006; Massberg et al., 2006).  Stellos and 
colleagues presented data showing that platelet-derived SDF-1  recruited CD34+ 
progenitor cells in murine small intestinal microcirculation following IR injury (Stellos 
et al., 2008).  Preliminary data from the Kalia lab has also demonstrated platelet-
haematopoietic stem cells interactions intravitally following arteriolar laser-induced 
injury.  Therefore, platelets within injured vessels may be a means of guiding stem 
cells to appropriate sites and may accelerate healing through recruitment of bone 
marrow-derived stem/progenitor cells. It would be interesting to monitor whether 
the individual platelets that adhere despite GPIb  inhibition can recruit potentially 
therapeutic stem cells to sites of injury.  
 
7.8. Concluding Remarks 
The primary aim of this thesis was to clarify whether platelets played a 
pathophysiological role in intestinal IR injury and identify the mechanisms governing 
their recruitment.   A more detailed understanding of the mechanisms governing 
platelet recruitment to the mucosal villi was only achieved after development of a 
novel methodology that allowed individual and aggregated platelets to be identified.  
We demonstrated that there was more than one cellular contributor to intestinal IR 
injury which meant it was impossible to achieve sustained tissue protection by 
targeting only platelets.   In this IR injury model, GPIb  was effective, but it may be 
that a chronic injury or an injury in a different organ may rely on different platelet 
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receptors.  Therefore, despite the general excitement about the development of new 
anti-platelet drugs, a major lack of understanding of how platelets contribute to the 
pathophysiology of injuries in specific tissues may hinder their overall success.  A 
move towards investigating the mechanisms governing platelet recruitment in 
clinically relevant experimental models is therefore a must rather than, or in addition 
to, investigating their role in animal models of thrombosis.   
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